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SUMMARY
A benzimidazole resistant strain (HFRO strain) and a benzimidazole susceptible strain 
(Bearsden strain) of the sheep abomasal parasite Ostertagia circumcincta were obtained 
and passaged through parasite naive lambs. Using egg hatch assays to detect resistance day 
to day changes in the susceptibility of the eggs from adult 0.circumcincta of these strains 
to the effects of the benzimidazoles, thiabendazole and albendazole were noted. Treatment of 
the lambs which were parasitised with the HFRO strain with fenbendazole at the normal 
dose rate caused a temporary increase in the resistance level measured by egg hatch 
assays. However, 12 treatments with fenbendazole over a 14 generation period with the 
HFRO strain produced a negligible rise in benzimidazole resistance for this strain.
A dose titration trial to determine the effectiveness of fenbendazole against adult 
parasites of the HFRO strain of O.circumcincta confirmed that the parasites were highly 
resistant to the effects of the benzimidazole anthelmintics. Treatment with increasing 
doses of fenbendazole used in the dose titration trial failed to increase the level of 
resistance in the eggs produced by the adult parasites remaining after treatment.
The establishment of 'clones' of the HFRO strain of O.circumcincta^ implantation of 
pairs of adult parasites into the abomasa of lambs was investigated. The offspring of these 
parents showed a reduced level of resistance to the benzimidazoles measured by egg hatch 
assays but after treatment with fenbendazole selection for resistance occurred rapidly.
The DNA from the two strains of O.circumcincta was isolated and compared after 
sectioning with restriction endonucleases. The banding obtained after gel electrophoresis 
was similar for the two strains.
Studies were carried out on the motility of infective larvae of the HFRO and Bearsden 
strains of O.circumcincta in the presence of benzimidazole anthelmintics, their 
metabolites and physostigmine. Prolonged incubation in the presence of benzimidazoles
IV
was required to reduce motility. Differences in the motility in the presence of 
physostigmine between benzimidazole resistant and benzimidazole susceptible strains of 
parasites were found. The activity of the benzimidazole metabolites against larval stages 
and eggs of O.circumcincta was studied and discussed.
A possible mode of action of the benzimidazole group of anthelmintics is binding to 
nematode tubulin causing depletion of microtubular structures with disruption of cellular 
transport systems. Tubulin was extracted from the pig intestinal nematode Ascarissuum 
and the sheep nematodes 0. circumcincta and Haemonchus contortus The benzimidazoles 
albendazole and mebendazole were shown to inhibit the binding of colchicine to tubulin 
extracts from Asuum. Tritiated albendazole, fenbendazole and mebendazole were 
synthesised and were used to study the binding of these drugs to tubulin extracts from 
Asuum, O.circumcincta and H.contortus Binding of these benzimidazoles was variable and 
was influenced by the protein content of the tubulin extract. High concentrations of 
tritiated benzimidazoles bound to extracts synthesised using low numbers (< 100,000 ) of 
infective larvae of O.circumcincta and H. con tortus
The differential binding of tritiated benzimidazoles to tubulin extracts from nematodes 
as a test for resistance in these parasites to the effects of benzimidazole anthelmintics was 
investigated using tritiated fenbendazole, albendazole and mebendazole. Extracts from 
H.contortus larvae which were resistant to the benzimidazoles bound less mebendazole and 
albendazole than extracts from benzimidazole susceptible larvae. With tubulin extracts 
from different strains of QcircumcinctarzzuWs were more variable and depended on the 
ligand used in the assays.
Displacement of albendazole binding to tubulin extracts from H.contortus by 
albendazole and its metabolites , albendazole sulphoxide and albendazole sulphone, was 
found with albendazole proving to be the most potent inhibitor. However, in assays using 
O.circumcincta tubulin extracts albendazole, albendazole sulphoxide, albendazole
sulphone and colchicine failed to inhibit, consistently the binding of tritiated albendazole.
An ELISA to measure binding of anti-alpha and anti-beta tubulin antibodies to extracts 
from O.circumcincta larvae found reduced binding of both antibodies to extracts from 
firs t stage and third stage larvae of the benzimidazole resistant strain compared with 
similar extracts from the benzimidazole susceptible strain. Treatment of the larvae with 
benzimidazoles prior to the ELISA for tubulin did not alter the antibody binding to extracts 
from both the resistant and susceptible strains of O.circumcincta
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INTRODUCTION
ANTHELMINTICS
Anthelmintics are a group of agents used in the therapy of internal parasitic infections 
in animals. These drugs should k ill parasites effectively without toxicity to the host, have 
good activity against adult and larva) stages, persist in tissues for sufficient time to kill 
the parasites but have a short withdrawal period to avoid tissue residues and be 
inexpensive to use.
The anthelmintics can be subdivided into groups according to their activity against 
different groups of helminths e.g. nematocides, anticestodal and antitrematodal compounds. 
They can be classified on their spectrum of activity against parasites -  broad spectrum or 
narrow spectrum. Some of the narrow spectrum anthelmintics were among the firs t to be 
used as anthelmintics in veterinary therapy. These narrow spectrum anthelmintics have 
activity against specific groups of parasites and include brotianide, bunamidine, 
clorsulon, diamphenethide, diethylcarbamazine, piperazine , praziquantel and 
salicylamlides e.g.closantel, rafoxamde, mtroxynil, oxyclosamde and niclosamide. Many of 
these compounds remain in use for their activity against trematode and cestode parasites. 
In the agricultural industry in the UK the most important group of anthelmintics used in 
the control of nematode parasite infestations are the broad spectrum anthelmintics 
including the benzimidazoles, pro-benzimidazoles, avermectins, organophosphorous 
compounds, imidathiazoles e.g. levamisole and tetrahydropyrimidines e.g. morantel and 
pyrantel. A brief description of the main groups of anthelmintics which are of importance 
to the UK agricultural industry is given below.
Avermectins
This is a group of macrocyclic lactones produced by the soil microorganisms 
Streptomyces averm itilis which were discovered in 1973 and investigations were
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carried out as to their suitability as anthelmintics (Burg at a/.J  979). Of the natural 
compounds avermectin B j has the greatest anthelmintic activity and chemical modification
of this molecule by selective hydrogenation produces 22,23,dihydroavermectin B|
ivermectin, the compound which is marketed as an anthelmintic in most countries 
including the UK and USA. As an anthelmintic ivermectin is highly potent,being active 
against some cattle and sheep parasites at doses as low as 0.025 mg/kg and overall 
ivermectin is about 1000 times more potent than thiabendazole (Eqerton et a t 1981). 
Activity of ivermectin against different species of parasites can be variable with efficacy 
against intestinal dwelling parasites lower than that against abomasal parasites (Fisher, 
1985). The pharmacokinetics of ivermectin may explain these differences in part ( Bogan 
eta/., 1988) but there seems to be species variation in susceptibility to the effects of 
ivermectin. Ivermectin shows activity against ectoparasites COstlind at a/., 1979 ; James 
at at, 1980), but has no activity against cestode and trematode parasites.
The route of administration of ivermectin influences the pharmacokinetics of the drug 
with subcutaneous administration giving higher plasma levels and a longer retention time 
compared with orally administered drug. In cattle after subcutaneous administration 
efficacy against abomasal parasites persists for 14 days (Barth , 1983) and for 
lungworm activity may extend for 21 days (Armour at at, 1985), In sheep, however, 
when ivermectin is administered by the subcutaneous or oral routes the persistent effect 
is much less (McKenna ,1986; McKellar and Marriner, 1987) Slow release 
intraruminal devices are being developed to prolong the activity of the drug.
Ivermectin is believed to act by potentiating the release and binding of the 
neurotransmitter gamma-aminobutyric acid (GABA) allowing the accumulation of GABA at 
the nerve synapse and thus blocking transmission of nerve impulses (Fritz at at., 1979; 
Campbell, 1981). This effect causes paralysis of the parasite which can then be removed
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from its predilection site. Ivermectin also has a suppressive effect on reproductive 
processes ( McKellar eta/., 1988) and possibly other effects on parasite metabolism at 
the biochemical level. The neurotoxic effects of ivermectin do not occur in the mammalian 
parasite host because GABA receptors are confined to the central nervous system and the 
high molecular weight and polarity of ivermectin prevents the molecule from passing 
through the blood-brain barrier. In some breeds of dogs there can be defective transport 
mechanisms in the blood-brain barrier and ivermectin has been shown to cause 
neurotoxicity (Pulliam etal, 1985 )
Ivermectin Clvomec', Merk, Sharp and Dohme) has been available as a subcutaneous 
injection for cattle in the UK since 1981 and has achieved widespread use especially as an 
autumn treatment prior to housing and in a pasture parasite control system which 
involves administration at 3,8 and 13 weeks after turn out onto pasture in the spring 
(Armour etal, 1987), For sheep ivermectin COramec' , Merk .Sharp and Dohme) has 
been available in the UK since 1983 but the oral preparation has poorer efficacy against 
ectoparasites and persistence is reduced and therefore the drug has not achieved 
widespread use as in the cattle industry. Avermectin has been introduced to the Australian 
market for sheep where its main indication will be on farms where parasites are resistant 
to the other broad spectrum anthelmintics, the benzimidazoles and levamisole/morantel. 
An oral paste formulation of ivermectin CEqvalan’ , Merk, Sharp and Dohme) is marketed 
for horses and is used frequently in the field.
As with the other anthelmintics problems of parasite resistance may develop (see 
later). The ecological effect of the use of ivermectin,particularly in slow release devices, 
involving the inhibition of the development of dung beetles and their larvae, the decreased 
rate of disintegration of faecal pats and the effect on pasture may be of significance over 
long periods of anthelmintic usage (Wall and Strong , 1987). However, the climatic
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conditions influence the speed of disintegration of faecal pats and a field study on the 
build-up of faecal material in pastures grazed by ivermectin treated and untreated 
animals failed to show any differences in pasture contamination ( McKeand eta/., 1988). 
Benzimidazoles and Pro-benzimidazoles
The benzimidazoles are a group of related anthelmintics with similar chemical 
structures based on the benzimidazole nucleus ( Fig. 1.1). Thiabendazole (TBZ) was the 
first of this group to be introduced in 1961 and was shown to have antifungal as well as 
anthelmintic properties C Davidse, 1975). Biochemical substitutions on the benzimidazole 
nucleus were used in the development of a range of anthelmintics with differing 
pharmacological properties and efficacy against parasites. The important members of the 
group are given in Table 1.1 along with their biochemical structures and dates of 
introduction. The later benzimidazoles have a carbamate group at position R2 which 
increases activity and the substituent on position R1 influences the solubility of the 
compound and hence its pharmacokinetics. TBZ is the only member of the group with 
antifungal activity. The earlier compounds e.g. TBZ, cambendazole (CBZ), parbendazole 
(PBZ), oxibendazole (OBZ), mebendazole! MBZ) and flubendazole (FLZ) have good activity 
against gastrointestinal parasites but poorer efficacy against lungworms and no activity 
against hypobiotic fourth stage larvae of Ostertagia spp. The modern benzimidazoles, 
namely fenbendazole,(FBZ), oxfendazole,(OFZ) and albendazole,(ABZ) are less soluble 
than the other members of the group and have better efficacy against nematode parasites 
including hypobiotic larval forms. Triclabendazole (TCZ) has no activity against nematode 
parasites but has good efficacy against trematodes, notably Fascwia Pepatwa, (Boray ei 
a/, 1983). ABZ is the other benzimidazole with antitrematodal action but high doses of the 
drug are required compared with those to kill nematodes and efficacy against trematodes is 
much poorer than with TCZ.
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Figure 1.1 
Chemical structure of benzimidazoles
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Table 1.1 
Chemical structures of the benzimidazole anthelmintics
Name R* R2
Thiabendazole H 4-thiazolyl
Cambendazole (CH^CH-O-CO-NH- 4-thiazolyl
Albendazole C3H7-S- -NH-C02CH3
Fenbendazole C5H5 -S-
Flubendazole F-C6H4-C0-
Mebendazole C6H5-C0-
Oncodazole 2-thienyl-CO-
Oxfendazole C6H5-S0-
Oxibendazole C3H7-0 -
Parbendazole ^ 9"
Ricobendazole C3H7-S0-
The pro-benzimidazoles are a group of compounds which are metabolised in the body to 
form benzimidazoles and owe their anthelmintic activity to the benzimidazole metabolite 
which is produced. Thiophanate is metabolised by organisms in the rumen microflora to 
produce a benzimidazole, carbendazim , with activity similar to the early benzimidazoles. 
Febantel is a phenylguanidine which is absorbed from the gastrointestinal tract and 
undergoes cyclisation in the liver to form FBZ and OFZ ( Delatour etal, 1982). Netobimin 
is a nitrophenylguanidine which undergoes metabolic reduction of a nitro group to an 
amino group prior to cyclising to form ABZ in the rumen or liver (McDougall et al, 
1985).
The limited water solubility of the benzimidazoles makes them unsuitable for 
subcutaneous administration and all the benzimidazoles are administered orally as 
drenches, pastes, powders, intraruminal boluses or in feed blocks. OFZ is also available as 
an intraruminal injectable preparation.
The benzimidazoles have a similar mode of action (see later) and differences in efficacy 
against parasites are due to variations in solubility and resulting pharmacokinetics among 
the compounds. The relatively water insoluble modern benzimidazoles e.g. FBZ, OFZ and 
ABZ have greater in vivo anthelmintic activity than the more soluble compounds e.g. TBZ. 
Because of their mode of action the length of time that parasites are exposed to the 
benzimidazoles is important to get effective anthelmintic activity. TBZ given as a single 
oral dose to cattle failed to remove hypobiotic larvae of 0 ostertagi (.Armour.1969) 
whereas administration of TBZ as an intraruminal infusion over 36 hours removed 901? 
of hypobiotic 0.ostertagi (Prichard etal, 1978). In animals with a rumen this organ acts 
as a store for the benzimidazoles and allows stead/ release of the anthelmintic into the 
rest of the gastrointestinal tract prolonging its availability. In monogastric animals the 
small volume of gastrointestinal contents, the steady depletion of contents and the limited
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solubility of the benzimidazoles reduces availability of the drugs. Dividing the dose of 
benzimidazole over several days in monogastric animals, especially carnivores, increases 
the availability of the drug and parasite exposure to the compound and therefore increases 
the efficacy (Burke and Roberson, 1978). There is evidence that dividing the dose of 
benzimidazoles increases the drug availability in ruminant animals ( Bogan etal, 1987). 
In addition malnutrition of the host or severe parasite infestations with diarrhoea, 
anaemiajpyrexiaetc. can affect, detrimentally the pharmacokinetics of the benzimidazoles 
and uptake of the drug by the parasites ( Prichard, 1980)
After oral administration of the benzimidazoles they are absorbed to some extent 
depending on their water solubility. Metabolism of the drugs occurs in the rumen, 
gastrointestinal tract and liver usually forming compounds with increased solubility or 
inactive products which are excreted. The main routes of metabolism for the 
benzimidazoles include reduction, oxidation (sulphoxidation, demethylation and 
hydroxylation) and conjugation prior to excretion (Van den Bossche e ta l, 1982). The 
modern benzimidazoles , ABZ, FBZ and TCZ are metabolised by reversible sulphoxidation. 
Various enzymes eg. liver microsomal oxidases, tissue oxidases and reductases are 
involved in the interconversions of sulphide to sulphoxide and the reverse. These reactions 
can occur in many tissues (Marriner and Bogan ,1981b) but there is limited 
interconversion of sulphides and sulphoxides in the rumen and gastrointestinal tract. 
There is a further slower, irreversible oxidation to the sulphone metabolite, ABZ, 
therefore is metabolised rapidly to ABZ sulphoxide (ABSX) with none of the parent ABZ 
identifiable in peripheral plasma. Further metabolism to the sulphone (ABSO) occurs 
along with formation of low levels of other metabolites ( Gyurik etal, 1981). Febantel, 
FBZ and OFZ are metabolically interconvertible with FBZ the sulphide, OFZ the 
corresponding sulphoxide and febantel the pro-benzimidazole which converts to FBZ
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(Delatour eta l, 1985; Marriner and Bogan, 1981b). The solubility of the compound 
which is administered has a significant effect on drug absorption and plasma levels of the 
drug. When administered orally small differences in solubility between the sulphide and 
sulphoxide forms, the sulphoxide being more water soluble, may have a significant impact 
on the drug availability and consequent efficacy against parasites (Marriner and Bogan, 
1985).
Both the sulphide and sulphoxide forms of the modern benzimidazoles are thought to be 
anthelmintically active in vivo (Marriner and Bogan, 1980 ; Marriner and Bogan, 
1981 a) but the sulphone is inactive (Averkin etal, 1975). Considering that a possible 
mode of action of the benzimidazoles is as anti-tubulins in parasites both the sulphide and 
sulphoxide forms bind to tubulin although there is conflicting evidence as to the potency of 
these two forms of the drugs as anti-tubulins (Barrowman etal, 1984; Ireland etal, 
1979).Because of the interconversion of the sulphides and sulphoxides in the tissues 
there may be little significance in identifying which form is most active biologically.
The pharmacokinetics of the benzimidazoles varies amongst species and with members 
of the group of compounds. Following are descriptions of the pharmacokinetics of some of 
the important benzimidazole compounds as applicable to sheep. (For a review of the 
anthelmintic activity of the benzimidazoles see Van den Bossche etal, 1982)
After oral administration TBZ is rapidly absorbed from the rumen and abomasum. In 
sheep after oral administration at the recommended dose rate of 44 mg/kg maximum 
concentrations in the plasma were reached at 2-4 h post-treatment and fell to 
undetectable levels by 36h post-treatment. The inactive metabolite of TBZ, 
5-hydroxythiabendazole (Tocco etal, 1964), reached maximum plasma concentrations 
in 6h and was undetectable in plasma by 24h post-treatment (Weir, 1987). 
Thiabendazole and 5-hydroxythiabendazole are conjugated to glucuronide or sulphate in
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the liver and excreted rapidly in the urine (Tocco etal, 1964). Thiabendazole has good 
efficacy against adult and immature gastrointestinal nematodes but the rapid clearance 
from the body leads to poorer efficacy against lungworms and hypobiotic larvae of 
Ostertagia spp
Albendazole has a lower water solubility than TBZ and therefore absorption is slower. 
In sheep after oral administration of ABZ none of the parent compound is detected in the 
plasma and it is only the metabolites ABSX and ABSO which are found. After oral 
administration of ABZ maximum concentrations of ABSX are found in the plasma at about 
20 hours post-treatment and maximum cones, of ABSO are found 10-12 hours later 
( Marriner and Bogan, 1980) .Both ABSX and ABSO can be detected in plasma for about 72 
hours post treatment. The increased persistance of ABSX in the tissues compared with TBZ 
produces better efficacy against immature gastrointestinal parasites including hypobiotic 
forms of Ostertagia spp and lungworms. At increased dosage rates ABZ has activity against 
adult and some immature Fascioia hepatica. Ricobendazole.which is ABSX, is now available 
as a drench for sheep and has similar anthelmintic activity to ABZ. However, it does not 
require conversion from the sulphide form within the animal and therefore may have 
increased availability compared with the parent compoundABZ.
After oral administration of FBZ to sheep maximum plasma concentrations of FBZ are 
found at 24h. FBZ is converted to OFZ and peak concentrations of this metabolite are 
detected at 30h. Both FBZ and OFZ can be detected in plasma for up to 5 days. The sulphone 
metabolite of FBZ and OFZ, FBZSO, is detected in plasma for up to 7 days with maximum 
concentrations at 36h after oral administration of FBZ (Marriner and Bogan, 1981b). 
When OFZ is administered orally maximum plasma concentrations of the drug are detected 
at 30h and levels persist in the plasma for up to 7 days. The sulphone metabolite, FBZSO , 
reaches maximum plasma concentrations at 48h after oral administration and can be
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detected in plasma for 8 days (Marriner and Bogan, 1981a). Both FBZ and OFZ have good 
activity against gastrointestinal nematodes, lungworms and hypobiotic forms of Ostertagia 
spp, These drugs have no activity against flukes.
The benzimidazoles are thought to have a similar mode of action and differences in 
efficacy of the drugs against groups of parasites probably reflect differences in the 
bioavailability of the drugs within the host animal. The more potent anthelmintics of the 
benzimidazole group of compounds have slower absorption and elimination rates 
(Prichard etal, 1978)
Studies to investigate the mode of action of the benzimidazole group of anthelmintics 
concentrated on the antimitotic properties of some members of the group. It was suggested 
that the antimitotic activity was due to disruption in the formation of the mitotic spindle 
(Seiler, 1975). Using oncodazole Hoebeke et al, (1976) studied the binding of this 
benzimidazole compound to rat brain tubulin and suggested that the antimitotic activity of 
the benzimidazoles was due to binding to tubulin. The attachment of benzimidazoles to 
tubulin molecules caused inhibition of the formation of microtubules resulting in 
disruption of cell division. A similar mechanism of tubulin binding and disruption of the 
microtubular framework within cells was suggested as a possible reason for the 
anthelmintic activity exhibited by the benzimidazoles ( Davidse and Flach, 1978).
Borgers and De Nollin (1975) noted changes in the ultrastructure of the parasite 
Asaris suum after treatment of pigs with MBZ which had been infected experimentally 
with these parasites. The changes in ultrastructure of parasite intestinal cells noted by 
these authors included alteration in the distribution of cell organelles and loss of 
microvilli. These changes were identified at periods of 6-9h after oral treatment of the 
host with MBZ. The ultrastructural changes in intestinal cells of A suum were obvious 
before alterations were noted in other cells of the parasites. Using radiolabelled MBZ
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higher concentrations of the benzimidazole were detected in the parasite gut than in other 
parasite tissues. Further studies on the effects of MBZ on the ultrastructure of intestinal 
cells of A.suum and Syngamus trachea and the tegumental cells of Taenia taeniaeformis 
have been reported (Borgers etal, 1975a; Borgers et ah 1975c). After exposure to 
MBZ there was disappearance of cytoplasmic microtubules causing disruption in the 
migration of subcellular organelles with a failure of transport of secretory granules. This 
resulted in prolonged storage of secretory material within the cells with eventual lysis of 
the cell cytoplasm and disintegration of the cells. Cell autolysis occurred within 15-24h 
of treatment with MBZ. There was no effect on the ultrastructure of host cells with the 
cytoplasm and mitotic spindle appearing normal and microtubule distribution remaining 
unaltered. These authors suggested that the anthelmintic action of the benzimidazoles was 
due to differences in the sensitivity of host and parasite cells to the effects of the 
benzimidazoles.
Similar changes in parasite cell ultrastucture were noted in the cestodes, Hymenoiepsis 
nana; after exposure to MBZ (Yerheyen et ah 1976), Using cytochemical analysis of 
hydrolase activity in the parasites the degeneration of the parasites was found to be due to 
autolysis of the tegument. The authors suggested that the MBZ caused a block in the 
transport of secretory granules within the cell. This prevented adequate nourishment of 
the cell and the prolonged intracellular storage of the enzymes within the secretory 
granules resulted in cellular autolysis. Microtubules are thought to be essential for 
enzyme secretion by parasites and studies of Nippostyrongylus hrasiJiensis in vitro 
(Watts et ah 1982) indicated that secretion of acetylcholinesterase was inhibited by 
benzimidazoles. Reduction in secretion of acetylcholinesterase in the presence of 
benzimidazoles has also been shown in Trichostrongy/us cok/hr ifo r mis and this was 
linked to disappearance of microtubules which were examined ultrastructurally (Sangster
etal* 1985)
The differences in the sensitivity of host and parasites to the effects of benzimidazoles 
may be due to differences in the structure of microtubules in their cells. Ultrastructural 
studies with Ascartdia gaJJi and I  cofutriform is revealed differences in the 
protofilament numbers in microtubules of cells of the parasites compared with 
mammalian cells (Davis and Gull, 1983).These authors found that mammalian cells had 
13 protofilaments in microtubules whereas the parasites had cells with 11, 12 and 14 
protofilaments in the microtubules.
In addition to studies on the effect of benzimidazoles on the ultrastructure of cells the 
binding of benzimidazoles to the protein tubulin has been studied. Experiments using 
extracts of tubulin from rat brain (Hoebeke at a/., 1976) identified the binding of 
oncodazole to the tubulin which prevented assembly of tubulin components into 
microtubules. Similar results were obtained using tubulin extracts from bovine brain 
(Friedman and Platzer, 1978). Extracts of tubulin from intestines of the pig nematode 
A,suum were used in studies of microtubule assembly in the presence of MBZ and 
colchicine (Kohler and Bachman, 1980) These authors discovered that MBZ acted as a 
competitive inhibitor of colchicine binding to tubulin and this suggested that MBZ and 
colchicine bound to microtubules at a structurally close site. Differences in the affinity of 
benzimidazoles for tubulin extracted from A.suum intestines and pig brains were 
approximately two fold. This small difference in the affinity for the tubulin derived from 
the mammalian and parasitic sources may account partially for differences in the activity 
of the benzimidazoles against the host cells and parasitic cells. The uptake of MBZ into the 
parasites also may affect the activity of the drug with the worms accumulating higher 
concentrations of MBZ than in the surrounding medium. These results suggested that the 
pharmacokinetics of the benzimidazoles may be important in determining the differences
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in toxicity of the drugs to the host and parasite cells.
Experiments on the binding of FBZ and MBZ to tubulin extracted from embryonic 
forms of A,suum indicated that inhibition of colchicine binding to these extracts was 
non-competitive and that tubulin extracts from embryonic forms of A.suum were very 
sensitive to the effects of the benzimidazoles (Friedman and Platzer, 1980a). At the 
embryonic stage the parasites are independent of external nutrients and the effect of 
anthelmintic on metabolic processes would be minimal. There was a 250-400 fold 
difference in the inhibition constants of colchicine binding in the presence of MBZ or FBZ 
to tubulin extracts from embryonic A suum and tubulin extracted from bovine brain. This 
suggested that differences in binding of these benzimidazoles to tubulin from parasites and 
mammalian tissues may account for the differential toxicity of the benzimidazoles between 
host and parasitic cells. However Dawson et a/., (1984) using tubulin from Ascot idie 
g a lli and mammalian tubulin found that MBZ, ABZ, FBZ, PBZ and OBZ had similar 
inhibitory activity against polymerisation of tubulin from nematodes and mammals. OFZ 
had greater activity against parasitic tubulin than mammalian tubulin. Gull et a l,
(1987) using purified tubulin extracts from /?.#?///found FBZ, PBZ and ABZ had similar 
potency as inhibitors of microtubule assembly against mammalian and nematode tubulin 
but OFZ and TBZ were more effective in preventing nematode microtubule assembly. 
Therefore, differential binding of benzimidazoles to tubulin from parasitic and 
mammalian sources did not account for differences in toxicity of some of the 
benzimidazoles to host and parasite cells.
Ireland etal, (1979) using tubulin extracted from sheep brain found some correlation 
between antimicrotubular activity in vitro and anthelmintic activity with PBZ, FBZ, 
OBZ, ABZ, CBZ and TBZ but not for MBZ and OFZ. These authors suggested that the possible 
discrepancies between the in vitro  and in vivo activity may be due to the
pharmacokinetics of the drugs in the host or differences in helminth and mammalian 
tubulin. Lacey et <?/,(1987) compared the efficacy of some of the benzimidazoles 
measured as their ovicidal activity with the tubulin binding of the drug to mammalian 
tubulin, extracted from sheep brain. These authors found that the potency of the drugs in 
one assay reflected drug potency in the other assay. They suggested that these results 
indicated that inhibition of tubulin polymerisation was the mode of action of the 
benzimidazoles when acting as ovicidal drugs against parasite eggs.
The benzimidazoles are effective against nematode parasites but efficacy against the 
trematodes e.g. Fasciolahepatfcaiz limited to ABZ and TCZ. Using tubulin extracted from F 
hepatica colchicine binding to the extracts was inhibited by CBZ, PBZ, OBZ, MBZ and ABZ. 
TCZ had no effect on colchicine binding to Fhepatica (Fetterer, 1986). This suggested 
that the action of ABZ against F.hepatica may be due to binding to tubulin but TCZ may 
have other actions against flukes.
The disruption of metabolic processes within parasites may be involved in the activity of 
benzimidazoles. Parasites can differ from their hosts in a number of pathways of 
respiratory metabolism. There are differences in the enzymes of the respiratory 
pathways and energy synthesis in mitochondria between the host and nematode parasites. 
Nematode parasites produce incompletely oxidised organic acids as end products of 
metabolism (Behm and Bryant, 1979).
Mebendazole was found to inhibit the uptake of glucose by A.suumK'ian den Bossche and 
De Nollin , 1973 ) and this inhibition was considered to be irreversible (Van den 
Bossche, 1972). A decrease in the glycogen content of the parasites' muscles along with 
decreased uptake of amino acids and fatty acids was reported for A suum in the presence of 
MBZ (Van den Bossche and De Nollin, 1973). Inhibition of glucose uptake and depleted 
glycogen reserves were found in S. trachea (Vdx\ den Bossche, 1972) in the presence of
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MBZ and similar effects were noted with PBZ and CBZ, This author noted that the reduction 
in glycogen reserves was related to the dose of benzimidazole to which the parasites were 
exposed. CBZ and MBZ were shown to inhibit glucose uptake, increase glycogen utilisation 
and decrease adenosine triphosphate (ATP) levels due to the activity of these
benzimidazoles on metabolic enzymes in Monieziaexpansa. Studies on intestinal material 
from Asuum revealed that uptake of sodium ions across the intestinal membrane was 
reduced after treatment with benzimidazoles (Beames eta/., 1976). This effect could be 
secondary to a reduction in glucose uptake by the parasites produced by the 
benzimidazoles. TBZ produces little effect on glycogen reserves in parasites. A 
substitution at position 5 or a carbamate group on the benzimidazole molecule may be 
essential to affect glycogen utilisation in nematode parasites ( Van den Bossche, 1972).
Benzimidazoles can act as potent uncouplers of oxidative phosphorylation in mammalian 
mitochondria (Jones and Watson, 1967). The activity of various metabolic enzymes in 
nematode parasites is inhibited by benzimidazoles. Both cytoplasmic and mitochondrial 
malate dehydrogenase in A.suum, F.hepaticamS M.expansa are inhibited by ABZ, PBZ, 
MBZ and TBZ (Tejada et a/, 1987). CBZ and MBZ inhibited phosphoenolpyruvate and 
fumarate reductase in M.expansa (Rahman and Bryant, 1977). TBZ inhibited fumarate 
reductase in Hcontortus{Prichard, 1970 and 1973). Fumarate reductase in Asuumms 
inhibited by MBZ, ABZ, FBZ, OFZ, ABSX and ABSO (Barrowman et al, 1984). Also, 
succinate dehydrogenase and fumarate reductase in Trichinel/aspiralis were inhibited by 
MBZ (Boczon, 1976). However higher concentrations of the benzimidazoles are required 
to inhibit fumarate reductase in nematode parasites than concentrations which can inhibit 
tubulin polymerisation (Dawson etal, 1984; Kohler and Bachmann, 1978).
The general structure of the benzimidazoles suggests that they are likely to interfere 
with reactions involving purine-like groups. When benzimidazoles interact with
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metabolic enzymes in parasites the lethal effect of the drugs is due to a decline in the ATP 
available to the parasites and therefore, they are unable to maintain their situation within 
the host ( Behm and Bryant, 1979).
Studies on the mode of action of benzimidazoles have revealed species differences in the 
biochemical effects on the parasites. Alteration in the microtubular transport systems 
within the parasites produced by the benzimidazoles may lead to changes in the metabolic 
reactions which occur within the parasites and the effect of the benzimidazoles on tubulin 
polymerisation and biochemical effects on respiratory enzymes may be linked ( Behm and 
Bryant, 1985).
The aim of the studies detailed in this thesis was to investigate the effect of 
benzimidazoles on tubulin molecules derived from nematode parasites. The experiments 
were carried out using the modern benzimidazoles ABZ and FBZ. The efficacy of 
benzimidazole metabolites was investigated. Studies on the mechanism of action of the 
benzimidazoles were expanded to include studies on possible differences in the effects of 
benzimidazoles on anthelmintic resistant and susceptible strains of parasites. 
Imldathlazoles
Tetramisole which is the racemic mixture of D and L forms, dexamisole and levamisole, 
was introduced into veterinary therapy in 1966. The L-isomer, levamisole, is more 
active and less toxic than the D-form and therefore levamisole is marketed separately as 
an anthelmintic. This drug is highly active against a wide range of nematodes but it is less 
active against immature gastrointestinal parasites than the benzimidazoles or ivermectin 
and has poor efficacy against hypobiotic fourth stage larvae of Ostertagia spp.
The mechanism of action of levamisole is due to ganglion stimulation producing 
reversible paralysis. At high concentrations levamisole causes inhibition of fumarate 
reductase in parasites inhibiting parasite metabolism. Levamisole is absorbed and
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excreted rapidly (Bogan eta l, 1982). The drug can be administered by subcutaneous 
injection or orally and is now available as a topical preparation for cattle. Maximum blood 
concentrations occur at 30-60 min after subcutaneous administration and 2-3 hours 
after oral administration. Excretion is rapid occurring within 24 hours of drug 
administration.
A survey of anthelmintic usage in the UK in 1982 (Thomas etal, 1982) indicated that 
the percentage of the anthelmintic market held by levamisole was 30S> for cattle, 15£ for 
sheep and 30£ for pigs. In cattle levamisole is used as a summer drench to remove adult 
and immature parasites when hypobiotic forms of 0. ostertagi are not present. Several 
species of nematode parasites have become resistant to the anthelmintic effect of 
levamisole (see later). These resistant parasites tend to show side - resistance with 
morantel/pyrantel.
Levamisole can be used as an immunostimulant in the therapy of chronic infections and 
cancer (Renoux,1978). This ability to produce immunostimulation may be the reason for 
the synergistic effect observed when levamisole is used at low dose rates in combination 
with a benzimidazole anthelmintic (Bennet etal, 1980)
Tetrahydropyrimidines
This group of anthelmintics is similar in structure to the imidathiazoles and the 
members of veterinary importance are pyrantel and its methyl ester analogue, morantel. 
These broad spectrum anthelmintics have good activity against adult gastrointestinal 
nematodes but are less effective against immature, mucosal dwelling larval forms. They 
are thought to act as depolarising muscle relaxants in parasites (Coles et a/, 1974) 
producing paralysis.
In the UK morantel is available only for cattle incorporated in an intraruminal 
continuous release bolus CParatect', Pfizer). However the drug is available as an oral
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drench for use in sheep and cattle in other countries.Pyrantel is used in horses and small 
animals. Parasites have become resistant to the effects of these drugs and in most cases 
there is side -  resistance with levamiso1e(see later).
ANTHELMINTIC RESISTANCE
Resistance is defined as a significant increase in the ability of individuals within a 
strain to tolerate doses of a compound which would prove lethal to the majority of 
individuals in a normal population of the same species. This resistance is genetically 
expressed and inherited (Kelly and Hall, 1979). Within a normal population there may be 
individual members with the characteristic necessary to develop resistance but these 
individuals do not dominate in the population unless there is selection pressure on the 
populations and these individuals have an advantage over other members of the population
Drug resistance in populations of bacteria, protozoa, arthropods and some mammalian 
cells has developed rapidly and become widespread. However, drug resistance in helminths 
to the effects of anthelmintics has developed relatively slowly and is sporadic in its 
occurrence (Waller and Prichard, 1986) The timescale of development of resistance to 
anthelmintics has paralleled the introduction of the individual anthelmintics onto the 
agricultural market. Reports have been published of resistance in nematode parasites to 
all the major groups of modern anthelmintics including the benzimidazoles, the 
levamisole/morantel group and the avermectins. If there is resistance in a nematode 
population to one drug in the benzimidazole group there is usually resistance to all 
members of the benzimidazole group of compounds (Hall et al, 1978b; Martin et a/.,
1985) This is designated side-resistance and has been defined as resistance to a compound 
which is the result of selection by another compound with a similar mode of action 
(Prichard etal., 1980). Parasites which are resistant to the effects of levamisole show
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side-resistance to morantel (Le Jambre and Martin, 1979; Sangster et al, 1979). 
However the reverse is not necessarily the case and Waller et al, (1986) reported 
resistance to morantel in a strain of T.coJubriformis and the parasites remained fully 
susceptible to the effects of levamisole. Cross-resistance is the term given to resistance 
which has developed to a compound as the result of selection by another compound with a 
different mode of action (Prichard eta l, 1980). When parasites become resistant to two 
or more anthelmintic groups, either as a result of selection by each group independently, 
or as a result of cross-resistance then multlple-resistance has developed (Prichard et 
al, 1980).
Resistance in Hcontortus to the effects of the phenothiazine group of anthelmintics was 
reported in the USA by Drudge etal, (1957). The introduction of the broad spectrum 
anthelmintics, e.g. the benzimidazoles led to a reduction and eventually cessation of use of 
the phenothiazines. However, resistance to these broad spectrum anthelmintics developed 
and was reported from the USA by Drudge et a/., (1964) in a strain of Hcontortus 
Further reports of resistance to benzimidazoles in Hcontortus in Australia followed 
(Smeal etal, 1968.). Resistance to anthelmintics in other sheep nematodes developed and 
a strain of T.colubriformis resistant to benzimidazoles was reported by Hotson et 
£/,(1970) and O.circumcincta by Le Jambre (1977). Coles, (1986) suggested that 
parasites which were resistant to phenothiazines were able to develop resistance to 
benzimidazole anthelmintics rapidly (Tritschler etal, 1987).
Resistance to anthelmintics in sheep nematodes is most prevalent in areas of Australia 
and several reviews decribing the importance of anthelmintic resistance have been 
written (Kelly and Hall, 1979; Prichard e ta l, 1980; Donald, 1982; Waller and 
Prichard, 1986; Waller, 1987). A survey of resistance in sheep producing areas of the 
Northern Tablelands in Australia revealed that the incidence of benzimidazole resistant
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Hcontortus was widespread (Webb etal, 1979). The failure of the benzimidazoles to 
clear resistant Hcontortus from sheep prompted a change to the use of levamisole or 
morantel on many properties and in the following period resistance to these anthelmintics 
was identified in Tcolubriform is and O.circumcincta (Waller, 1986). However, 
resistance to levamisole or morantel in Hcontortus was slower to develop and was first 
reported by Green et al, (1981). The use of benzimidazoles followed by levamisole and 
morantel led to multiple resistance to anthelmintics in T.coiubriform is^angster etal, 
1979), Hcontortus (Green e ta l,  1981) and similar problems of resistance to 
anthelmintics in nematodes from goat farms (Hall etal, 1981). A survey of properties on 
the Northern Tablelands found a high incidence of anthelmintic resistance in 
T.coiubriform is^ O.circumcincta (Love, 1985). In other areas of Australia there is 
widespread resistance to anthelmintics in Tcolubriformis and O.ctrcumcincta (Waller,
1986).
In other countries anthelmintic resistance has been identified and has become a problem 
to sheep and goat producers. Surveys of anthelmintic resistance in New Zealand on sheep 
farms identified resistance in T.coiubriformis and Hcontortus ( Kemp and Smith, 1982) 
and resistance has been identified in strains of O.ctrcumcincta ( Hughes and Seifert, 
1983) and Nematodirus spp (Middleberg and McKenna, 1983). Resistance to 
anthelmintics on goat farms has been identified as a particular problem in New Zealand 
(Kettle etal, 1983).
The climate of Argentina, Brazil and Uruguay resembles that in areas of Australia and 
Hcontortus infections can be a problem in some areas of all these countries. In Brazil 
Hcontortus infections with parasites resistant to anthelmintics are widespread (Amaral, 
1985) and strains of T.coiubriformis , O.circumcincta and Nematodirus spp show 
resistance to anthelmintics (for review see Waller, 1986 ). Similar climatic conditions
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and incidence of anthelmintic resistance in sheep nematodes are found in South Africa with 
strains of Hcontortus resistant to bemmidazoles (Berger, 1975) salicylanilides (Van 
Wyck eta!., 1987) and ivermectin (Van Wyk eta!., 1987).
Anthelmintic resistance was first reported in the USA but these cases occurred on 
research farms and there have been few reports of field cases of anthelmintic resistance 
in sheep nematodes (Coles, 1983).
In Europe resistance to anthelmintics was described in Switzerland by Jordi (1980). In 
the Netherlands there have been reports of resistance to anthelmintics in Hcontortus 
(Boersema et a!., 1982: Eysker et a l, 1982: Eysker et a l, 1983) and a survey of 
anthelmintic resistance in the Netherlands was carried out and low levels of resistance 
were found in H. contortus on a large number of properties (Boersema et a l, 1987). 
Resistance in the U K was reported first by Britt ( 1982) after a survey of sheep 
parasites from 33 flocks. A strain of O.circumcincta resistant to thiabendazole was 
identified on one of the farms. Further studies on this strain of O.circumcincta were 
described ( Britt and Oakley, 1986). Other reports of benzimidazole resistance in strains 
of O.circumcincta were made (Cawthorne and Whitehead, 1983) and a survey of 
anthelmintic resistance in the south-east of England (Cawthorne and Cheong, 1984) found 
benzimidazole resistance in Hcontortus on seven farms. During a survey of sheep farms 
in the north of England ( Evans, 1988) parasites showing resistance to anthelminics were 
not identified. Levamisole resistance in sheep abomasal parasites was reported by Britt 
(1986). Currently a survey of anthelmintic resistance on sheep farms in the south of 
England is being conducted (Taylor, personal communication). In other European 
countries surveys for anthelmintic resistance have not been reported and the incidence of 
anthelmintic resistance is unknown
Resistance to anthelmintics in nematodes infecting species other than sheep has been
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identified. The prevalence of resistance in cattle parasites to the effects of anthelmintics is 
low but there have been reports of benzimidazole resistance m Triciiostrongyias axel 
from Australia (Eagleson and Bowie, 1986), of levamisole resistance in Ostertagia 
ostertagm  Belgium (Geerts etal., 1987), morantel resistance in Ostertagia ostertagi in 
the Netherlands (Borgsteede, 1988) and benzimidazole resistance in Coopenaoncophora 
in New Zealand (Jackson etal, 1987a). Resistance to benzimidazole in horse strongyles 
has been reported widely in Australia (Kelly et al, 1981), the U.S.A. (Drudge et al, 
1979), in Canada (Slocombe and Cote, 1977), in Cermany (Bauer etal, 1986) and in 
the U.K. (Round e ta l, 1974; B ritt,1984; Herd, 1986; Ryan e ta l, 1987 and Lumsden 
and Ryan, 1987). Resistance in the pig parasite Oesophagostomum spp to pyrantel was 
reported in Denmark (Roepstorff etal, 1987). A report of resistance to anthelmintics in 
dog parasites was made by Jackson et al, ( 1987b). These authors identified a strain of 
Ancylostomacaninum resistant to pyrantel and oxantel discovered in New Zealand.
A number of methods, both in vivo and in vitro, are available to identify resistance to 
anthelmintics in nematode parasites. Initially resistance to anthelmintics may be noticed 
on the farm as a failure of the anthelmintic used clinically to cure parasitic 
gastroenteritis in sheep. Further studies can be instituted to identify an anthelmintic 
resistant strain of parasites and to isolate the strain. In some cases failure of 
anthelmintics to reduce parasite populations in sheep may be caused by factors other than 
anthelmintic resistance eg. inadequate dosage of drug, poor management allowing 
immediate reinfection of animals and rapid drug metabolism. The latter can be a problem 
in goats especially with levamisole and cases of resistance identified by Kettle et 
al,{ 1985) may have been due to inadequate dosing of qoats with levamisole rather than 
levamisole resistance in the parasites ( McKenna, 1984)
The faecal egg count reduction test (FECR test) is an in vivo test which can be used on
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farms and commonly is used in the investigation of parasite resistance to anthelmintics. In 
Australia this test is used routinely to evaluate the success of worm control programmes 
and to try  to investigate the reasons for failures in the control systems. This test 
compares the faecal egg counts in animals before and after treatment with an anthelmintic 
and the percentage reduction in faecal egg count is calculated. A group of untreated control 
animals is included in the test to monitor day to day fluctuations in the faecal egg counts. 
Faecal egg counts are taken 7-10 days after treatment with anthelmintics because 
levamisole and benzimidazoles have a suppressive effect on egg production (Martin etal, 
1985) and faecal egg counts taken in the period immediately post treatment may give an 
overestimation for the depressive effect of the anthelmintics. Another problem with this 
test is that faecal egg counts may not reflect the adult worm burden carried by the animals 
for some species of parasites (Martin et al, 1985) and there can be between animal 
variation in worm burdens and egg output with large group sizes required for the test.
Reduction in egg count of <90% after treatment with anthelmintics is indicative of 
parasite resistance to anthelmintics (Webb etal, 1978; Kettle etal, 1981). To identify 
the species of parasites resistant to anthelmintics in mixed populations the faeces 
collected after treatment with anthelmintics can be cultured and the parasites identified at 
the infective larval stage (Presidente, 1985). This test has been used for the initial 
identification of parasite resistance to anthelmintics in sheep, goats and horses (Webb et 
a l, 1979; Hotson etal, 1970; Kelly etal,) 981) The test was used for the identification 
of resistance during surveys of the prevalence of anthelmintic resistance, reviewed by 
Presidente (1985).
The controlled anthelmintic efficiency test is the most reliable test to confirm the 
presence of resistance in nematode parasites but It is costly to perform. It is used to 
confirm resistance in isolates of parasites and to quantify the level of resistance in a
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particular strain of parasite . All types of anthelmintic can be used in this assay. The test 
is a dose titration trial (Moskey and Harwood, 1941; Gibson, 1964; Powers etal, 1982) 
comparing the worm counts of experimentally infected animals treated with increasing 
doses of anthelmintic with worm counts in untreated animals. Worm burdens should be 
assessed at necropsy approximately 7 days after treatment of the animals with the 
anthelmintic to ensure that all susceptible parasites are removed from the host (Prichard 
eta/., 1980). An LD50 (concentration of anthelmintic which kills 50£ of the nematodes) 
can be calculated for the resistant parasites. This test has been used to confirm the 
presence of resistance in a range of parasite species in sheep and goats (for review see 
Presidente, 1985). A controlled anthelmintic efficiency test has been described for 
T.eo/ubriformis using guinea pigs as an alternative animal model to sheep to reduce the 
cost of the test ( Kelly etal, 1981).
Several in vitro  tests have been described to detect resistance in nematodes to the 
effects of anthelmintics. To detect benzimidazole resistance the in vitro egg hatch assay is 
used most commonly (Le Jambre, 1976; Coles and Simpkin, 1977). This assay involves 
the incubation of freshly collected parasite eggs in the presence of a range of dilutions of 
the benzimidazole, usually TBZ, and the assessment of the hatchability of the eggs. There 
are a variety of modifications to the method with incubation times varying from 24-72h 
and assessment of effectiveness of the anthelmintic given as either number of eggs failing 
to hatch to larvae or number of eggs failing to develop (Boersema, 1982). An ED50 
(concentration of drug which prevented development of 505? of the eggs) can be calculated 
from a dose response curve. Some workers use a log-dose probit plot to calculate the ED50 
(Le Jambre et al, 1979) or Arc-sin transformations (Cawthorne and Whitehead, 
1983). There can be day to day variation in the egg hatch assay results ( Borgsteede and 
Couwenberg, 1987; Le Jambre, 1976). Le Jambre (1976) used comparison of ED50 for
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a reference susceptible strain of parasites and a resistant strain to overcome the problem 
of day to day variability in the assay. Where a mixed infection of parasites is being tested 
the eggs can be cultured to the infective larval stage to identify the species which are 
resistant to the benzimidazoles (Whitlock eta l, 1980).
The in vitro  egg hatch assay test can be modified to test resistance to other 
anthelmintics including levamisole, morantel and ivermectin. Eggs collected in the faeces 
are cultured in the presence of the drug and prevention of development of the free-living 
stages of the parasites to the infective larvae is measured (Waller and Lacey, 1986). This 
test is now being standardised as a larval development assay to detect resistance (Coles er 
a l, 1988; Lacey, personal communication; Taylor, personal communication). Dobson et 
al, (1986) have described an egg hatch assay for use with levamisole.
An in vitro larval motility assay can be used to detect resistance to levamisole and 
morantel (Martin and Le Jambre, 1979). This assay assesses the paralysis of larvae in 
the presence of increasing concentrations of the anthelmintic. The motility of Hcontortus 
in the presence of drugs has been assessed using a micromotility meter (Folz et al, 
1987). Differences have been found in the quantities of cholinesterase enzymes in 
benzimidazole resistant and susceptible Hcontortus, T.cotudriformisml O.circumcincta 
(Sutherland et at, 1988). This led to the development of a larval paralysis assay for 
benzimidazole resistance using incubation of infective larvae in the presence of 
physostlgmine (Sutherland etal, 1988).
A tubulin binding assay to measure the differential binding of tritiated benzimidazoles 
to tubulin extracts from benzimidazole resistant and susceptible parasites has been 
described (Lacey, 1985; Lacey and Prichard, 1986; Lacey and Snowdon, 1988). In this 
assay the extracts from benzimidazole resistant parasites bind less benzimidazole than 
extracts from benzimidazole susceptible parasites. A comparison between the ovicidal
2 7
activity of benzimidazoles and their ability to bind to tubulin extracts (Lacey at al, 
1987) showed good correlation for a range of benzimidazoles. However MBZ is the 
benzimidazole of choice for this assay ( Lacey and Snowdon, 1988).
The mechanisms by which parasites have become resistant to the effects of anthelmintics 
are unknown. Changes in the carbohydrate metabolism in benzimidazole resistant 
parasites have been noted compared with metabolism in susceptible parasites (Bennet, 
1981; Rew et al, 1982). There was no reduction in the uptake of benzimidazoles by 
parasites resistant to these drugs (Prichard etal, 1978; Sangster and Prichard, 1984; 
Weston etal, 1984). The benzimidazole anthelmintics are thought to affect microtubules 
in parasites. Differences were found in the binding of benzimidazoles to tubulin from 
benzimidazole resistant and susceptible strains of Aspergillus nidulans ( Davidse and 
Flach, 1977). In nematodes Sangster et a l, (1985) noted differences in the 
acetylcholinesterase secretion between benzimidazole resistant and susceptible strains of 
Tcolubriformis in the presence of benzimidazoles. This correlated with the
presence of microtubules in intestinal cells of the benzimidazole resistant parasites 
compared with disappearance of microtubules in susceptible parasites examined 
ultrastructurally at intervals after incubation with the benzimidazoles. Binding of 
benzimidazoles to tubulin extracted from benzimidazole resistant strains of Hcontortus 
was reduced compared with binding to tubulin from susceptible strains (Lacey and 
Prichard, 1986). Differential binding of benzimidazoles to tubulin extracted from 
benzimidazole resistant and susceptible strains of O.circumcincta and T.coiubriformis 
also was shown(Lacey and Snowdon, 1988). Reduced binding of benzimidazoles to tubulin 
was suggested as the biochemical mechanism for development of resistance to 
benzimidazole anthelmintics (Lacey, 1985). Foster etal, (1987) discovered a mutant 
form of the p  tubulin molecule in a benzimidazole resistant strain of Physarum
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polycephalum and suggested that this could be responsible for the benzimidazole 
resistance. The mechanism of resistance to levamisole and morantel has not been studied in 
sheep parasites. A levamisole and morantel resistant strain of Caenorhabditiselegans^?& 
found to have fewer acetylcholine binding sites than susceptible strains of this nematode 
(Lewis etal, 1980).
The mechanisms by which resistance is genetically transferred are unknown. Studies on 
benzimidazole resistance in Hcontortus have produced conflicting theories on the mode of 
inheritance of resistance in this species. Le Jambre et a/, (1979) found that 
thiabendazole resistance in Hcontortus was not sex-linked, was inherited as a 
semi-dominant trait and probably involved more than one gene. Herlich e ta l, (1981) 
also found that benzimidazole resistance in Hcontortus was not sex-linked but these 
authors suggested that resistance was probaby inherited recessively and was multigenic. 
Studies on a levamisole resistant strain of T.colubriform isiW tiW  eta l, 1985) and the 
production of a mathematical model of the development of resistance in this strain ( Dobson 
e ta l, 1987) suggested that levamisole resistance in T.coiubriformis was determined by 
a single dominant gene. Resistance to benzimidazoles in a strain of T.coiubriformis was 
found to be controlled by more than one gene and resistance was inherited as a 
semi-dominant trait with some maternal influence (Martin etal, in press). A similar 
mechanism for inheritance of benzimidazole resistance in O.circumcincta has been 
suggested (Martin, personal communication). Breeding studies using sheep nematodes to 
try  to elucidate the genetic mechanisms controlling resistance are difficult because of the 
life-cycles of the parasites. However, work on the inheritance of anthelmintic resistance 
in the free-living parasite Celegans may produce results which could be of relevance in 
the study of anthelmintic resistance in parasitic nematodes (Waller, 1986)
A wide range of factors may influence the development of resistance to anthelmintics in
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the field. The prevalent species of parasites has an important influence on the speed of 
development of resistance with benzimidazole resistance predominating in areas where 
Hcontortus infections are a major problem in sheep (Waller, 1986). The frequency of 
anthelmintic treatments has a direct relationship on the development of resistance 
(Barton, 1983; Martin at ah 1982). If the interval between treatments is shortened to 
near the pre-patent period for the parasite then selection for resistance is increased 
because only parasites which can survive anthelmintic treatment are contributing eggs to 
the pasture which will develop into the next generation of parasites (Donald, 1982). 
Trials investigating the control of parasites by strategic dosing with anthelmintic at 
particular times during the grazing season and suppressive treatments throughout the 
season have shown that high levels of resistance are attained more rapidly with the 
suppressive treatments (Martin at ah 1982; Waller at ah in press). Another important 
factor is the number of parasites contaminating the pasture at the time of anthelmintic 
treatment. Studies by Martin at ah (1981) indicated that resistance to benzimidazoles in 
a strain of Hcontortus was slower to develop if  a large number of parasites remained in 
refugia Coles, (1988) suggested that the ability of larvae of Ostertagia spp to inhibit 
within the host and thus avoid the action of anthelmintics may reduce the speed of 
development of resistance.
Many parasite control schemes rely on a drench followed by moving the animals to clean 
pastures.This practice may encourage the development of resistance because the small 
proportion of parasites which can withstand anthelmintic treatment will be the source of 
eggs for development of the next generation of parasites. Increased levels of resistance 
with this type of management has been reported in O.circumcincta by Cawthorne and 
Whitehead, (1983) and in Hcontortus by Eysker et at.X 1983). However, similar 
studies with strains of Hcontortus and T.coJubriformis failed to show increased
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resistance in these parasites subjected to a dose and move regime compared with a 
set-stocked system (Waller etal, in press).
Reversion to susceptibility in benzimidazole resistant strains of Hcontortus and 
f.co/ubriform ism s reported by Simpkin and Coles (1978). However, in other studies 
reversion to suseptibility in benzimidazole resistant parasites has not occurred (Hall et 
a/., 1982). The fitness of the resistant parasites to survive in the environment will 
influence the development of resistance. Comparison of the physiological characteristics of 
benzimidazole resistant and susceptible Hcontortus suggested that the resistant parasites 
exhibited increased fitness (Kelly et a/, 1978). Increased fitness in anthelmintic 
resistant parasites also has been suggested by Martin (1987).
Treatment of a benzimidazole resistant strain of Q.circumcinctawMh levamisole over a 
number of generations was found to cause reversion to benzimidazole susceptibility faster 
than in an untreated strain and this was termed counterselection (Donald eta/., 1980). 
Similar counterselection against benzimidazole resistance with levamisole was reported 
by Waller eta/, (1983) and Martin eta/., (1988). Counterselection against levamisole 
resistance by using a benzimidazole in T co/ubriformis also has been reported (Waller ez 
a/, in press).
Methods to control anthelmintic resistance are now being implemented in some 
countries. The development of new anthelmintics is unlikely because of the prohibitive 
costs involved and therefore control of nematode parasites must rely on the present 
anthelmintics.
Ivermectin has a persistent action and has activity against benzimidazole reistant and 
levamisole/morantel resistant strains of parasites (Waller, 1986). However resistance 
to ivermectin has been reported already in Hcontortus in South Africa (Van Wyk eta/,
1987) and in Brazil (Echevarria and Trindade, in press) and in 7 co/ubriformis in the
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U.S.A. (Giordiano e ta l, in press) and may develop in other areas. Studies with frequent 
dosing of ivermectin over a five year period failed to induce ivermectin resistance in 
strains of Hcontortus and T.cotubriformis (Waller et a/., in press). Closantel, a 
salicylanilide, is active against Hcontortus as well as flukes and has a persistent action. 
This drug has proved useful in the control of anthelmintic resistant strains of Hcontortus 
in Australia and recently has been introduced to the U.K. market. Resistance in flukes to 
the effects of salicylanilides may have developed as a result of intensive use of closantel to 
control Hcontortus infections in sheep in Australia (Boray, personal communication,) 
The other drugs available to control nematodes are the benzimidazoles , levamisole and 
morantel and resistance to these drugs is prevalent in some areas. Combinations of drugs 
may have a greater effect against anthelmintic resistant parasites and low levels of 
levamisole, in combination with the benzimidazoles, can increase the efficacy of the 
benzimidazole anthelmintic (Bennet etal.y 1980). The use of parbendazole combined with 
a modern benzimidazole increases the duration of action of the benzimidazole and may 
increase the efficacy of the benzimidazole against resistant parasites (Hennessy et a/, 
1985). Prolonging the exposure time to anthelmintics for benzimidazole resistant 
nematodes may increase the efficacy of the benzimidazole (Le Jambre, 1982). Studies to 
evaluate the use of controlled release devices and sustained release devices for the delivery 
of anthelmintics and their effect against anthelmintic resistant parasites are being carried 
out in Australia (Anderson, personal communication),
The dose of anthelmintic administered to the host animal can affect the efficacy of the 
drug and the development of anthelmintic resistance. A dose of anthelmintic which kills the 
entire population of parasites within the host w ill prevent survivors from contributing 
resistant offspring to the next generation (Dash et at, 1985). Recommendations for 
dosing animals include calculating the dose rate of anthelmintic using the heaviest sheep in
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the flock rather than the average weight. If the average flock weight was used this would 
result in underdosing of some animals and there is evidence that this practise may 
accelerate the development of resistance (Waller and Prichard, 1986; Waller, 1987).
Rotation of anthelmintics, every approximately 12 months, in order to prevent the 
development of high levels of resistance has been recommended (Prichard et al, 1980; 
Donald and Waller, 1982, Dash et a l, 1985). However, rapid alteration between 
anthelmintic groups can select for resistance more rapidly ( Le Jambre eta/., 1977).
In Australia parasite control schemes have been introduced to try to reduce the 
frequency of anthelmintic treatments given to sheep flocks and overcome some of the 
problems of anthelmintic resistance in nematodes at the same time as trying to prevent 
further development of resistance to anthelmintics. The 'WormkilT programme was 
introduced for the Northern Tablelands of Australia ( Dash et al, 1985) which involved 
strategic drenching of sheep flocks using a broad spectrum anthelmintic (benzimidazoles 
or levamisole/morantel) combined with closantel. The latter has a persistent effect and 
controls Hcontortus infections. This scheme was publicised and has been successful 
during its initial phase of implementation. Other control schemes eg. 'Drenchplan' used 
in the Central and Southern Tablelands and 'Wormbuster' used in South East Queensland 
have been developed. An advantage of these schemes, which are organised by the local 
department of agriculture in coordination with C.S.I.R.O., is that any problems involving 
parasite control which arise on farms are investigated and advice is available to farmers 
on the use of anthelmintics and pasture management.
Other methods to prevent gastrointestinal parasitism in sheep are being investigated 
and may be of use in the control of anthelmintic resistance. Advances in vaccine 
development and manufacture may lead eventually to the production of vaccines for 
roundworm infections in sheep. An alternative approach is the breeding of sheep which can
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resist infection by parasites. In Australia a Merino ram which resisted infection by 
T.colubriformis and Hcontortus was discovered and breeding programmes using 
offspring from this sheep mar/ establish flocks which can resist infection by 
gastrointestinal parasites (Gray, 1987; Albers etal, 1987).
Studies desribed in this thesis were initiated to investigate a strain of O.circumcincta 
showing resistance to the benzimidazole anthelmintics. The effect of anthelmintics on the 
development of resistance in this strain of parasites was studied and factors contributing 
to increased anthelmintic resistance were discussed. Investigations with comparisons 
were carried out on various methods used to detect anthelmintic resistance. The 
biochemical action of benzimidazoles on nematode tubulin along with the examination of 
the role tubulin plays in the development of resistance to anthelmintics was investigated. 
Using the benzimidazole resistant strain of O.circumcincta studies were carried out on the 
genetic changes involved in the development of resistance and their mechanisms of 
inheritance.
RESISTANCE IN NEMATODES TO THE EFFECTS OF
BENZIMIDAZOLES 
GENERAL MATERIALS AND METHODS
Strains of Parasites
HFRO Strain -  This strain of Ostertagia circumcinctd was obtained from the Hill Farming 
Research Organisation and It was first Isolated from premises at Hartwood Farm, Shotts 
when routine treatment of sheep with a benzimidazole anthelmintic failed to reduce faecal 
egg counts. Faecal material was collected from the sheep and taken to Glasgow University 
Veterinary School where larvae were cultured and the parasites used to infect lambs. 
Passage of this strain through lambs was carried out to produce sufficient larvae for 
investigation of the resistance status of the parasites and further studies on development 
of resistance. The passage history of this strain of O.circumcincta is shown in a flow chart 
( Fig. 2.1).
Moredun Strain -  This strain of O.circumcincta ms isolated from sheep at the Animal 
Diseases Research Association, Moredun Institute, Edinburgh.
Bearsden Strain - This strain of O.circumcwctafm been maintained in the Parasitology 
Department at Glasgow University Veterinary School. The parasites have been passaged 
through lambs for approximately 15 years without treatment using anthelmintics.
V.R.S.G. Strain -  This benzimidazole resistant strain of Haemonchus contortus was 
obtained from Dr. E. Lacey, C.S.I.R.O. Division of Animal Health, McMaster Laboratory, 
Sydney, Australia.
McMaster Strain -  This benzimidazole susceptible strain of Hcontortus was obtained 
from Dr. E. Lacey, C.S.I.R.O. Division of Animal Health, McMaster Laboratory, Sydney, 
Australia.
McMaster Strain - This benzimidazole susceptible stain of Ocircumcinctams obtained 
from Dr. E Lacey, C.S.I.R.O, Division of Animal Health, McMaster Laboratory, Sydney,
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Australia.
KS79, KR79 and KS;KR Strains -  These strains of O.circumcincta were obtained from 
Mr. P. Martin, C.S.I.R.O. Division of Animal Health, Parkville Laboratory, Melbourne, 
Australia. The KS79 strain was benzimidazole susceptible, the KR79 was benzimidazole 
resistant and the KS;KR strain was produced by infecting a lamb with a 40;60 mixture of 
larvae of the strains to produce a partially resistant strain of O.circumcincta
Passage of O.circumcincta HFRO, Moredun and Bearsden Strains through 
Lambs
Materials.
The animals used were parasite naive Dorset or Suffolk cross lambs and Scottish Blackface 
cross lambs.
Fenbendazole- Panacur 108 suspension, Hoescht, administered orally at the normal dose 
rate of 5mg/kg.
Method.
1. Lambs were infected by oral administration of 10,000 infective larvae of the relevant 
strain of O.circumcincta
2. At day 20-21 post-infection faecal samples were collected and a McMaster faecal egg 
count (see below) was carried out to confirm that patency had been reached.
3. At a variable interval after patency was attained some of the lambs were treated with 
FBZ at the normal dose rate of 5mg/kg administered orally.
4. At least 5 days were allowed to elapse after treatment before all faecal material was 
collected using a leather faecal bag with plastic liner changed daily. The faeces were used 
for a McMaster faecal egg count and the remainder was incubated at 27-28°C for at least 
10 days in plastic pots. Infective larvae were collected using a Baermanisation technique 
(see below)
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Collection of 0.cfrcumcinctQ\T\iec\\vQ Larvae by Baermanisation
Method.
1. After incubation 20ml warm water was added to each pot and left to stand for 4 h.
2. The material was passed through a coarse wire mesh sieve and the fluid collected.
3. This was loaded onto two 20cm cloth milk filters (Maxa filters -  McCaskie) under 
vacuum. The filters were placed on top of a Baerman funnel filled with warm water and 
left to sit overnight.
4. Larvae were collected from the base of the funnel and were stored at 4°C
McMaster Faecal Egg Count Method
( Method from Oordon and Whitlock, 1939)
Method.
1. Weighed out 3 g of faeces which were placed in a beaker and 42ml water added.
2. The faecal pellets were macerated using an electric homogeniser for approximately 3 
min
3. The homogenate was filtered through a 250micron sieve. The filtrate was mixed and a 
15ml aliquot was placed in a glass tube.
4. This was centrifuged at 1500g for 3-5mins and the supernatant removed.
5. Added 15ml saturated salt to the pellet and mixed well.
6. After thorough mixing an aliquot of the material was loaded into both chambers of a
McMaster slide. _  ____  ________________
7. The eggs within the grid were counted by examining the slide under a binocular 
microscope. The number of eggs in each chamber was added and multiplied by a factor of 
50 to give eggs per gram of faeces.
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Calculation of Adult Worm Burden at Necropsy
( Method from Ritchie etal, 1966)
Method.
1. At necropsy the abomasum was removed from the lamb and opened along the greater 
curvature.
2. The abomasal contents were collected and the surface of the abomasum was washed with 
warm water. All washings and contents were collected and the volume made up to 2 litres.
3. After thorough mixing, two 200ml samples were collected and 20ml 40£v/v formalin 
was added to each. Equal portions of the samples (2-5m l) were stained with 45£ iodine in 
potassium iodide and decolourised with 2.6£ w/v sodium thiosulphate and examined under 
a binxular microscope. The number of adult parasites in each aliquot was counted.
4. The abomasum was divided at the pyloric - fundic juntion and the mucosa scraped off. 
This was finely chopped and digested with pepsin/HCl for 6h at 42°C.
5. Formalin was added to the digested material and the volume was adjusted to a suitable 
value. The material was mixed thoroughly and a 200ml sample was taken.
6. The number of parasites in the sample was counted by the method given above (3.) and 
the total worm burden for the animal calculated by adding the number of parasites in the 
abomasal contents to the number in the digest.
Collection of Faeces from Parasitised Lambs
Method.
1. Leather harnesses were placed on each male lamb which had been infected 
experimentally with the relevant parasites.
2. The faeces were collected in a leather faecal bag with a plastic liner which was attached 
to the harness.
3. For collection of eggs for egg hatch assays the faecal bags were placed on the lambs for
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2-4 h and the contents of the bag were used immediately or stored at 4°C.
Collection of O.circumcincta Eggs from Faeces of Lambs 
Method I ( Method modified from method described by Le Jambre, 1976)
Method,
1. Faecal material was collected by the method given above and this was used to obtain eggs 
for egg hatch assays and for tubulin extraction.
2. Approximately 3-4g of faeces were combined with 10ml saturated salt and homogenised 
for 1-2 min in an electric homogeniser. The faecal/salt mixture was passed through a 
250 micron sieve and the filtrate was placed in a flat tray.
3. Several aliquots of faeces treated in this wey were combined and salt solution was added 
to a depth of 5-7cm.
4. In saturated salt solution the parasite eggs float on the surface, A plastic sheet was 
placed on the surface of the faeces/salt mixture and after 1 - 2 min was removed carefully 
and the material adhering to the sheet was washed into a beaker using water. This step was 
repeated 4 times.
5. All washings were combined and passed through a 38micron sieve. The material which 
collected on the sieve was washed with water into a urine flask. The eggs of O.circumcincta 
cannot pass through a 38micron sieve and therefore collect on the mesh and can be washed 
from the surface of the mesh.
6. In water the eggs sink and the urine flask was allowed to stand for 1-2h at 4°C. The 
supernatant was poured from the urine flask and the concentrated egg suspension which 
had collected at the base of the flask was retained.
7 This egg suspension was examined under a binocular microscope to check for the 
presence of eggs and then the suspension was subjected to a further cleaning process.
8. The suspension was centrifuged at 1,400g for 5- lOmin and the supernatant removed.
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Saturated salt was added in the ratio of 2 parts salt to 1 part egg suspension and the tube 
mixed.
9. This was centrifuged at 1,400g for 5 min. The supernatant was collected and passed 
through a 38micron sieve. The eggs collected on the mesh were washed into a collecting 
beaker with water.
10. To concentrate the egg suspension it was centrifuged at 2,000 g for 5 min and the 
supernatant removed.
11. Three aliquots of lOul of the egg suspension were examined under the binocular 
microscope to estimate the number of eggs present.
Collection of O.circumcincta Eggs from Faeces of Lambs
Method II (Method modified from that described by Coles and Simpkin,( 1977). This
method was developed to try  to reduce the time taken to collect eggs from faecal material.)
Method.
1. Homogenised 2 X 10-20g faeces in water using an electric homogeniser. The 
homogenate was placed in a 200ml centrifuge bottle and the volume made up to 200ml 
using water.
2. Centrifuged for 3 min at 2,000r.p.m using a Mistral refrigerated centrifuge at 4°C. 
Supernatant was removed.
3. The pellet was mixed with saturated salt and volume made up to 200ml using saturated 
salt. Centrifugedat 1,600 r.p.m. for 2.5 min.
4. The supernatant was decanted through a 125micron sieve to remove large particulate 
material. The filtrate was passed through a 38micron sieve and the eggs were washed from 
the mesh using water.
5. The egg suspension was examined under a binocular microscope and if necessary the 
cleaning and concentrating steps described for Method I (7-11) were carried out to
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remove contaminating faecal material.
Egg Hatch Assay for the Detection of Benzimidazole Resistance in Nematode 
Parasites
( Method modified from Coles and Simpkin , 1977 and Le Jambre, 1976)
Reagents.
Suspensions of O.circumcincta eggs in water were isolated by the method given above. 
Benzimidazole stock solutions -  Stock solutions of ABZ and TBZ in methanol over a 
concentration range of lOug/ml -  1 mg/ml.
Sodium thiosulphate solution -  2.6£ w/v of sodium thiosulphate.
Iodine solution - 45£ iodine in potassium iodide.
Sterilin 16 well plastic plates.
Method,
1. Approximately 100 eggs per well were placed in the multiwell plates.
2. The volume in each well was adjusted to 990ul using tap water.
.3. In duplicate I Oul of each concentration of the stock solutions of TBZ or ABZ were added
to wells in the plate. In 2 wells ( blanks)!Oul water were added and in 2 wells lOul
methanol were added ( methanol controls).
4. Plates were agitated to mix the contents of each well then incubated at 37°C for 48h.
5. Plates were removed from the incubator and the parasites were killed using one drop of 
iodine per well.
6. The iodine was decolourised using several drops of the sodium thiosulphate solution.
7. Plates were examined under a binocular microscope and the number of undeveloped 
eggs, larvated eggs and larvae present in each well were counted.
8. For each well the number of undeveloped eggs was expressed as a percentage of the total 
number of parasites in the well. This value was corrected for natural mortality by
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subtracting the average value from the methanol control wells. The corrected values for 
each drug concentration were meaned and the value was expressed as a percentage of the 
total number of parasites which developed in the methanol control well.
9. This corrected percentage failing to hatch was plotted against the drug concentration. 
From the graph the effective dose 50£ (ED50), the concentration of drug which prevents 
development of 50& of the eggs, was calculated.
10. In some studies the percentage failing to hatch was converted to probits and these 
values were plotted against the log of drug concentration. From this plot an ED50 was 
calculated.
Production of First Stage Larvae of Ostertagio circumcincta
Method.
1. Faeces were collected from lambs which had been infected experimentally with the 
relevant strains of O.circumcincta as described previously.
2. Faeces were incubated at 28°C for 48h in plastic pots.
3. Larvae were collected using the Method described previously (see Collection of infective 
larvae of O.circumcincta by Baermanisation).
Collection of Adult Ostertagia circumcincta from the Abomasum of Lambs 
at Necropsy
(Method modified from the modified Baermanisation technique described by Henriksen, 
1965)
Method.
1. The abomasum was removed at necropsy and opened along its greater curvature
2. Aliquots of abomasal contents were placed on a double layer of gauze which was folded to 
form a bag.
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3. This was suspended on rods in a beaker of warm water (30-37°C) and adult parasites 
migrated from the abomasal contents collecting in clumps at the base of the beaker.
4. Adult parasites were examined under a binocular microscope to determine their sex and 
then maintained at 37°C prior to use in transplant experiments.
Exsheathment of Ostertagia circumcincta Infective Larvae
Materials.
Double Strength Milton 2 Sterilising fluid (sodium hypochlorite 2$w/v, sodium chloride 
16Xw/v)
Larvae obtained after culture of faeces (see previously)
Method.
1. To approximately 15ml of larval suspension added 0.75ml Milton 2
2. Tube was mixed thoroughly and incubated at 37°C for up to 5 min. Larvae were
examined at intervals during the period of incubation to check for exsheathment.
3. The mixture was divided into 2 aliquots which were placed in 1 Oml centrifuge tubes and 
the volume in each tube was made up to 1 Oml using water.
4. Tubes were centrifuged at 1,400g-2,000g for 3-5min and the supernatant was 
removed retaining a volume of 1ml.
5. The tubes were refilled with water and the above step repeated twice to ensure that all 
the hypochlorite solution was removed because it is toxic to larvae.
6. The final larval suspension was mixed well and aliquots were examined under a
binocular microscope and an estimate was made of the number of larvae present.
RESULTS AND DISCUSSION 
Routine Passages of Ostertagia circumcincta HFRO, Bearsden and Moredun 
Strains 
Results
The passage history of the HFRO strain of O.circumcincta is shown in Fig. 2.1. Each 
treatment was with FBZ at the normal dose rate of 5mg/kg administered orally. The 
Bearsden susceptible strain of O.circumcincta was passaged in parallel with lambs 
infected on the same day and where possible eggs collected for egg hatch assays on the same 
day post-infection for the susceptible and resistant strains.
The results of the egg hatch assays for the HFRO strain of O.circumcincta are shown in 
Tables 2.1 and 2.2. The time in days after experimental infection of the lambs is stated 
along with the time after treatment of the lambs with FBZ where applicable. Table 2 3 
shows results of egg hatch assays carried out on eggs from lamb DB4 which was infected 
experimentally with larvae of the HFRO strain which had been stored for 4 months at 4°C. 
Results of egg hatch assays on eggs collected from the faeces of lamb B2 which was infected 
experimentally with the Moredun strain of 0circumcincta are shown in Table 2 4 and 
Fig. 2.7. All the ED50s in Tables 2.1, 2.3 and 2.4 were calculated from graphs of probits 
against the log concentration of benzimidazole. Results in Table 2.2 were obtained from 
graphs of percentage failing to hatch against drug concentration. Figs. 2.2-2.7 show 
graphically the day to day changes in resistance as measured in egg hatch assays using TBZ 
or ABZ in the benzimidazole resistant strains of O.circumcincta 
Discussion
The HFRO strain was identified when a group of ewes was treated with TBZ as a routine 
worming drench and this failed to reduce the faecal egg output measured in the ewes. There 
had been reports of benzimidazole resistance in O.circumcincta in the U.K. (B ritt, 1982, 
Cawthorne and Whitehead, 1983) and the poor efficacy of TBZ observed in the case
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Figure 2.1
Passage history of the HFRO benzimidazole resistant strain of
O.circumcincta.
Lamb Number Passage Number and Treatment Number
using Fenbendazole at Smo/kq
DB67
*
DB75
DB48----------------------------------------------  Passage 1, Treatment 1
4^
OB 1 ----------------------------------------------  Passage 2, Treatment 1
4^
DB61----------------------------------------------  Passage 3, T reatment 1
4^
DB74----------------------------------------------  Passage 4, Treatment 2
4^
DB16----------------------------------------------  Passage 5, T reatment 3
:DB25--------------------------  Passage 6, Treatment 3
I
DB62--------/ — 1-------------------------------  Passage 6, Treatment 4
DB 5 --------------------------  Passage 7, Treatment 4
)B 2   Passage 7, T reatment 3
D B 3------------------------------------------------  Passage 7, T reatment 5
4^
DB63----------------------------------------------  Passage 8, Treatment 6
4>
DB 8 ------------------------------------------------  Passage 9, Treatment 7
4>
DB26----------------------------------------------  Passage 10, T reatment 8>
f Sr —i
I DB3:
>B34------------- 1
I DB3
i  I
►B39------------- 1-
i  1
DB32------------------------- Passage 11, T reatment 8
DBJ 9 ------------ ^ ------------------------------ Passage 11, Treatment 9
33------------------------- Passage 12 , T reatment 8
I
DB_ -V ---------------------------- Passage 12, Treatment 10
38  Passage 13, T reatment 8
DB3 ----- ------------------------------ Passage 13, Treatment 11
DB42  Passage 14, T reatment 8
DB41   Passage 14, T reatment 12
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Table 2.1
Results of egg hatch assays carried out during routine passages of the HFRO 
benzimidazole resistant strain of O.circumcincta using TBZ and ABZ
Lamb Number_______Time (Davs)____________________ ED50 (ua/m l)
Post
Infection
Post
Treatment
TBZ ABZ
DB74 23 - 1.53 2.37
DB16 25 - 3.36 3.83
32 1 3.26 0.92
33 2 2.01 5.34
34 3 1.92 -
39 8 0.98 0.92
DB62 27 - 2.81 4.53
28 1 2.83 8.26
29 2 3.06 2.56
30 3 1.40 2.70
34 7 1.68 2.82
38 11 1.60 -
42 15 - 3.50
44 17 3.46 2.92
DB25 27 - 2.44 4.01
28 - 1.31 2.02
29 - 1.31 2.22
30 - 1.91 4.43
36 - - 10.74
38 - - 3.66
42 - - 2.48
44 - 1.30 -
50 - 0.31 1.56
51 - 0.19 0.34
55 - 0.19 1.69
56 - - 3.47
57 - - 1.35
59 - - 2.39
62 - 0.72 2.23
64 - - 2.29
66 - - 0.98
69 - - 2.87
73 — 0.67 1.98
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Table 2.1 (continued)
Lamb Number_______Time (Pays)____________________ED50 (un/m il
Post
Infection
Post
Treatment
TBZ ABZ
DB 5 20 - 0.76 1.58
22 - 1.00 1.97
25 - 0.96 0.75
27 - 1.96 2.19
29 - 1.59 4.33
32 - 0.80 2.25
33 1 0.91 5.13
34 2 0.71 5.90
35 3 - 0.66
39 7 1.13 2.19
41 9 1.50 1.54
46 14 1.59 0.92
48 16 1.46 0.98
55 23 1.70 3.74
63 31 - 2.65
DB2 21 _ 0.76 2.34
26 - 0.81 0.68
28 - 2.09 2.67
30 - 1.85 4.66
DB3 33 6 2.47 6.37
34 7 0.81 0.84
38 11 1.34 2.63
DB63 30 - 1.48 2.02
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Table 2.2
Results of egg hatch assays carried out during routine passages of the HFRO 
benzimidazole resistant strain of O.circumcincta using TBZ and ABZ
Lamb Number______Time (Days)_________________ ED50 (un/mi)
Post
Infection
Post
Treatment
TBZ ABZ
DB 8 31 - 2.38 4.20
39 7 1.78 2.55
DB26 23 - 1.50 2.81
27 - 2.17 4.01
34 - 1.60 1.83
41 5 2.45 2.98
47 11 1.65 0.81
55 19 1.57 1.05
DB19 28 - 1.61 2.82
35 - 1.42 1.99
42 5 1.99 3.63
DB32 26 - 2.02 3.71
40 - 1.32 2.48
DB34 35 - 1.60 1.83
67 10 1.04 1.16
DB33 35 - 1.65 2.30
67 - 1.12 1.07
DB41 28 - 1.92 2.00
30 - 1.45 2.50
42 11 1.36 1.49
49 18 1.84 2.40
1.90 2.81
1.80 2.23
1.47 2.25
1.78 2.41
DB42 28
30
42
49
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Table 2.3
Results of egg hatch assays carried out on eggs passed in the faeces of a 
lamb inoculated with Infective larvae of the HFRO benzimidazole resistant
strain of O.circumcincta which were stored at 4°C for four months 
Lamb Number Time (Pays)____________________EP50 (uo/m l)
Post Post TBZ ABZ
Infection Treatment
DB 4 22 - 1.42 2.24
30 - 1.55 2.04
Table 2.4
Results of egg hatch assays carried out on eggs from the faeces of Lamb B2 
infected with the Moredun benzimidazole resistant strain of O.circumcincta
Lamb Number Time (Pays)____________________ED50 (uo/m l)
Post
Infection
Post
Treatment
TBZ ABZ
B 2 26 - 1.30 0.70
28 - 1.48 0.59
35 - 1.29 2.49
40 - 1.01 1.83
41 1 1.04 -
42 2 0.68 1.12
43 3 1.00 1.54
47 7 1.49 1.18
49 9 2.04 2.39
54 14 2.04 4.22
Figure 2.2
Level of resistance as measured by the ED50 with TBZ and ABZ during 
Passage 5 of the HFRO strain of O.circumcincta in Lamb DB16. Treatment 
with FBZ (Treatment 3 ) was carried out on Day 31 post infection.
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Figure 2.5
Level of resistance as measured by the ED50 with TBZ and ABZ during 
Passage 6 of the HFRO strain of O.circumcincta in Lamb DB62. Treatment 
with FBZ (Treatment 4 ) was carried out on Day 27 post infection.
5 3
H - Z  
Zuj n  n  i—h- <
UJ
u j  o:q: h-
•“  h- 
uj cr.'a o 
cl a
rsj is i 
CQ CCt
o o in in o  o
UJ UJ
!□
i m w
k ^ W W V
i m r n w
o
inT
ro
CM
OV
O 'ro
CO {-Jro c
r*-ro
MDro
h-«no
CL
in cnro
"tro
roro
CMro
ro
oro
O '
(N
>-
<
D
B ir— <  <  &
u j  cn2  o  a. cl
IM IS»aa co 
< < 
o o  in in o  o
IS
F X V v V A
LSW \ \
i 3 X \ V
vO'T
in
<T
ro'T
CM'T
OT
O ' Sro o
HCO uro uj 
u .r- Z 
ro
vD g  ro © a.
inro
Vro
roro
CMro
ro
oro
O '
CM
N W w W k V W V T ^
in
>
<
a
|u i /6 i /281 0CG3 |u i/6 « /20V 0CG3
5 4
Figure 2.4
Level of resistance as measured by the ED50 with TBZ and ABZ during 
Passage 6 of the HFRO strain of 0.circumcwcta in Lamb DB25. The iamb 
was not treated with FBZ during this passage.
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Figure 2.5
Level of resistance as measured by the ED50 with TBZ and ABZ during 
Passage 7 of the HFRO strain of O.circumcincta in Lamb DB5. Treatment 
with FBZ (Treatment 4 ) was carried out on Day 32 post infection.
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Figure 2.6
Level of resistance as measured by the ED50 with TBZ and ABZ during 
Passage 10 of the HFRO strain of O.clrcumclncta in Lamb DB26. Treatment 
with FBZ (Treatment 8 ) was carried out on Day 36 post infection.
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Fioure 2.7
Level of resistance as measured by the ED50 with TBZ and ABZ of the 
Moredun strain of O.circumcincta in Lamb B2. Treatment with FBZ 
(Treatment 1) was carried out on Day 40 post infection.
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described above suggested that anthelmintic resistance may have developed on this farm. 
TBZ had been used on the farm as the anthelmintic for routine treatment of ewes and lambs 
for many years.
Faeces were collected from the ewes on the farm and were cultured to provide infective 
larvae which were used to infect lambs experimentally (DB67 and DB75). These passages 
were used to complete isolation of the possibly benzimidazole resistant strain of 
Ocfrcumcfncta and to increase the number of infective larvae which could be used in 
future studies on anthelmintic resistance in the parasite strain.
Lamb DB48 was infected experimentally with the strain and this was classified as 
Passage 1 for convenience because studies on the strain were to be initiated from this 
point. The previous passages used to isolate the strain and increase the number of 
available larvae have not been taken into account when passages were counted.
During Passage 1 the lamb (DB48) was treated with FBZ at a dose rate of 5mg/kg 
administered orally. The faecal egg output was monitored and after treatment the faeces 
were cultured to provide infective larvae for further passages. The faecal egg output from 
DB48 dropped after treatment but sufficient larvae were cultured to continue passages of 
the strain. Two further passages through lambs DB1 and DB61 were carried out without 
treatment and larvae cultured from the faeces of DB61 were stored at 4°C for 4 months 
prior to infecting DB74 the following spring.
The egg hatch assay was used to test for resistance in the eggs produced in the faeces of 
DB74 on day 23 post infection. An egg hatch assay using eggs of the Bearsden 
benzimidazole susceptible strain on Day 25 post inoculation gave an ED50 of 0.16ug/ml 
for TBZ. The resistance ratio calculated for the HFRO strain and Bearsden strain using TBZ 
in the egg hatch assays was 9.56 indicating that the HFRO strain was highly resistant to 
benzimidazoles.
When lamb DB 74 was treated with FBZ at a dose rate of 5mg/kg administered orally
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the faecal egg count fell to approximately 50 e.p.g. and at this low level it was impossible 
to collect sufficient eggs to carry out the egg hatch assays. However, faeces were cultured 
and sufficient larvae were obtained to infect a lamb for the next passage (DB 16). During 
all the passages 5-14 egg hatch assays were carried out to measure changes in resistance 
Generally in the in vitro  egg hatch assay TBZ is the benzimidazole used to test for 
resistance. The HFRO strain was being selected with FBZ and it was therefore decided to 
carry out the egg hatch assays using one of the broad spectrum benzimidazoles, ABZ , in 
addition to TBZ. FBZ cannot be used in egg hatch assays because of its low ovicidal effect 
and poor solubility (Boersema, 1982). From Figs. 2.2-2.6 changes in resistance were 
paralleled fairly well with these drugs although fluctuations in resistance appeared more 
marked when ABZ was used in the assays. The resistant strain was selected using FBZ and 
although there is side resistance with all benzimidazoles the use of one of the more modern 
compounds with a structure similar to FBZ, ABZ in this case, in the egg hatch assay may 
improve the sensitivity of the test. However, the resistance ratio calculated by comparing 
the HFRO and Bearsden strains is similar for TBZ and ABZ e.g. for passage 8 (DB63) the 
resistance ratio with TBZ was 9 02 and for ABZ was 10 00 
In all passages there was day to day variation in the ED50 calculated from the egg hatch 
assays using both ABZ and TBZ. The ED50 for the period around Day 27 post-infection was 
relatively high. It may be that the more resistant members of the population are fitter and 
more prolific laying eggs at this point. Alternatively responsiveness of the eggs to the 
effect of benzimidazoles may alter with the stage of infection. Perhaps some within-host 
differences at particular stages of the infection may influence the level of resistance in the 
parasite eggs which are produced (see later).
After noting changes in the level of resistance of the HFRO strain during Passage 5 
(DB16) (Fig. 2.3) it was decided to run an untreated infection (DB 25) along with the 
pressurised infection (DB62) during the next passage. Results of the egg hatch assays are
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shown in Table 2.1 and Figs. 2.3 and 2.4. The ED50 was similar for each infection at Day 
27 post infection. After treatment of DB62 with FBZ the ED50s measured in eggs from 
this treated animal were higher than ED50s measured in eggs from the untreated lamb 
( DB25). At Day 28 post infection (24h post treatment) the ED50s were 1.31 ug/ml TBZ 
and 2.02 ug/ml ABZ for DB 25 (untreated ) and 2.83 ug/ml TBZ and 8.26 ug/ml ABZ in 
DB62 (treated). This apparently higher ED50 immediately post treatment was 
unexpected. Benzimidazoles are considered to act by binding to tubulin causing 
disintegration of microtubules in parasite cells (Borgers and De Nollin, 1975). After 
treatment of the lamb with FBZ it was thought that the FBZ would bind to tubulin in the 
resistant eggs. During the egg hatch assay less TBZ or ABZ would then be required to 
prevent hatching because of the presence of bound FBZ. This should produce a reduced 
ED50. However, the results from DB62 and DB25 are at variance with this theory In 
other passages shown in Figs. 2.2, 2.5 and 2.6 there is an increase in the ED50 after 
treatment with FBZ although for these passages there is no untreated passage to allow a 
direct comparison betweeen treated and untreated and changes in ED50 could reflect day to 
day variation in the ED50 which was found in all passages. The changes in ED50 after 
treatment appeared more pronounced when ABZ was used in the egg hatch assays.
After treatment there may be a change in the egg laying population with only some 
females producing eggs immediately post treatment with FBZ. During some passages 
(4 -8 ) there was a fall in faecal egg count after treatment with FBZ which rose again after 
5-7 days . One week post treatment in all passages the ED50 had returned to around the 
pre-treatment level and this may correlate with the return to normal egg laying capacity 
observed from faecal egg counts.
During the untreated passage ( DB25) results of egg hatch assays using both TBZ and ABZ 
show day to day variability, Unfortunately the first egg hatch assay was carried out on Day 
27 post infection rather than immediatly after patency of the infection (Day 21 post
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infection). For DB25 the level of resistance measured using ABZ in the egg hatch assay 
showed a high level for Days 27-30 reaching a peak at Day 36 then falling to a low level 
at Day 50-51 before rising again later in the infection although never attaining the high 
level encountered during the early part of the infection. A similar pattern was found using 
TBZ in the egg hatch assays but fewer egg hatch assays were carried out with this drug. 
During Passage 7 (DB5) egg hatch assays were performed at patency (Day 20 post 
infection) and the results (Fig. 2.5) indicated a low ED50 at Day 20 rising to a higher 
level by Day 27-29 post infection. The pattern of day to day variation in results of the egg 
hatch assay with the HFRO strain of 0. circumcincta seems to indicate a low level of 
resistance at patency which rises rapidly to reach a higher level by Day 27 , remains high 
up to day 40-45 then falls to a low level around day 50-55 before rising again later in 
the infection. Changes in the level of resistance during an infection have also been noted by 
Borgsteede and Couwenberg (1987). These authors measured the level of resistance in 
experimental infections with a benzimidazole resistant and benzimidazole susceptible 
strain of H.contortus using an egg hatch assay from Day 22-77 post infection. They found 
a low level of ED50 at Day 22 which rose steadily with highest values for the ED50 Days 
40-60 post infection then a slight decrease in the ED50 towards the end of the infection. 
The pattern was similar in both the resistant and susceptible strains. Throughout the 
infection the variation in the ED50 was by a factor of 2. Le Jambre (1976) noted day to 
day variation In the egg hatch assay results and considered that changes in the ED50 may 
reflect differences in the stage of development of the eggs at the time the egg hatch assay 
was started. To overcome this problem it was recommended that a susceptible strain was 
tested at the same time and under the same conditions as the resistant strain and the 
resistance ratio calculated. This ratio appears to be an accurate measure of resistance and 
shows little day to day variation. From Borgsteede and Couwenberg (1987) it would 
appear that changes in the ED50 found during an infection are similar for the resistant
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and susceptible strain therefore the resistance ratio will remain constant. Throughout 
passages of the HFRO strain a susceptible strain of O.circumcincta, the Bearsden strain, 
was run in parallel and an ED50 for this strain measured at the same time as the resistant 
strain in order to ensure that the resistance level was measured accurately.
The reasons for the changes in the ED50 noted above are unknown. In a review of 
methods used to detect anthelmintic resistance Boersema (1982) described the variations 
in methods used in the egg hatch assays by various authors and described some of the 
results for ED50s found for benzimidazole susceptible strains of H.contortus achieved 
using these methods. For the Bearsden strain of O.circumcincta the ED50 was 
approximately 0.16ug/ml TBZ and 0.20 ug/ml ABZ which is high compared with results 
for susceptible strains assayed by Cawthorne and Whitehead (1983) who gave ED50s for 
two susceptible strains of O.circumcincta as 0 038ug/ml TBZ and 0.036ug/ml TBZ. 
These discrepancies between resistance levels are probably due to differences in the 
technique used in the egg hatch assay or differences in the strains of O.circumcincta The 
Bearsden strain has been maintained at Glasgow Veterinary School for approximately 15 
years without pressurisation and should be susceptible to the effects of benzimidazole 
anthelmintics. Results of tubulin binding assays with MBZ (see later) comparing 
different strains of O.circumcincta showed the Bearsden strain to be highly susceptible to 
benzimidazoles. The higher ED50s calculated for the Bearsden strain compared with 
ED50s for susceptible strains measured by Cawthorne and Whitehead (1983) are not 
likely to be due to possible resistance in the Bearsden strain. However, differences in the 
actual ED50 values found in assays carried out in different laboratories are probably not 
as important as the comparison of ED50s between resistant and susceptible strains studied
in individual laboratories.
The time of incubation used during the egg hatch assay also may influence the results 
of the assay. Le Jambre (1976) used incubation for 72h, Coles and Simpkin (1977) and
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^oersema ( 1982) used 48h, Cawthorne and Whitehead (1983) used 24h and most of the 
egg hatch assay methods used in Australia involve 24h incubation. During passage 7 (DB 
2) the egg hatch assay was carried out comparing 24h and 48h incubation on Day 21 post 
infection and the ED50s calculated were identical. When calculating ED50s in the above 
assays the hatched larvae and eggs showing development (embryonated eggs ) were counted 
as alive and those eggs which failed to develop were counted as dead and the percentage 
failing to develop was used when calculating the ED50. Workers in Australia have noted 
higher resistance factors because they count only hatched larvae as alive and consider all 
eggs, developed and undeveloped, as dead. Smith-Buijs and Borgsteede (1986) found high 
levels of embryonated eggs in low drug concentrations of benzimidazoles with their 
susceptible strain of Hcontortus in egg hatch assays, whereas the majority of eggs of the 
resistant strain hatched to larvae at low concentrations of benzimidazoles. These authors 
suggested that in the susceptible strains the benzimidazoles prevent hatching of the eggs 
whereas in the resistant strains the benzimidazoles have little effect on hatching. Similar 
results were found during the routine passages of the Bearsden and HFRO strains of 
O.circumcincta and the percentage of embryonated eggs was high in egg hatch assays 
immediately post treatment of the HFRO strain with FBZ and in assays during the later 
period of an infection (Day 60 onwards). In order to maintain consistency of results 
embryonated eggs were counted as developed in all assays. However, contrary to results 
found with the HFRO and Bearsden strains of O.circumcincta, Hall eta/. (1978a) found 
more consistent results in egg hatch assays with Hcontortus and T.co/ubriformis when 
embryonated eggs were counted as dead rather than alive.
Another problem with the egg hatch assay is the stage of development of the eggs at the 
start of the period of incubation with drug in the egg hatch assays. Coles and Simpkin
(1977) noted that embryonation of nematode eggs occurs rapidly and these authors stated 
that eggs for the egg hatch technique should be collected from fresh faeces and tested within
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4h of expulsion from the host animal. Le Jembre (1976) also noted that variation in 
EDSOs from day to day may reflect changes in the stage of development of the eggs when 
tested, brought about by variation in the ambient temperature during the time of eqg 
collection Faecal egg counts during infections with Hcontortus or* considerably higher 
than with O.circumcincta therefore sufficient eggs can be collected over a short period of 
time. During the early passages of the HFRO and Bearsden strains faecal material was 
collected from the lambs overnight and material from the top of the faecal bags was used 
for collection of eggs for the egg hatch assay to try to ensure that the eggs were as freshly 
passed as possible. The variation in the stage of development of the eggs collected may have 
had some effect on the egg hatch assay results increasing variability of results.
From Passage 7 onwards a different collection schedule was followed with faeces 
collected over a 3-4h period With this shorter period of collection and therefore more 
predictable age of eggs the results of the egg hatch assays still showed day to day variation. 
Smith- Buijs and Borgsteede (1986) studied the effect of storage of eggs on the results of 
the egg hatch assays. These authors found that storage of eggs for 0, 24 and 72h at 4°C 
prior to use In the egg hatch assay had no effect on the resultant ED50 However the 
hatchability of the eggs was reduced to between 40-50® when eggs were stored for 72h 
and storage for Iweek at 4°C totally prevented eggs from hatching. It is possible that 
prolonged storage of larvae is more detrimental to hatchability in Hcontortus rather than 
to O.circumcincta mb T.colubrnormis (Smith-Buijs and Borgsteede, 1986)
Le Jambre (1976) found that higher concentrations of benzimidazoles were required to 
prevent hatching of embryonated eggs compared with unembryonated eggs. The reasons for 
this reduced susceptibility of embryonated eggs to benzimidazoles may be due to changes in 
the metabolism of eggs after embryonation (Weston etat, 1984).The uptake of TBZ was 
reduced in embryonated eggs compared with unembryonated eggs possibly because of the 
lower level of lipid in the embryonated eggs. Uptake of benzimidazoles is thought to be by
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passive diffusion into the eggs and therefore the lipid content of the embryonated egg, 
which can be approximately 60% less than the lipid content of the undeveloped egg, can 
have an effect on the uptake of lipid soluble benzimidazoles. As the eggs develop oxygen 
uptake increases and there is evidence of an increasing level of aerobic metabolism in 
embryonated eggs compared with undeveloped eggs. If a possible mechanism of action of the 
benzimidazole is inhibition of fumarate reductase which is associated with anaerobic 
metabolism a shift to aerobic metabolism will reduce the effect of the drug and therefore 
embryonated eggs may be less susceptible to the effect of the benzimidazoles.
The uptake of the benzimidazoles into the eggs is affected by the nature of the 
benzimidazole and possibly the solvent used in the egg hatch assay. Because of the low 
solubility of FBZ this benzimidazole is not suitable for use in the egg hatch assay. Kirsch
(1978) in studies on the ovicidal effect of FBZ found that after oral administration of FBZ 
to the host parasite eggs passed in the faeces showed atypical development. However, 
increasing drug concentrations of FBZ in egg hatch assays with Too/ubriformis did not 
increase the ovicidal effect. This was thought to be due to poor solubility of the drug 
limiting its uptake into the eggs. FBZ is metabolised to OFZ and testing this metabolite in 
egg hatch assays failed to show any ovicidal effect at the highest concentrations where the 
drug could be solubilised (Boersema etal, 1982). Failure of this drug to prevent egg 
hatching could be due to lack of absorption of the drug through the shell of the eggs (See 
later for discussion on the ovicidal activity of ABSX and ABSO). Bone and Coles ( 1987) 
have decribed the use of a toxin from Bocillus thurmgiensis /srooIons ism  combination 
with benzimidazoles in egg hatch assays using Icolubriformis. The bacterial toxin caused 
a decrease in the ED50s possibly by increasing the uptake of drug into the eggs by an 
alteration in egg permeability (Bone and Coles, 1987) This work suggests that uptake of 
benzimidazoles into eggs occurs by passive diffusion and any alteration in permeability of 
the egg shell will affect drug uptake.
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Differences in the solvent for the benzimidazole used in the egg hatch assays may be 
partly responsible for differences in the ED50s found between different workers. Le 
Jambre (1976) used TBZ in 0.1 ^sodium chloride, Coles and Simpkin (1977) used 
DMSO, Hall eta/., (1978a) used commercial drug preparations diluted in distilled water 
and Cawthorne and Whitehead (1983) used methanol. High concentrations of solvents are 
lethal to nematode eggs and therefore for the assays a concentration of < 5£ methanol was 
used for each concentration of the drug. DMSO acts as an agent which can increase drug 
penetration into tissues and this may account for some of the differences in the ED50 when 
this drug was used as the solvent for benzimidazoles in egg hatch assays carried out in 
other laboratories. However, a control well with the equivalent concentration of solvent 
was used throughout the egg hatch assays to ensure that any measured effect on 
hatchability of the eggs was due to the benzimidazole anthelmintic. The percentage of the 
eggs failing to hatch in control wells varied from day to day therefore controls were 
necessary for each assay. Day to day variation in hatchability was noted also by Coles and 
Simpkin (1977).
After isolation of the HFRO strain of Qcircumcinctd the level of resistance of the 
parasites as measured by the egg hatch assay was studied over the 14 passages with or 
without pressurisation using FBZ. The ED50s for both TBZ and ABZ were very similar at 
Passage 4 (DB74), Passage 8 (DB63) and Passage 14 (DB41) indicating that constant 
pressurisation with FBZ did not increase the level of resistance in the strain. Martin e t 
a/., (1984) found that after producing a highly resistant strain of O.circumcincta in a 
field experiment by treating with TBZ 17 times per year for two years further 
treatments over the next three years failed to increase the level of resistance. The level of 
resistance to TBZ estimated using a single in vitro  egg hatch assay each year remained at 
14 times higher than an untreated benzimidazole susceptible field strain. However, with a 
less resistant strain of O.circumcincta which had a resistance level 3 times the
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susceptible level they found that treatment with TBZ 5 times yearly in the field increased 
the resistance level to 6 times that of the susceptible over two years. The HFRO strain may 
be highly resistant and therefore further selection cannot increase the overall resistance 
level which is approximately 10 times that of the Bearsden susceptible strain. However, 
from the results in Fig. 2.4 it is possible to encounter a higher level of resistance in egg 
hatch assays which were carried out at a particular time during the course of an 
infection.
Removal of pressurisation also appeared to have little effect on the level of resistance in 
the HFRO strain of O.circumcincta From Passage 11 onwards two lines, a FBZ pressurised 
and an unpressurised line, were maintained and studied in parallel. There was no 
significant difference in the ED50s measured for the differentially treated lines. Rapid 
reversion to benzimidazole susceptibility was not observed. This is contrary to the results 
obtained by Simpkin and Coles (1978) using T.coiubriformis and Hcontortus. These 
authors found that the level of resistance measured by the egg hatch assay fell if parasites 
were passaged through lambs without pressurisation and pressurisation with TBZ selected 
for worms producing eggs which were more resistant to TBZ, CBZ and PBZ but not MBZ in 
egg hatch assays. This differential resistance exhibited by individual benzimidazoles was 
thought to be due to the polygenic nature of the inheritance of resistance (see later). The 
reversion to susceptibility on removal of selection pressure with benzimidazoles noted by 
Simpkin and Coles (1978) was not found by other authors in separate trials. Hall eta/. 
(1982) using benzimidazole resistant strains of T.coiubriformis and H. contortus 
passaged the parasites over 12 generations in the laboratory without TBZ and found no 
significant change in the level of resistance measured by egg hatch assays. These authors 
noted that compared with the field situation there was no chance of dilution of the strain 
with susceptible parasites which may have remained on pasture. However, they implied a 
similarity with a self contained flx k  stating that it was unlikely that reversion to
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susceptibility would occur if a population of parasites had been selected heavily for 
resistance without the reintroduction of large numbers of susceptible parasites. 
Maintenance of a high level of benzimidazole resistance was also noted by Le Jambre eta/. 
(1982) in a strain of Hcontortus when selection pressure was removed over 4 
generations and these authors suggested this implied that the resistant parasites were as 
f it as the non-resistant parasites and therefore were not likely to be removed from the 
population even when selection pressure with benzimidazoles was removed.
Donald eta/., (1980) used a benzimidazole resistant strain of O.circumcincta in trials 
comparing the level of resistance measured by egg hatch assays and anthelmintic 
efficiency trials in untreated field infections with infections treated with levamisole 
every 4 weeks. They found that levamisole selected positively against benzimidazole 
resistance. Similar results were found by Waller et a). ,(1983) and Martin et at. , 
(1988) using Ostertagia spp where counter selection with levamisole over several 
generations reduced the level of benzimidazole resistance compared with an untreated 
strain where reversion to susceptibility did not occur. The reason for this counter 
selection using an anthelmintic with a different mode of action in the field is unknown but 
may involve changes in the population dynamics of the parasites and therefore an 
alteration in the ability of the benzimidazole resistant parasites to survive. For reversion 
to susceptibility to occur the susceptible phenotype must have a fitness advantage over the 
resistant phenotype. However, experience with insecticidal resistance suggested that after 
intense selection the genome of the insects becomes reorganised in order that the resistant 
phenotype becomes as fit as the susceptible even in the absence of the selecting agent 
(Georghiou and Tavlor, 1976 ; McKenzie eta/., 1982; McKenzie and Purvis, 1984). In 
this situation where the resistant parasites are not disadvantaged in the absence of the 
selecting agent the resistance level in the population w ill remain stable until introduction 
of different genetic material or a change in the factors affecting the fitness of the
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parasites.
In the field situation the rate of development of resistance depends on the percentage of 
the population exposed to the selecting agent ( Martin et a f  1981). The percentage of the 
population of the parasites whichescapes selection is known as the population in refugia. 
For nematode parasites the free living larval stages on the pasture can escape selection 
with anthelmintics and act as a source of susceptible parasites maintaining the gene pool of 
susceptible characteristics. Where a small proportion of the larvae are in refugia, 
resistance to the selecting agent develops rapidly and where an increased proportion of the 
larvae are in refugia , resistance is slower to develop. The increase in the level of 
resistance was inversely proportional to the percentage of the population in refugia. All 
experiments with the HFRO strain of O.circumcincta^^ carried out in the laboratory 
with experimental infection of lambs using larvae obtained from previous passages and 
therefore none of the parasites were in refugia This could account for the high level of 
resistance found at the initial egg hatch assay (Passage 4, DB74) because resistant 
parasites would be selected intensively after the initial treatment (Passage 1, 
Treatment!) without dilution by unselected parasites and also the failure to revert to 
susceptibility on removal of selection pressure (Passages 11-14).
After treatment of lamb DB74 with FBZ at the normal dose rate the faecal egg count of 
the lamb fell to approximately 50 eggs per gram making collection of eggs for egg hatch 
assays impossible. Prior to infection of the lamb the larvae had been stored at 4°C for 4 
months throughout the winter period when suitable hosts which could be used to continue 
passaging the parasites were not available. Although from results of a single egg hatch 
assay prior to treatment with FBZ the parasite population was resistant the fall in faecal 
egg count after treatment suggested that the resistance level may have fallen. The effect of 
storage of larvae over a four month period was then studied using lamb DB4. Larvae 
collected from the faeces of DB74 prior to treatment with FBZ were stored at 4°C for 4
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months then used to infect DB4. This lamb was infected at the same time as lamb DB63 
during the routine passages and the results of egg hatch assays on eggs passed in the faeces 
of the lambs are shown in Tables 2.1 and 2.3. Storage of larvae over the period had no 
effect on the level of resistance and the results for DB4 infected with stored larvae from 
DB74 (Passage4, Treatment 1) were similar to results for DB63 (Passage 8, Treatment 
5). The reason for the fall in faecal egg count after treatment of DB74 with FBZ cannot be 
explained by a fall in resistance over the period of storage of the larvae. However, during 
the initial passages of the HFRO strain there was a tendency for faecal egg counts to fall 
immmediately post-treatment with anthelmintics and rise again after approximately 5-7 
days. This fall in egg count immediately post treatment has been noted by other workers 
(Martin, personal communication) and it could be due to reduced reproductive function in 
the resistant parasites over the period of treatment.
A strain of benzimidazole resistant O.circumcincta was obtained from the Moredun 
Institute and the resistance level as measured by egg hatch assays was compared with the 
HFRO strain. Results of egg hatch assays on eggs passed in the faeces of lamb B2 which was 
infected with the Moredun strain are shown in Table 2.4 and Fig. 2.7. Egg hatch assays 
during the initial period post-infection ( Days 26 and 28) showed a low ED50 for ABZ 
compared with the ED50 for TBZ. In the majority of egg hatch assays on the HFRO strain 
of O.circumcincta the ED50 for ABZ was higher than the ED50 using TBZ. Side resistance 
to the other benzimidazoles may have been less with the Moredun strain than the HFRO 
strain. Immediately post treatment with FBZ there was no effect on the ED50 but in the 
later part of the infection (Days 49 and 54) the level of resistance was higher. This is 
the opposite effect to the HFRO strain where during the later stages of infection the ED50 
had a tendency to fall (see previously), It is possible that the population dynamics within 
the host differ for these two strains of O.circumcincta with individual parasites within 
the population laying different numbers of eggs at different periods during the infection.
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However, calculation of the mean ED50 for the Moredun strain for both TBZ and ABZ 
suggested that this strain was less resistant than the HFRO strain and further studies on 
this strain were abandoned in favour of the more resistant HFRO strain of O.circumcincta
Dose Titration Trial
The dose titration trial was set up to examine the effect of treatment with increasing 
doses of FBZ on the level of benzimidazole resistance in the HFRO strain of O.circumcincta 
measured by an anthelmintic efficiency test and in vitro  egg hatch assays.
Experimental Design.
Experiment 1. A dose titration trial (Moskey and Harwood, 1941; Gibson, 1964 , 
Prichard eta/, 1980; Powers eta/., 1982) was carried out using 3 groups of 5 male 
lambs. The lambs were infected on Day 0 with 10,000 O.circumcincta infective larvae 
cultured from the faeces of lamb DB25 (Passage 6, treated on 3 occasions). Patency was 
shown by positive faecal egg counts on Day 21, and on Day 23, 4 lambs of each group were 
treated with FBZ administered orally at dose rates of 5,10, 20 and 40 mg/kg respectively 
with the remaining lamb in each group used as an untreated control. Lambs were 
slaughtered one week post treatment and worm burdens were measured (see General 
Materials and Methods).
Experiment 2. Five male lambs were infected experimentally on Day 0 with 10,000 
O.circumcincta infective larvae cultured from the faeces of lamb DB25 . On Days 31, 35 
and 38 parasite eggs were collected from the lambs' faeces to be used for in vitro  egg 
hatch assays. On Day 44,4 lambs were treated with FBZ administered orally at dose rates 
of 5, 10, 20 and 40 mg/kg and one lamb was an untreated control. On Day 49 and Day 51 
parasite eggs were collected from the lambs' faeces and used in egg hatch assays. On Day 58 
the lambs were slaughtered and parasite burdens calculated.
Experiment 3. Five female and five male lambs were inoculated on Day 0 with 10,000
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infective larvae of O.circumcincta cultured from the faeces of DB25. On Day 21, 4 of the 
female lambs were treated with FBZ administered orally at dose rates of 5, 10,20 and 40 
mg/kg and the remaining female was left untreated. On Day 29 all 5 female lambs were 
killed and their worm burdens calculated. At necropsy, faeces were collected from the 
terminal colon and rectum and used to obtain parasite eggs for egg hatch assays. On Days 
23 and 24, parasite eggs were collected from the faeces of the 5 male lambs. On Day 29, 4 
of the male lambs were treated with FBZ administered orally at dose rates of 5, 10, 20 
and 40 mg/kg and one lamb remained as an untreated control. On Days 35 and 36 parasite 
eggs were collected from the lambs' faeces and used in egg hatch assays. On Day 42, the 5 
male lambs were slaughtered and worm burdens calculated.
Results
The results of the dose titration trials in Experiments 1, 2 and 3 are given in Table 2.5. 
The parasite burdens found at necropsy are listed together with the percentage reduction 
in parasite numbers compared with those of the control animals. Dose titration curves for 
each of the experiments are shown in Fig. 2.8 and a mean dose titration curve using 
combined data from all three experiments is shown in Fig. 2.9. The means were calculated 
by adjusting the values for Experiment 2 by a factor of 1.44 to give the equivalent worm 
burden in the control animal as was found in the other experiments. The mean values for 
percentage reduction in worm burden were 205?, 285?, 505? and 675? for lambs treated 
orally with 5mg/kg, 1 Omg/kg, 20mg/kg and 40mg/kg of FBZ respectively.
The ED50s calculated from egg hatch assays using TBZ or ABZ in Experiment 2 are given 
in Tables 2.6 and 2.7 respectively. Results from the assays conducted prior to and after 
treatment of the lambs with the stated doses of FBZ are shown. The results are represented 
graphically in Figs. 2.10 and 2.11. Tables 2.8 and 2.9 show the ED50s calculated from egg 
hatch assays carried out during Experiment 3 using TBZ and ABZ respectively. For the 5 
male lambs results were obtained before and after treatment of the lambs with the stated
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doses of FBZ. Included In the table are the egg hatch assay results obtained for eggs 
collected at necropsy, 7 days after treatment with FBZ of the 5 female lambs in 
Experiment 3. In all cases egg hatch assays were carried out at least 5 days after 
treatment of the lambs with FBZ to avoid possible fluctuations in results (see 
previously). Graphs of the results of egg hatch assays in Experiment 3 are shown in Figs. 
2.12 and 2.13.
In Experiment 2, a mean value for percentage eggs failing to develop at each 
concentration of TBZ or ABZ used in the egg hatch assay was calculated using the values 
obtained from all 5 male lambs on the three occasions prior to treatment with FBZ. These 
values were used to plot a dose response curve of mean percentage failing to develop 
against drug concentration for TBZ and ABZ shown in Fig. 2.14. From these dose response 
curves the mean ED50 for the HFRO strain of O.circumcincta was calculated at 1.61 
ug/ml TBZ and 2.61 ug/ml ABZ. The data obtained from egg hatch assays prior to 
treatment of the lambs with FBZ in Experiment 3 were treated in a similar way. Mean 
values for percentage of eggs failing to develop were used to plot the dose response curves 
shown in Fig. 2.15 The mean ED50s for the parasites prior to treatment with FBZ were 
1.65 ug/ml TBZ and 2.87 ug/ml ABZ.
Discussion
The HFRO strain of O.circumcincta^ shown to be highly resistant to the effects of the 
benzimidazole anthelmintic in the dose titration trials. The normal therapeutic dose rate 
for FBZ in sheep is 5mg/kg and in all of these experiments this dose had poor efficacy with 
percentage reductions in parasite burden of 0%, 67£ and 56£ in Experiments 1, 2 and 3 
respectively. Data from the egg hatch assays also indicates a high level of resistance
(Tables 2 6-2.9 and Figs 2 10-2 13)
The variability in the effect of FBZ on adult worms was marked. In Experiment 1, three 
groups of lambs were used and therefore the results are a mean of three animals treated at
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Table 2.5
Results of dose titration Experiments 1, 2 and 3 on Iambs infected with 
O.circumcincta and treated with FBZ administered orally at dose rates of 0 , 5, 
10, 20 and 40mg/kg, showing adult worm counts at necropsy, mean worm 
counts for each experiment and percentage reduction in worm counts compared
with control animals.
Dose FBZ Experiment 1 Experiment 2 Experiment 3
(mg/kg) 6p 1 6p 2 Gp 3 Mean %* M %* M F Mean %*
control 4750 4100 4350 4400 3050 3600 5250 4425
5 7650 3900 4500 5350 0 1000 67 1750 2100 1925 56
10 3050 4300 3400 3583 19 2150 30 1300 4250 2775 37
20 3200 3400 1500 2700 39 2150 30 600 1300 950 78
40 1900 2500 950 1783 60 100 97 3200 50 1025 63
♦Percentage reduction in mean worm counts compared with the control animals 
M-Male lambs F- Female lambs
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Figure 2.8
DOsa titration: curves plotting percentage reduction in worm burden against 
dosage of FBI ((mg/kg) used orally in lambs in dose titration Experiments
1-3.
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Figure 2.9
A mean dose titration curve plotting percentage reduction in worm burden 
against dosage of FBZ (mg/kg) used orally in lambs using combined data 
from dose titration Experiments 1 -3 .
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Table 2.6
Results of egg hatch assays using TBZ for lambs in Experiment 2 before and 
after treatment with FBZ at the stated dose rates
ED50 (gg/ml TBZ) calculated from eoo hatch assays 
Dose of FBZ used in Lambs
Time * control 5ma/ka 1Oma/ka 20ma/ka 40ma/ka
(days)
31 1.73 1.67 1.65 2.06 1.66
35 1.67 1.81 1.72 1.78 1.71
38 1.60 1.68 1.71 1.40 1.36
1.60 1.44 1.50 1.55 1.67
Z \ * * 1.61 1.67 1.60 1.57 1.70
♦Days post inoculation of lambs with 10,000 0. circumcincta L3 larvae.
♦♦Post treatment of the lambs with FBZ administered orally at the stated dose rates.
Table 2.7
Results of egg hatch assays using ABZ for lambs in Experiment 2 before and 
after treatment with FBZ at the stated dose rates
ED50 (uq/ml ABZ) calculated from eoo hatch assays 
Dose of FBZ used in Lambs
Time *
(days)
control 5mo/ko 10ma/ka 20ma/ka 40ma/ka
31 2.99 2.51 2.15 3.17 2.66
35 2.83 3.40 2.76 2.85 3.49
38 2.13 1.97 2.79 1.63 2.02
49* * 2.88 2.66 2.64 2.62 2.82
51** 2.75 3.16 2.94 2.74 2.58
*Days post inoculation of lambs with 10,000 0 cfrcumcincta L3 larvae.
**Post treatment of the lambs with FBZ administered orally at the stated dose rates.
Table 2.8
Results of egg hatch assays using TBZ for lambs in Experiment 3 before and 
after treatment with FBZ at the stated dose rates
ED50 fug/ml TBZ) calculated from eoo hatch assays 
Dose of FBZ used in Lambs
Time *
(days)
control 5ma/ka 10ma/ka 20ma/ka 40ma/ka
23 1.89 1.64 1.67 2.01 1.94
24 1 74 1 50 1 75 1 29 1 83
29* * 1.41 1.47 1.51 1.72 -
3 5 *** 1.68 1.44 1.94 1.65 1.61
3 6 *** 1.49 1.59 1.59 1.54 1.50
*Days post inoculation of lambs with 10,000 G circumcincts L3 larvae.
**Egg hatch assav results for the female lambs after treatment with FBZ administered
orally at the stated dose rates.
***Post treatment of the lambs with FBZ administered orally at the stated dose rates.
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Table 2.9
Results of egg hatch assays using ABZ for lambs in Experiment 3 before and 
after treatment with FBZ at the stated dose rates
ED50 (uo/ml ABZ) calculated from eoo hatch assays 
Dose of FBZ used in Lambs
Time *
(days)
control 5ma/k.a 1Oma/'ka 20ma/ka 40ma/ka
23 3.68 3.18 3.28 3.33 3.50
24 2.03 2.10 2.27 2.41 2.37
29** 2.00 1.87 1.78 2.64 -
35 *** 2.25 1.58 2.87 2.30 2.13
3 6 *** 1.88 2.20 1.88 202 1 60
*Days post inoculation of lambs with 10,000 0. circumcincta L3 larvae.
**Egg hatch assay results for the female lambs after treatment with FBZ administered 
orally at the stated dose rates.
***Post treatment of the lambs with FBZ administered orally at the stated dose rates.
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Figure 2.10
The level of resistance measured by the ED50 with TBZ in lambs before and 
after treatment of the lambs with increasing doses of FBZ in dose titration
Experiment 2 .
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Figure 2.11
The level of resistance measured by the ED50 with ABZ in lambs before and 
after treatment of the lambs with Increasing doses of FBZ in dose titration
Experiment 2 .
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Figure 2.12
The level of resistance measured by the ED50 with TBZ in lambs before and 
after treatment of the lambs with increasing doses of FBZ in dose titration
Experiment 3.
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Figure 2.15
The level of resistance measured by the ED50 with ABZ in lambs before and 
after treatment of the lambs with increasing doses of FBZ In dose titration
Experiment 3 .
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Figure 2.14
Dose response curves plotting the mean percentage failing to develop of 
eggs collected from faeces of 5 lambs in dose titration Experiment 2 t prior 
to treatment with FBZ and exposed to increasing concentrations of ABZ or 
TBZ in egg hatch assays on 3 occasions.
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Figure 2.15
Dose response curves plotting the mean percentage failing to develop of 
eggs collected from faeces of 5 male lambs in dose titration Experiment 3, 
prior to treatment with FBZ and exposed to increasing concentrations of 
ABZ or TBZ in egg hatch assays on 2 occasions.
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each dose of FBZ. In the other two experiments one and two lambs respectively were 
treated at each dose level. These low numbers of animals could account for the non-linear 
dose response curve achieved in Experiment 3. In Experiment 2 the lambs were killed at a 
late stage in the infection, Day 58, and the worm burdens could have been affected by 
natural mortality of adult parasites.
In Experiment 3, the yield of adult parasites at slaughter was greater in the female 
sheep than the male sheep except for the male lamb treated with FBZ at 40mg/kg which 
retained a high parasite burden compared with the comparably treated female lamb. The 
differences may reflect variation in the infection rate within the animals used in this 
experiment. In Experiment 1, the LD50 to adult O.circumcincta for orally administered 
FBZ calculated from the dose titration curve is 31 .Smg/'kg. The dose titration curve using 
the mean of values from all six lambs treated at each dose of FBZ (Fig. 2.9) has a similar 
slope to the dose titration curve drawn using results from Experiment 1 (Fig. 2.8). The 
LD50 calculated using the mean dose titration curve is 25.7mg/kg FBZ which is lower 
than that calculated in Experiment 1. The efficacy of orally administered FBZ as measured 
by the percentage reduction in adult worm burden was greater, but not significantly, in 
Experiments 2 and 3 than in Experiment 1 at dose rates of 5mg/kg and lOmg/kg. This 
may reflect individual variation and emphasises the disadvantages of this method for 
measuring anthelmintic resistance accurately in that large numbers of animals are 
required to overcome biological variation (Powers at at, 1982). For the controlled 
anthelmintic efficiency test it has been estimated that 16 animals per group are required 
to give accurate measurement of a two fold difference in resistance status because of 
between animal variation in worm burdens ( Martin atal, 1982).
Hall at al, (1978b) performed a dose titration study using resistant strains of 
Hcwtortus and TcaMnfarm/s with 3 dose rates and 3 lambs in each group similar to 
Experiment 1 described above, and obtained linear log dose, log response curves. These
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were used to calculate an effective dose ED95 (95£ reduction in worm counts) for the 
compound used in their experiment. However, from Fig. 2.9 it is impossible to obtain a 
figure for ED95 for the HFRO strain of O.circumcincta because of the lower efficacy of the 
FBZ at the dose rates used and the high level of resistance of this strain of O.circumcincta 
Another tria l in the United Kingdom to establish the resistance to orally administered FBZ 
of a benzimidazole resistant strain of O.circumcincta { Britt and Oakley, 1986) showed 
FBZ at dose rates of 5mg/kg and lOmg/kg to have efficacies of 142% and 91.3& 
respectively. These levels of efficacy are much higher than values obtained in the current, 
experiments (Table 2.5).
In Experiments 2 and 3, a comparison between the egg hatch assay and the controlled 
anthelmintic efficiency test was investigated. In each egg hatch assay a dose titration curve 
is constructed for the effect of varying concentrations of TBZ or ABZ on the eggs produced 
by the benzimidazole resistant worms. The ED50 for the egg hatch assays is a measure of 
the level of resistance of the eggs produced by the population. Prior to treatment with FBZ 
the population of parasites in each lamb should be the same. In Figs. 2.14 and 2.15 the 
dose response curves for egg hatch assays carried out prior to treatment in Experiments 2 
and 3 show the similarity of the populations. There is no significant difference between 
the slopes of the curves and the ED50s calculated for each population prior to treatment. 
Comparison of these dose response curves in Figs. 2.14 and 2.15 with the mean dose 
titration curve (Fig. 2.9) confirms that measurement of a high ED50 in the in vitro egg 
hatch assay correlates with a high LD50 in the in vivo controlled anthelmintic efficiency 
test. Good correlations among results of in i//k?faecal egg count reduction tests , results of 
in vitro egg hatch assays and results from controlled anthelmintic efficiency tests have 
b e e n  f o u n d  previously in Australian studies (Martin eta/., 1982; Presidente, 1985)
These results indicate that the in vitro egg hatch assay gives a good indication of levels 
of resistance in the field. A direct comparison of ED50 in the egg hatch assay and LD50
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from the in vivo dose titration trial would suggest that an ED50 for TBZ of 1.61-1.65 
ug/ml and ABZ of 2.61 -2.87 ug/ml for the egg hatch assay correlates with a dose rate of 
25.7-31.5 mg/kg FBZ. This type of comparison will vary between laboratories because of 
the different methods used in the egg hatch assay and also which member of the group of 
benzimidazole anthelmintics is used in the field. In this case FBZ was used in the dose 
titration study but a more appropriate comparison with the egg hatch assay results could 
have been made if TBZ had been used.
Results of egg hatch assays show consistency amongst animals. For both Experiments 2 
and 3 prior to treatment with FBZ the populations of parasites in the lambs should be 
similar and this is reflected in the consistent results from egg hatch assays. In previous 
work using the egg hatch assay technique there was day to day variation in results. 
However in the dose titration studies egg hatch assay results were consistent from day to 
day, particularly in assays carried out using TBZ. In assays using ABZ there was some day 
to day variability in results (Figs. 2.11 and 2.13) but assays carried out on the same day 
gave similar results.
After treatment of the lambs by oral administration of FBZ at different dose rates the 
population of the adult worms in the abomasa of the lambs was changed because there was a 
reduction in the worm burdens. The level of resistance was measured in egg hatch assays 
using eggs collected after FBZ treatment to investigate if there was any difference in the 
resistance after selection with anthelmintics at increasing dose rates. In both Experiments 
2 and 3 there was no significant difference (p>0.01) between egg hatch assay results in 
each lamb before and after treatment with FBZ (Tables 2.6-2.9 and Figs. 2.10-2.13). 
The use of FBZ orally at high dose rates of 20mg/kg and 40mg/kg in the lambs reduced 
worm burdens compared with the control animals and was therefore selectively killing 
less viable parasites leaving more resistant parasites in the abomasum. From the results 
of egg hatch assays the level of resistance measured in the eggs of these selected parasites
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was not significantly different from unpressurised control animals. Waller etaiX 1985) 
found that increasing the level of benzimidazole used for selection of a resistant strain of 
Tcolubriformis did not increase the ED50 in the egg hatch assays carried out on the 
offspring. Similarly Waller et al (1986) found that selection of levamisole resistant 
Tcolubriformis over 12 generations resulted in an increase in the ED50 calculated from 
an egg hatch assay in each generation up to 8 generations, then from generations 8-12 
there was a period with little alteration in the level of resistance. The HFRO benzimidazole 
resistant strain of O.circumcincta has been pressurised over several generations with no 
significant increase in resistance to benzimidazoles (see previously). The parasite 
population reaches a high level of resistance and further pressurisation cannot increase 
this level. The decrease in the adult worm burden in lambs treated with high doses of FBZ 
suggests that less resistant adults were being removed. However, the more resistant 
parasites which remain do not seem to confer any increased resistance to their offspring. 
These more resistant parasites may have a phenotypic advantage but be genetically 
similar.
Alternatively, differences in resistance of the adult parasites to the effects of orally 
administered benzimidazoles may not be reflected as a difference in hatchability of 
parasite eggs in the presence of benzimidazoles. Le Jambre eta!., (1979) noted that it is 
possible that resistance in eggs and adults of H.contortus are not controlled by the exact 
same series of genes. The ability of eggs to hatch in the presence of TBZ has been shown to 
be related to resistance in the adult worms. However, it has been suggested that due to the 
possible polygenic nature of the genetic control of benzimidazole resistance there could be 
differences between eggs and adults ( Le Jambre et a!., 1979). In Australia studies on the 
genetic inheritance of resistance (Le Jambre et al, 1979) have suggested that it is 
inherited as a polygenic trait in H contortus whereas resistance to levamisole in 
Tcolubriformis is caused by a single gene (Waller et a!., 1986). In the case of the HFRO
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strain of O.circumcinctd continuous selection of the parasites could have produced a 
homogeneous population. The steepness of the slope of the dose response curves from the 
egg hatch assays is suggestive of a homogeneous population of resistant parasites. If this 
was the case pressurisation with increasing doses of FBZ would not increase the level of 
resistance in the parasite population. This, however, does not explain the differences in 
resistance of adult parasites to high doses of FBZ given orally to lambs. It appears that 
continuous pressurisation of the HFRO strain with benzimidazole anthelmintics has 
produced a population with a uniformly high level of resistance but, as with all 
populations, there is variation in the fitness or viability of individuals.
Transplant Experiments
The method of transferring a single male and female adult parasite of the HFRO strain 
of O.circumcincta into the abomasum of lambs was investigated to establish if adult 
parasites survived, mated and could produce fertile eggs from a known parentage. This 
method could then be used to investigate the genetic transfer of characteristics conferring 
resistance.
Transplantation of Adult O.circumcincta into the Abomasum of Lambs 
Materials and Method
Materials.
Lambs -  Parasite naive Dorset cross or Suffolk cross bred lambs, reared indoors.
Method.
1. Lambs were treated with Ivermectin (Oramec - M.S.D.) at the normal dose rate 
200ug/ml administered orally 2-3 weeks prior to commencement of the experiment.
2. Lambs were starved for 24h prior to surgery
3. They were anaesthetised using pentobarbitone sodium (Sagatal -  RMB Animal Health 
Ltd.) and anaesthesia was maintained using incremental doses of the same anaesthetic.
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4. Using a sterile surgical technique the abomasum was located and partially exteriorised. 
A small fistula was produced into the abomasum into which were placed the adult 
parasites. Adult parasites were obtained from donor lambs freshly slaughtered (see 
General Materials and Methods).
5. The abomasal fistula was closed surgically as were the muscle layers and skin.
6. The lambs were treated with penicillin (Duplocillin L.A. -  Gist-Brxades Animal 
Health) injxted intramuscularly to help prevent wound infxtion.
7. Leather harnesses and faecal bags were placed on the lambs 5 days after surgery to 
x llect faeces for culture of larvae (see previously).
Experimental Design.
Donor lambs were infxted with 10,000 infxtive larvae of the HFRO rxistant strain 
of O.circumcincta and were killed on Days 35 and 49 post-infxtion respectively. Adult 
parasites were isolated from the abomasum of these lambs and surgically implanted into 
parasite f r x  rxipient lambs. Lambs 1 and 2 received adult parasites from the donor 
killed on Day 35 post infection and Lambs 3 and 4 adults from the lamb killed on Day 49 
post infxtion, At the same time as the transplantation into Lambs 1 and 2 a single female 
parasite was transplanted into Lamb 5. Similarly Lamb 6 was implanted with a single 
female at the same time as transplantation of pairs of parasites into Lambs 3 and 4 . All 
fa x x  were collxted from Lambs 1-6 from Day 5 post transplantation to Day 19 post 
transplantation and cultured to obtain parasite larvae.
Further passages of the larvae obtained from Lambs 1 and 2 were carried out and the 
progeny of these larvae were tested for resistance using egg hatch assays. A flow diagram 
of the passages and treatments of the lambs used to study the offspring of the transplanted 
parasites is shown in Fig. 2.16. The larvae from Lamb 1 were used to infect FR 51 and 
the larvae from Lamb 2 were used to infect FR 52. Both of these lambs (FR 51 and FR 52) 
contained adults of the F1 generation of the transplanted parents. Eggs passed in the faeces
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Figure 2.16
Plan of the development of 'clones' of the HFRO strain of O.circumcincta 
after transplantation of pairs of parasites Into donor lambs.
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of these lambs were used in egg hatch assays and these eggs would form the F2 generation 
from the transplanted parents. At the same time faeces were cultured to obtain sufficient 
larvae to infect lambs FR59 and FR61 with infective larvae of the F2 generation which in 
turn matured to F2 adults which mated producing eggs of the F3 generation. These F3 
generation eggs were tested for resistance using egg hatch assays. The lambs FR59 and 
FR61 were treated orally with FBZ at the normal dose rate of 5mg/kg and eggs passed in 
the faeces after selection of the F2 adults were tested for resistance using egg hatch assays.
Lambs FR51 and FR52 which contained the F1 generation adults were treated orally 
with FBZ at the normal dose rate of 5mg/kg. Eggs passed in the faeces after treatment were 
used for egg hatch assays and were cultured to produce larvae which were used to infect 
lambs FR62 and FR63. These lambs FR62 and FR63 therefore contained the F2 generation 
of the original transplant parents which had been selected with FBZ during the FI 
generation. The eggs produced by these F2 generation of adults were tested for resistance 
using egg hatch assays and lamb FR63 was treated orally with FBZ at the normal dose rate 
of 5 mg/kg and eggs produced after selection of the F2 adults were tested for resistance 
using egg hatch assays.
Results
The number of larvae cultured from the faeces of Lambs 1 -6  are shown in Table 2.10. 
Lambs 1 -4  were implanted with pairs of adult parasites and Lambs 5 and 6 were each 
implanted with a single adult female. The number of larvae cultured from faeces on the 
stated days is listed along with the total number of larvae collected from each lamb. Five 
days were allowed to elapse after implantation to ensure that eggs passed in the faeces 
were the result of matings between the implanted pair and were not fertilized eggs present 
in the female at the time of implantation (LeJambre etaly 1979)
Results of egg hatch assays carried out on the F2 generation of eggs pre-treatment and 
post treatment with FBZ are shown in Table 2.11. Results of egg hatch assays on the F3
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lable Z A P
Number of larvae collected from faeces of lambs after implantation of adult
0. circumcincta into the abomasum
Divs after implantation
Age* of 
Parasites
Implant Lamb
No.
6 7 8 12 13 14 15 19 20 Total 
No. of 
Larvae
35days 1* 15. 1 0 1 0 0 196 0 38 100 58 393
35days 1& 19. 2 50 37 6 0 65 71 48 86 62 425
49days 3 0 0 2 0 0 0 31 20 0 53
49days i(^t 1 4 0 0 0 0 0 11 0 3 5 19
35days 5 0 0 0 0 0 0 0 0 0 0
49days 6 0 0 0 0 0 0 0 0 0 0
"Number of days after infestation of donor lambs with L3 larvae.
1 0 8
Table 2.11
Results of egg hatch assays carried out on eggs of the F2 generation of
O.circumcincta ‘clones' 
produced by transplantation of adult parasites into lambs.
Time (Davs)_____________________________ED50 (uo /m l)______________
Post Post TBZ ABZ
Infection Treatment________________________________________________
FR51 FR52 FR51 FR52
26 - 0.51 0.37 0.61 0.28
27 - 0.74 0.43 0.74 0.70
32 -  0.95 0.43 0.49 0.31
36 -  0.96 0.79 1.00 0.75
54  14 >2.0 -  >2.0
60 20 1.31 " 1.23
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Table 2.12
Results of egg hatch assays carried out on eggs of the F3 generation of 
O.circumcincta 'clones1 produced by transplantation of adult parasites into
lambs.
 Time ( DaysT_______________________________ ED5<?(uQ/mi)_________
Post Post TBZ ABZ
Infection Treatment________________________________________________
FR59 FR61 FR63* FR59 FR61 FR63*
22 - 0.37 0.50 0.99 0.74 0.50 1.95
25 - 0.36 0.50 1.43 1.05 1.33 2.36
32 - <0.2 0.25 0.80 0.19 0.46 1.22
35 -  0.29 0.33 1.10 0.53 0.85 2.01
54  7 1.56 1.08 1.43 1.50 -  1.56
*Lamb infected with larvae cultured from faeces collected after treatment of the F1 
generation ( in lamb FR51) with FBZ administered orally at 5mg/kg.
1 1 0
Figure 2.17
Level of resistance as measured by the ED50 with TBZ for eggs collected 
from the faeces of Lambs FR59, FR61 and FR63 infected with 'clones' of 
the HFRO strain of Q.circumcincta before and after treatment of the lambs
with FBZ.
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Figure 2.18
Dose response curves for eggs collected from Lamb FR59 plotting 
percentage of eggs failing to develop against concentration of TBZ. The lamb 
was treated with FBZ on Day 47 post infection.
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Figure 2.19
Dose response curves for eggs collected from Lamb FR61 plotting 
percentage of eggs failing to develop against concentration of TBZ. The lamb 
was treated with FBZ on Day 47 post infection.
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Figure 2.20
Dose response curves for eggs collected from Lamb FR63 plotting 
percentage of eggs failing to develop against concentration of TBZ. The lamb 
was treated with FBZ on Day 47 post infection.
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generation eggs produced from Lambs FR59, FR61 and FR63 are shown in Table 2 ,12 and 
Fig. 2.17 before and after treatment of each of the lambs with FBZ. Graphs of percentage of 
eggs which developed against concentration of TBZ for egg hatch assays on the F3 
generation eggs produced from Lambs FR59, FR61 and FR63 before and after treatment of 
eacn of the lambs with FBZ are shown in Figs, 2 .18-2.20 respectively.
Discussion
In all cases where a pair of adult parasites was implanted into the abomasum of lambs 
fertilized eggs were passed in the faeces. Faecal egg counts using the McMaster technique 
carried out during the period of faecal collection for culture of larvae from Lambs 1-4 
were negative on all occasions. However, from Lambs 1 and 2, 393 and 425 larvae 
respectively were cultured and from Lambs 3 and 4 , 53 and 19 larvae were cultured. 
The single female worms implanted into Lambs 5 and 6 did not produce any fertilized eggs. 
These single implants were used to show that mating between the male and female 
parasites was necessary in order to obtain fertilized eggs. In Lambs 1 -4  the single male 
and female parasites may have had some mechanism to allow them to identify each other 
and come into contact within the large area of the abomasum.
The donor lamb used to provide adult parasites for implantation into Lambs 1 and 2 
was killed earlier in the course of infection, Day 35 post infection, than the lamb used,as a 
donor for adults implanted into Lambs 3 and 4 and this might explain the lower fecundity 
of the females In the latter lambs,. The egg output by the female worms in Lambs 1 and 2 
was high and may reflect increased fecundity in the absence of other parasites (Michel,, 
1967). The high level of larvae obtained from faecal culture of faeces from Lambs 1 and 2 
allowed further passages of these single clones of parasites to be attempted (Fig. 2., 16). 
From Lambs 3 and 4 the yields of larvae were poor and further passages were not 
possible.
Lambs FR51 and FR52 harboured adults of the F1 generation and faecal, egg counts from,
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these lambs varied from day to day but were >50 e.p.g. on all occasions tested. Egg hatch 
assay results on the progeny of matings between adults of the FI generation (Table 2.11) 
gave low ED50s with TBZ and ABZ for both lambs. These eggs were of the F2 generation . 
ED50s on Day 26 post infection were 0.5lug/ml TBZ and 0.61 ug/ml ABZ for FR51 and 
0.67ug/mlTBZ and 0.28ug/ml ABZ which were much lower than the expected ED50 for 
the HFRO resistant strain of O.circumcincta calculated during routine passages at 
approximately 1.6 ug/ml TBZ and 2.5 ug/ml ABZ. In all assays the ED50s calculated for 
eggs passed in the faeces of FR52 were consistently lower than ED50s for eggs produced by 
FR51. Both of the original transplants were carried out using adults from the same 
population of the HFRO strain of O.circumcincta. Differences in the ED50 for eggs of the 
F2 generation may be due to variation in the genetic make-up of the two 'clones' of 
parasites which had been established from the original transplants. However, the 
differences in ED50s were small and only a single animal was infected with each ‘clone1 of 
O.circumcincta^ therefore conclusions on minor variations in the resistance status of 
the offspring could be misleading in that no account could be taken of possible host 
influences on the parasite population 
In previous work with egg hatch assays (see Routine Passages and Dose Titration Trial) 
the ED50 for ABZ was higher than for TBZ for the HFRO strain of O.circumcincta Results 
of assays on the F2 generation from transplant experiments show similar ED50s for TBZ 
and ABZ. This could Indicate variation in the level of side-resistance to different 
benzimidazoles or possibly different sensitivities of the egg hatch assays with individual 
benzimidazoles.
The disappointingly low level of ED50 measured for the F2 generation suggests that 
there was loss of resistance by the parasites. There could be several explanations for this 
including selection of less resistant members of the population for the initial transplants, 
loss of resistance brought about by the severe pressure on the original transplanted
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parents to survive and reproduce or contamination of the recipient sheep with susceptible 
parasites which could mate with members of the ’clone'.
To guard against the contamination of lambs with O.circumcincta at the time of 
transplantation the lambs, which had been reared indoors, were treated with ivermectin 
It was difficult to ensure that animals were totally parasite free. This would require 
animals to be isolated in a parasite free environment and fed material with no risk of 
parasite contamination. To prove that the animals were parasite free would require 
culture of faeces for several days to check that no larvae were obtained and during the 
period required for larval culture from faeces immature parasites could mature to become 
egg laying or the animal could have become infected with larvae from the environment. In 
the transplant experiment on both occasions a lamb was given a single female parasite, 
Lambs 5 and 6. No larvae were cultured from the faeces of these lambs ( Table 2.10). This 
would suggest that the animals were parasite free at the start of the experiment. 
Contamination of the ’clones' could have occurred at the next generation , Lambs FR51 and 
FR52 , however, every precaution possible was taken to try to use lambs reared indoors 
and animals had negative faecal egg counts at the time of inoculation with infective larvae 
cultured from the faeces of the transplanted sheep.
Alternatively the individuals selected for the transplants may have been less resistant 
members of the population. Within the population of HFRO benzimidazole resistant 
O.circumcincta there will be differences in the susceptibility of individual parasites to 
the effects of the anthelmintic. A small proportion of the population may be fully 
susceptible to the benzimidazoles and have avoided removal by selection with 
anthelmintics. Also, members of the population showing the characteristics of resistance, 
which could be transferred genetically , may be heterozygous for these characteristics and 
therefore a proportion of the following generation could revert to susceptibility. When 
selecting individuals for transplantation they were picked randomly from the population
and therefore the 'clones' produced could have characteristics which vary from the mean 
characteristics exhibited by the population taken as a whole. However, it seems unlikely 
that both 'clones' which were established had a low level of resistance suggesting that one 
or other of the parents had a low level of resistance to benzimidazoles.
The mechanism of inheritance of resistance characteristics in O.circumcincta is 
unknown. Herlich etal, (1981) and Le Jambre etal,{ 1979) have suggested that the 
inheritance of benzimidazole resistance in H. contortus is not sex linked and resistance is 
controlled by more than one gene. Herlich etal.,{ 1981) found that in crosses between 
resistant and susceptible strains of H.contortusXhe FI generation was similar to the 
susceptible strain as regards benzimidazole resistance. These authors suggested that 
resistance was therefore a recessive characteristic. Le Jambre et a l, (1979) found 
similar results but these authors noted that offspring of crosses with the resistant 
component from the maternal side showed increased resistance on egg hatch assays. Martin 
etal, (in press) also noted a maternal influence on the resistance level in crosses with 
benzimidazole resistant and susceptible strains of T.colubriformis They suggested that 
benzimidazole resistance in T.coJubriformis was inherited as a semi-dominant trait with 
some increased maternal effect and overall resistance was controlled as a polygenic trait. 
The maternal influence on resistance noted in eggs produced by crosses of resistant and 
susceptible parasites could be due to the structure of the egg which is produced in the 
female parasite and therefore there would be a greater maternal effect on the egg ( Le 
Jambre et al, 1979). However Martin etal, (in press) found the increased level of 
resistance in crosses where the resistance characteristics were of maternal origin rather 
than paternal origin to persist in the later parasitic stages of the nematode although
differences were less than those detected in eggs.
jf^g pgsults of the transplant experiments with O.circumcincta suggested that there was 
a fall in the level of resistance in the FI and F2 generations. If one resistant parasite and
one susceptible parasite were selected at the time of implantation then the offspring would 
nave reduced resistance unless resistance to benzimidazoles in O.circumcincta was 
inherited as a dominant trait. If resistance was recessive the offspring, FI generation, 
would be fully susceptible to the effects of benzimidazoles and 3/4 of the F2 generation 
would be fully susceptible to the effects of benzimidazoles. Martin eta l {in  press) found 
that with a population of T.co/ubnformis^here 25£ of the parasites were resistant to 
benzimidazoles it was impossible to detect any alteration in resistance from a fully 
susceptible population in controlled anthelmintic efficiency trials. Therefore with a low 
percentage of the O.circumcincta population with resistance characteristics it would be 
difficult to detect the presence of resistant parasites if the characteristics of the whole 
population were examined. This was not the case in the F2 generation of the transplanted 
O.circumcincta ‘clones' where there was a low but significant level of resistance 
measured in the egg hatch assays. If resistance was a polygenic trait then the combination 
of possible crosses which would produce an F2 generation with the resistance 
characteristics found in eggs from FR51 and FR52 would be difficult to predict. The fact 
that, the resistance status of the maternal component of the cross may have a greater 
influence on the resistance characteristics of the eggs in O.circumcincta os occurs in 
Hcontortusile Jambre etal, 1979) and T. coiubriformis(Martin e ta l , in press) 
produced further complications. It therefore was impossible to estimate the resistance 
status of the transplanted parents from the egg hatch assay results of the F2 generation 
because the genetic mechanisms involved in inheritance of resistance in O.circumcincta 
are poorly understood. The slight differences between the resistance level in the offspring 
of the two transplants o w  be suggestive of polygenic resistance with transfer of different 
characteristics in each 'clone'. Both transplants Involved the transfer of resistant 
characteristics to at least some of the offspring because treatment with benzimidazoles 
failed to remove all the adult parasites ot the F1 and Fl generations. The rapid selection
for resistance on treatment with benzimidazoles could be suggestive of a small number of
genes involved in the development of resistance with possibly semi-dominant expression.
The loss of resistance in the F2 and F3 generation may reflect the pressure on the low
numbers of parasites to survive and produce offspring, The egg production of nematode 
parasites may be controlled by the number of established parasites at the site. Michel, 
0  967) noted that the fecundity of parasites was limited by the size of the population. In the 
transplant experiments the transplanted O.circumcincta parents in Lambs 1 and 2 
produced a surprisingly large number of larvae (Table 2 10). These larvae were then 
used to infect FR51 and FR52 and they became established as egg laying adults. The 
number of larvae of the FI generation was low and therefore these adults in FR51 and 
FR52 were again under pressure to produce large numbers of offspring. The possible 
increased fecundity of these FI adult parasites in FR51 and FR52 may have reduced the 
rate of passage of the eggs, or length of time of storage in the gravid female parasites. 
Therefore there could be an alteration m the tubulin content of the eggs which could have 
some effect on the resistance of the eggs to the effects of benzimidazoles.
After treatment of FR51 and FR52 orally with FBZ at the normal dose rate of 5mg/kg 
the faecal egg count from both animals was reduced compared with the faecal egg count 
prior to anthelmintic treatment. This suggested that the adults of the F1 generation in the 
lambs were less resistant to the effects of orally administered benzimidazoles. Sufficient 
eggs were obtained in the faeces of FR51 to allow egg hatch assays post treatment but this 
was not the case for FR52 where the egg count dropped to < 50e.p.g. This fall in faecal egg 
count possibly indicated a loss of resistance in the parasites compared with the HFRO 
strain of O.circumcincta which was used to establish the 'clones'. However sufficient 
larvae were obtained after faecal culture from FR51 and FR52 post treatment with FBZ 
suggesting that the population had some level of resistance to the effects of FBZ 
administered orally.
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Eggs were collected from the faeces of FR51 on Days 14 and 20 post treatment with FBZ 
and used in egg hatch assays to measure the level of resistance. The ED50s calculated were 
higher than results for egg hatch assays carried out prior to treatment with FBZ (Table
2.11). Results for assays using ABZ and TBZ in the egg hatch assays were similar unlike 
results from routine passages where ED50s with ABZ were higher. These results 
suggested that there had been selection of more resistant adult parasites which produced 
offspring with a higher level of resistance. For the FI generation from the transplant 
experiments selection of the parasites with FBZ at the normal dose rate increased the 
resistance of the offspring unlike results from the routine passages (Table 2.1) and the 
dose titration trial (Tables 2.6-2.9) where selection with FBZ at the normal dose rate and 
with increasing doses failed to increase the resistance measured in the progeny of the 
selected parasites. The increase in the level of resistance after treatment with FBZ is 
indicative of the presence of a mixed population of resistant and susceptible parasites and 
therefore the 'clones1 produced by transplantation were not highly resistant to the effects 
of benzimidazoles.
The ED50s for eggs of the F3 generation were significantly different for the selected 
(FR63) and unselected lines (FR59 and FR61),(Table 2.12). The EDSOs for eggs 
collected from FR59 were lower than the ED50s for FR61 except for Day 22 post 
infection in the assay using ABZ. This was the converse of results from egg hatch assays in 
the previous generation where eggs from FR52 showed lower ED50s than eggs from FR51. 
These differences could be due to host effects on the level of resistance or the dynamics of 
the parasite population with possible alterations in the genetic make-up of the population. 
These host effects may influence the percentage of susceptible and resistant parasites 
produced in the progeny from a mixed population.
Eggs produced from the FI generation showed a similar ED50 for TBZ and ABZ (Table
2.11) whereas eggs produced by the F2 generation had a higher ED50 for ABZ in the egg
hatch assays in most assays although levels were rather variable for FR59 and FR61 
(Table 2.12). From results in Table 2.12 the ED50s showed day to day variation with eggs 
collected from all the animals on Day 35 post infection having a lower ED50 than on other 
occasions. However the ratios of ED50s calculated by comparing ED50s from FR59 or 
FR61 with EDSOs from FR63 on the same occasion were similar. Prior to treatment with 
FBZ the mean ratio of FR59/FR63 was 3.61 for TBZ and 3.77 for ABZ and for 
FR61 /FR63 was 2.84 forTBZ and 2.67 for ABZ. The ratios of resistance are similar with 
TBZ and ABZ. They also indicate that there was a difference in the level of resistance 
between the strain which had been selected with FBZ which was used to infect Lamb FR63 
and the unselected strains in Lambs FR59 and FR61.
Selection of the F2 adult parasites was carried out by treating lambs FR59, FR61 and 
FR63 with FBZ administered orally at 5mg/kg. Egg hatch assays were carried out on eggs 
passed in the faeces 7 days post treatment. For Lambs FR59 and FR61 there was a 
significant increase in the ED50s found post treatment compared with the ED50 
pre-treatment (Table 2.12 and Fig. 2.17). For FR63 there was little difference between 
the ED50s pre-treatment and the ED50s post treatment (Table 2.12 and Fig. 2.17) 
Treatment with FBZ in Lambs FR59 and FR61 selected more resistant members of the 
'clones' and the offspring of these selected parasites showed an increased level of 
resistance. The parasites in FR59 and FR61 had not been selected with FBZ during the 
previous generation. However, the parasites in FR63 had been selected with FBZ during 
the FI generation and selection during the F2 generation did not increase the level of 
resitance in the offspring, the F3 generation eggs. Results from this selected strain in 
FR63 suggested that there was rapid selection for resistance by treating the F1 generation 
with FBZ. Comparison of the resistance measured as the ED50 for F3 generation eggs of 
the three transplanted strains post treatment with FBZ was carried out by calculating 
resistance factors using FR63 as the resistant standard. For FR59/FR63 the factor was
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0.92 for TBZ assays and 0.96 for assays using ABZ. For FR61 /FR63 the factor was 1.04 
for the assays using TBZ and there was no assay carried out on FR61 with ABZ. These 
resistance factors show that there is no difference in the level of resistance measured 
between the strains selected on one occasion at the F2 generation ( FR59 and FR61) with 
the strain selected twice with FBZ at both the FI and F2 generations (FR63). These 
resistance factors can be compared with factors calculated prior to selection of the F2 
generation (see previously) with FBZ and show that rapid selection for resistance had 
occurred. However, the level of resistance measured in the F3 generation eggs does not 
appear to be as high as the resistance measured in eggs from the routine passages of the 
HFRO strain of O.circumcincta which was the original source of the transplanted 
parasites. This rapid selection for resistance may have important implications when 
examining results of egg hatch assays after isolation of the HFRO strain of O.circumcincta. 
The level of resistance was measured by an egg hatch assay at Passage 4 prior to treatment 
2 (Lamb DB74). The strain was pressurised with a single dose of FBZ during Passage 1 
(Lamb DB48) and from results in the transplant experiment it would appear that this 
single dose could have been sufficient to select the strain which would then produce a high 
ED50 when first tested by the egg hatch assay during Passage 4.
The egg hatch assays may not be suitable for detection of small changes in resistance 
and therefore any differences in the level of resistance measured between the selected and 
unselected strains of transplanted 'clones' may not be identified. Larvae cultured from the 
faeces of Lamb FR61 post treatment with FBZ were used to produce a tubulin extract and 
tested for resistance using a tubulin binding assay with tritiated MBZ and tritiated ABZ 
(see later). Results of the tubulin binding assays are shown in Table 3.20 and 
comparison of resistance with other strains of O.circumcincta including the routinely 
passaged HFRO strain and the Bearsden strain is shown in Table 3.21. From the tubulin 
binding assay the extract from FR61 showed a low level of resistance which was similar to
1 2 7
the level for the Bearsden susceptible strain of 0. circumcincta Egg hatch assay results 
comparing these three strains show that eggs from FR61 have an ED50 slightly lower 
than the highly resistant HFRO strain but much higher than the Bearsden susceptible 
strain. There could be differences in the level of resistance measured during different 
stages of development of the parasite with eggs showing a higher level of resistance than 
larvae. During the dose titration trial (see previously) oral dosage of lambs selected for 
more resistant adult parasites but there was no alteration in the level of resistance shown 
by progeny of the selected parasites when tested using egg hatch assays. Again these 
differences could be the result of possible alterations in the mechanism or genetic 
transfer of resistance at the different stages of development of the parasites. These changes 
in resistance may occur because of the possibly polygenic nature of resistance in some 
nematode parasites (Le Jambre etal, 1979). Martin etal (in press) also found slight 
differences in the resistance level measured in T.colubriformisfor eggs in egg hatch 
assays and adult parasites tested by an anthelmintic efficiency trial.
Alternatively the tubulin binding assay measures differences in binding of tritiated 
benzimidazoles to tubulin extracts from the parasite larvae whereas in the egg hatch assay 
the effect of the benzimidazole on the complete parasite is measured. If there were any 
differences in the action of benzimidazoles on resistant parasites these could be detected 
using egg hatch assays. However, the tubulin binding assay would detect changes in a 
specific component of the parasite which is probably involved in the mechanism of action 
of the benzimidazoles but may not reflect all the actions of the benzimidazoles on the 
parasites and alterations in the parasites causing resistance to benzimidazoles. Therefore, 
results from the tubulin binding assay , which indicated a low level of resistance in the F3 
generation from FR61, showed that there was little alteration in the benzimidazole 
binding capacty of tubulin extracted from these parasites but egg hatch assay results 
indicated that the eggs were resistant to the effects of benzimidazoles. This could indicate
that alteration in the binding of benzimidazoles to tubulin is not the only mechanism of 
resistance to benzimidazoles (see later).
The effect of benzimidazoles on the F3 generation eggs from FR59, FR61 and FR63 was 
studied by constructing dose titration graphs for each of the egg hatch assays carried out 
with TBZ before and after treatment of the lambs with FBZ (Figs. 2.18, 2.19 and 2.20). 
For FR59 and FR61 the slope of the dose titration graph was steep and there was a shift of 
the graph, although little alteration in the steepness of the slope, after treatment with 
FBZ. For FR63 there was day to day variation in the steepness of the graphs. Graphs drawn 
for egg hatch assays on Days 25 and 32 post infection showed a step in the slope of the line. 
A step in the slope of the graph also was found in the graphs for egg hatch assays on eggs 
from FR59 and FR61 post treatment with FBZ. This could posssiblv indicate that the 
population was not uniform and consisted of two sub-populations with differing resistance 
status (Le Jambre etal, 1982). However the graphs for FR63 before treatment on two 
occasions did not show a step in the slope.
Graphs for egg hatch assays on eggs passed in the faeces of FR63 ( Fig 2.20) showed day 
to day variation in the steepness of the slope of the curve There was also no shift in the 
curve or alteration in the steepness of the graph after treatment of FR63 with FBZ. 
During the early routine passages of the HFRO strain of O.circumcinctaVmz was day to 
day variation in the dose titration curves drawn for egg hatch assays and variation in the 
ED50s calculated during these passages. However, in the dose titration trial there was less 
day to day variation in the ED50s and dose titration plots drawn for each egg hatch assay. 
This could indicate that during the early passages of the HFRO strain of O.circumcincta the 
parasite population contained members with variable levels of resistance whereas after 
several passages with selection the population became more homogeneous. If this was the 
case it would suggest that the F2 population within Lamb FR63 was a mixed population 
containing members with differing levels of resistance. The significance ot changes in the
slopes of egg hatch assay dose titration curves was difficult to assess because low numbers 
ot animals were used and changes in the resistance levels could be due to host factors. This 
may have an effect on the egg laying pattern of individual female worms within the 
population. A single animal was used for each 'clone' of parasites because low numbers of 
infective larvae were available to infect the animals and the nature of the egg hatch assay 
makes it impossible to test large numbers of animals at the same time.
Further transplant experiments were carried out to try  to produce highly resistant 
'clones’ of 0. circumcincta On one occasion the above transplant experiment was repeated 
with a single pair of adult parasites from a donor lamb being transplanted into each of two 
parasite free lambs. Culture of faeces of the two lambs from Day 5 post transplantation 
yielded low numbers of O.circumcincta larvae with contamination of the cultures by 
Stron&'loidesspfx larvae. These larvae were not used for further passages because of the 
possibility of contamination of the supposedly parasite free lambs. Another transplant 
tria l was carried out where adult parasites collected from the abomasum at necropsy of 
one of the lambs from the dose titration trial (see previously) treated orally with FBZ at a 
dose rate of 40mg/kg were used to select parents which were transplanted into 2 parasite 
free lambs. One of the lambs was treated with FBZ administered orally at a dose rate of 
5mg/kg 24h after transplantation of the adult parasites. Faeces of both lambs were 
cultured from Day 5 post transplantation and no larvae were obtained from the faeces of 
either of the lambs. The age of the adult parasites or their exposure to high levels of 
benzimidazoles, 8 times the normal dose rate, may have reduced the ability of the 
transplanted parasites to survive . The high dose level of benzimidazoles also may have 
reduced the fecundity of the female parasites. During passages of the HFRO benzimidazole 
resistant strain treatment with FBZ at the normal dose rate resulted in a reduction in the 
faecal egg output post-treatment for several days. This was thought to be due to reduced 
reproductive function in female parasites brought about by the effects of the
benzimidazole. The poor results from these transplant experiments prevented further 
studies on the mechanisms of genetic transfer of resistance.
LARVAL MOTILITY TESTS 
Larval Motility Test using Infective Larvae of Ostertagia circumcincta 
Incubated with Anthelmintics 
Materials and Method
Materials.
Infective larvae - cultured from faeces and prepared by the Method described previously 
(see General Materials and Methods).For the assays larvae were exsheathed (see General 
Materials and Methods).
Anthelmintic stock solutions - Stock solutions of various anthelmintics were prepared in 
methanol.
Larval culture medium (Jenkins et a l, 1980) - 2g pancreatic digest of casein 
(Bacto-casitone, Difco), 1 g yeast extract (Difco), 0.5g D-glucose, 0.08g di-potassium 
hydrogen orthophosphate, 0.08g potassium dihydrogen orthophosphate made up to 100ml 
with permanganate distilled water. Divided into 20ml aliquots and autoclaved for 15min. 
Prior to use 20mg sodium benzylpenicillin, 25mg streptomycin sulphate and Img 
natamycin was added to each aliquot.
Sterilin 16 well plastic plates.
Methol
1. Approximately 50-70 infective larvae were added to each well in the Sterilin plates. 
The volume in each well was made up to 1.98ml using culture medium for incubations 
>48h or water where incubation of approximately 24h was used.
2. In duplicate 20ul of each stock solution of the test anthelmintic was added to the well. 
For the blank added 20ul water and the methanol control added *:0ul methanol.
3. Plates were covered and sealed with cling film to prevent evaporation of water over the 
period of incubation which would cause concentration of the anthelmintic, Plates were 
incubated at 37°C for a given time. The larvae were examined periodically under a 
binocular microscope and the motility assessed by observing each larva for approximately 
30 seconds.
4. The percentage motility for the larvae in each well was calculated and corrected for 
natural mortality by subtracting the value obtained from the methanol control well.
Incubation of Infective Larvae of HFRO and Bearsden Strains of 
O.circumcincta with Thiabendazole, Albendazole and Albendazole 
Sulphoxide. 
Results
Infective larvae were incubated in larval culture medium with the benzimidazoles TBZ, 
ABZ or ABSX at concentrations of 3, 5, 10 or 20ug/ml. Motility of the larvae was assessed 
at intervals during the incubation period and the mean percentage of parasites motile, 
corrected for natural mortality using the controls, at each drug concentration was 
calculated and is shown in Table 2.13 for the Bearsden Strain and Table 2.14 for the HFRO 
benzimidazole resistant strain.
Discussion
During the transplant experiments difficulty was experienced in obtaining sufficient 
material to test the individual clones for resistance. It was impossible to test for 
resistance at the FI generation because insufficient eggs were passed in the faeces of the 
lambs to allow egg hatch assays to be carried out and all the faecal material was retained 
for culture of infective larvae. Offspring of the F1 generation adults were tested because 
sufficient eggs were available in the faeces to allow egg hatch assays to be performed. 
However, to study the genetic inheritance of resistance it would be more appropriate to
Table 2.15
M otility of infective larvae of the Bearsden strain of O.circumcincta 
incubated in various concentrations of TBZ, ABZ or ABSX. Percentage of 
larvae which were motile was assessed at intervals during the incubation 
period and results corrected for natural mortality using the controls.
Druo concentration % Motility of Larvae
(ug /m l)
24h 48h 72h 120h
TBZ -
20 ABZ 78.5 86.5 77.5 76.7
ABSX 81.8 67.6 90.8 44.1
TBZ 100 83.8 93.0
10 ABZ 83.0 83.1 78.1 77.8
ABSX 88.4 99.4 79.5 74.1
TBZ 100 92.3 100
5 ABZ 89.5 92.3 86.5 73.6
ABSX 94.2 98.0 92.7 71.5
TBZ 100 85.6 100
3 ABZ 94.8 83.9 86.8 73.6
ABSX 83.3 100 92.7 62.5
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Table 2.14
M otility of infective larvae of the HFRO strain of O.circumcincta incubated 
in various concentrations of TBZ, ABZ or ABSX. Percentage of larvae which 
were motile was assessed at intervals during the incubation period and 
results corrected for natural mortality using the controls.
Druo concentration % Motility of Larvae
(ug /m l)
24h 48h 72h 120h
TBZ -
20 ABZ 100 86.5 97.4 100
ABSX 100 100 98.2 94.8
TBZ 96.5 92.0 100
10 ABZ 99.9 98.1 95.2 100
ABSX 100 93.2 96.0 100
TBZ 95.8 90.2 90.6
5 ABZ 97.3 97.8 94.1 100
ABSX 100 89.4 94.7 98.3
TBZ 95.2 93.7 100
3 ABZ 95.4 95.8 98.0 100
ABSX 100 91.0 95.2 100
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test the resistance of the F1 generation. In order to quantify the level of resistance at the 
F1 generation an alternative test for resistance, possibly using low numbers of larvae, 
would need to be found.
Infective larvae of the Bearsden benzimidazole susceptible strain and the HFRO 
benzimidazole resistant strain were incubated with benzimidazoles to investigate if 
differences in the level of resistance could be detected using this method. The mode of 
action of the benzimidazoles is thought to be by binding to tubulin and therefore causing 
disruption of the microtubular framework in the parasite and death (Hoebeke et al.,
1976; Friedman and Platzer, 1978). There may also be an effect on the metabolism of the 
parasite by disruption of the fumarate reductase enzyme ( Barrowman etal, 1984). From 
Tables 2.13 and 2.14 it was shown that incubation in benzimidazoles had little effect on 
larval motility for 72h. After incubation In 20ug/ml ABZ or ABSX for 120h there was 
reduced motility but many of the larvae remained alive and motile after this long period of 
incubation with the anthelmintic drug. The infective larvae were exsheathed to try  to 
improve uptake of the drugs from the surrounding medium. Normally the infective larvae 
are encased in the sheath of the previous stage of development and this could act to protect 
the larvae and also reduce drug uptake into the parasites. The benzimidazoles rely on their 
inhibitory effects on parasite metabolic processes to kill them and in the case of infective 
larvae metabolism is very slow. Infective larvae can remain on pasture over the winter 
period and therefore their survivability depends on their ability to withstand harsh 
climatic conditions and retain a slow metabolic rate. Therefore, it is necessary to incubate 
the larvae in high concentrations of the benzimidazoles for several days to reduce the 
motility of the larvae. Culture medium containing antimicrobials was essential to prevent 
overgrowth with fungi and bacteria during the Incubation period and the medium provided 
nutrients to the exsheathed larvae. The motility of the larvae in the control wells varied 
over the period of the experiment but remained at >90^ motile throughout. When
assessing larval motility the parasites showed periods of activity and periods of inactivity. 
In order to get a fairly consistent value for motility larvae which were non-motile were 
examined for a period of 30 sec. Larvae seemed to exhibit rest/move cycles with periods 
of Immobility for up to 30seconds and therefore close examination of the larvae was 
necessary to ensure that results were consistent. From the results in Tables 2.13 and 
2.14 some of the larvae which were non-motile on one occasion appeared to recover their 
motility by the next occasion.
The difference in motility between benzimidazole resistant and benzimidazole 
susceptible parasites was not significant for incubations of 24h, 48h and 72h. The 
percentage motile was significantly different between resistant and susceptible larvae 
using a Student's t-test (p<0.01) after 120h incubation with ABZ and ABSX. Incubation 
with TBZ was not carried out for >72h in the experiment. Although there was a significant 
difference in the motility between the two strains at 120h incubation the benzimidazole 
susceptible strain retained motility ranging from 73.6-77.8£ for ABZ and 44.1 -74.1 % 
for ABSX. Therefore some of the benzimidazole susceptible parasites were able to survive 
in the presence of the anthelmintics. Both ABZ and ABSX were ineffective against infective 
larvae of the the benzimidazole resistant strain of O.circumcincta 2.14). The 
HFRO strain of O.circumcincta was shown to be highly resistant to the effects of 
benzimidazoles with an approximately 10 fold difference in ED50s between this strain and 
the Bearsden benzimidazole susceptible strain when resistance was tested using egg hatch 
assays. Although the differences in motility were significant they were not very large 
between these two strains on incubation of infective larvae with benzimidazoles and 
therefore strains of O.circumcincta with a low level of resistance may not be detected 
using this method.
The reduction in motility of infective larvae in the presence of ABZ was not dose related. 
At 120h the motility of larvae was similar in 3, 5, 10 and 20ug/ml ABZ. It was
impossible to calculate an ED50 for ABZ against infective larvae. For ABSX, one of the 
metabolites of ABZ, the reduction in motility was greatest in a concentration of 20ug/ml 
but in 5ug/m1 and lOug/ml the larval motility was similar. The results for reduction in 
motility were similar for ABZ and its metabolite ABSX except at 120h in a concentration 
of 20ug/ml where the ABSX had a greater effect. Results from egg hatch assays showed that 
ABSX failed to prevent hatching of O.circumcincta eggs and therefore the metabolite had no 
ovicidal effect in w//7?(see Table 2.15). However ABSX appeared to have similar, if not 
slightly greater activity, to the parent compound ABZ when used against larvae in vitra  
Differences in activity of ABZ and ABSX against different stages of O.circumcincta may be 
due to differences in drug solubility or their ability to penetrate into the parasites.
Incubation of both strains of O.circumcincta in TBZ produced no effect on motility over a 
72h period. The period of incubation may have been insufficient to cause a reduction in 
motility compared with controls. The concentration of TBZ used in the assay may have been 
too low to produce a reduction in motility. The oral dose rate of TBZ required to treat 
parasitised animals is higher for TBZ than the modern benzimidazoles e.g. ABZ. This is 
because of the greater solubility of TBZ which is excreted from the host more rapidly than 
the more modern, less soluble benzimidazoles and therefore TBZ has less effect on the 
nematode population within the host. The greater solubility of TBZ would suggest that if 
TBZ was used for in vitro  tests with parasite eggs or infective larvae uptake of the drug 
into the parasites could be increased. This may be the case in egg hatch assays where the 
ED50s calculated for TBZ were lower than the ED50s for ABZ (see previously). However 
in the larval motility test TBZ was not as effective as ABZ at reducing larval motility 
(Tables 2.13 and 2.14) although these slight differences in efficacy of the two 
benzimidazoles against infective larvae were not significant. The reduction in motility of 
infective larvae in the presence of anthelmintics as a test for resistance to levamisole or 
morantel tartrate has been described (Martin and Le Jambre, 1979). Modification of this
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method for use to test for benzimidazole resistance using infective larvae of 
Ocircumcincta was not possible because of the mode of action of the benzimidazoles and 
possibly the limited uptake of these drugs by larvae.
In the above tria l the majority of the larvae maintained motility in the presence of 
benzimidazoles (Tables 2.13 and 2.14). Benzimidazoles however, are effective in 
removing larval stages of O.circumcincta when used in vivo. Rahman otal, (1977 ) 
studied the effect in vivo of MBZ on adult H contortus. These authors found that MBZ 
caused inhibition of parasite energy metabolism and the parasites became detached within 
9 -15h of drug administration. These detached worms remained alive suggesting that in the 
presence of benzimidazole anthelmintics the inability of parasites to maintain their 
position in the host animal was not due to death of the parasites. Therefore the efficacy of 
benzimidazoles in vivo may not be linked to their ability to k ill larvae or adults which 
can be tested in vitro  The host-parasite interaction is important in expulsion of 
benzimidazole affected parasites. In the larval motility test the ability of benzimidazoles 
to k ill both resistant and susceptible parasites was poor and differences between the two 
strains were slight. However metabolic changes sufficient to cause expulsion of parasites 
from the host may have occurred before death of the larvae or larvae became non-motile 
and these changes may differ between resistant and susceptible strains but they cannot be 
detected using this type of assay.
Bennet and Pax (1986) described the use of a micromotility meter to measure worm 
movement. The micromotility meter operates on the principle that movement of worms 
within a tube changes the amount of light which can be transmitted though the tube. These 
changes in pattern of light transmitted depend on the motility of the worms and can be 
expressed as a motility index. Studies by these authors using O.circumcincta infective 
larvae found an 8 fold difference in the motility score between fully motile parasites and 
heat killed parasites. However, there are disadvantages with this technique in that a high
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concentration of larval suspension is required (>500 larvae/ml) and small differences in 
the motility may not be detected e.g. between partially resistant and susceptible strains of 
parasites in the presence of anthelmintics. Folz eta/, (1987) described the use of the 
micromotility meter to detect the effect of various anthelmintics on infective larvae of
H.contortus These authors used higher doses of ABZ than in the experiments described 
above 50-200ug/ml compared with 3-20ug/ml which were used in the above 
experiment. Folz eta/..(1987) also suggested the use of the micromotility meter to detect 
resistance to anthelmintics by comparing the motility of resistant and susceptible larvae 
in the presence of anthelmintics. The test would be more appropriate in the measurement 
of resistance to drugs which act by causing paralysis of parasites e.g. levamisole, 
morantel tartrate or ivermectin rather than benzimidazoles which required a prolonged 
period of exposure to the drug to exert their effect and therefore reduce motility of 
parasites.
Again a problem with the micromotility meter would be the number of parasites 
required to carry out a viable test for resistance. During work on the transplant 'clones' 
of O.circumcincta a test for anthelmintic resistance using low numbers of parasites was 
sought. Using the micromotility meter several replicates would be required at a variety of 
drug concentrations and approximately 250 larvae per replicate would be required 
(Bennet and Pax, 1986). These numbers of parasites would not be available to allow tests 
to be carried out on infective larvae of the FI generation of the single transplanted 
parents. Work with the micromotility meter to assess the effect of drugs using a single 
adult parasite has been descibed (Nowak etal, 1987). These authors used single adult 
males of Onchocerca gibsoni to measure parasite motility in the presence of drugs. 
Similar tests using a single adult O.circumcincta are not feasible because of the much 
smaller size of this parasite compared with adult Onchocerca gibsoni The poorer 
survivability of adult O.circumcincta oofm\\\ the host compared with survivability ot
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Onchocercd gibsoni would also be a limiting factor especially with the benzimidazole 
anthelmintics where a prolonged exposure time is necessary to cause an anthelmintic 
effect in parasites. In addition adult Onchocerca gibsoni are available from surface 
nodules whereas adult O.circumcincta are available only from the abomasum which 
usually requires slaughter of the host.
Studies of the Effects of Albendazole, Netobimin and the Albendazole 
Metabolites, Albendazole Suphoxide and Albendazole Sulphone, on Eggs and 
Infective Larvae of the Bearsden Benzimidazole Susceptible Strain of 
O.circumcincta.
Results
Egg hatch assays were carried out using eggs collected from the faeces of lambs infected 
with the benzimidazole susceptible strain of O.circumcincta. The percentage of eggs which 
failed to hatch in the presence of increasing concentrations of netobimin, ABZ, ABSX and 
ABSO are shown in Table 2.15.
Infective larvae of the Bearsden strain of O.circumcincta were exsheathed and incubated 
in larval culture medium containing increasing concentrations of ABZ, ABSX and ABSO. 
Larval motility was assessed after 24h, 72h and 96h incubation. The percentage of larvae 
which remained motile expressed as a percentage of the total number of larvae remaining 
motile in control wells was calculated and results are shown in Table 2.16.
After incubation of the larvae with the appropriate drug for 96h the material in each of 
the sample wells with ABZ atlOug/ml, ABSX at lOug/ml and ABSO at 3ug/ml was 
collected. The larvae were filtered from the culture medium and the remaining material 
was extracted to isolate benzimidazoles, reconstituted in methanol and injected onto an 
HPLC system to determine the concentration of ABZ, ABSX and ABSO in each sample (for 
method see section describing the method used for analysis of purity of tritiated
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Table 2 .IS
Development of eggs of the Bearsden benzimidazole susceptible strain of 
O.circumcincta used in egg hatch assays with netobimin, albendazole, 
albendazole sulphoxide or albendazole sulphone.
Drug concentration % Failing to Develop ± SD
(u g /m l)
Control 11.4 ±0.9
ABZ ( lOug/ml) 100
ABZ (5ug/ml) 100
ABZ (lug/ml) 99.6 ± 0.5
ABSX ( lOug/ml) 12.7 ±4.2
ABSX (5ug/m1) 11.2 ± 1.6
ABSO (3ug/ml) 12.8 ±0.8
ABSO (lug/ml) 11.2 ±0.7
Netobimin (20ug/ml) 8.4 ± 1.4
Netobimin ( lOug/ml) 12.9 ±3.5
Netobimin (5ug/m!) 8.7 ±2.0
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Table 2.16
M otility of infective larvae of the Bearsden strain of 0. circumcincta after 
incubation in albendazole, albendazole sulphoxide or albendazole sulphone.
Druo Concentration % of larvae motile
(ug /m l) 24h 72h 96h
ABZ (lOug/ml) 61.2 49.2 30.7
ABZ (5ug/ml) 51.7 57.1 53.1
ABZ (0.5ug/ml) 67.3 55.0 44.0
ABSX (20ug/ml) 64.5 47.6 40.4
ABSX ( lOug/ml) 59.8 40.3 48.2
ABSX (5ug/ml) 87.7 57.7 54.5
ABSO (3ug/ml) 98.3 72.0 63.4
ABSO (lug/ml) 97.0 97.6 93.3
ABSO (0.5ug/ml) 96.9 100 90.8
Table 2.17
Concentration of albendazole, albendazole sulphoxide and albendazole 
sulphone expressed as a percentage of the total drug concentration 
measured by HPLC in standard solutions and extracts from larval culture 
medium after incubation of O.circumcincta infective larvae in albendazole 
( lO ug/m l), albendazole sulphoxide ( lOug/ml) or albendazole sulphone
(3ug/m l) for 96h.
Sample Drug Concentration (S )
ABZ ABSX ABSO
Standard ABZ 98.54 1.24 0.22
Post-Culture ABZ 98.51 1.17 0.32
Standard ABSX 0.46 97.56 1.98
Post-Culture ABSX ND 95.35 4.65
Standard ABSO ND 0.12 99.88
Post-culture ABSO ND ND 100
ND- drug not detected in samples
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benzimidazoles). The standard solutions of ABZ, ABSX and ABSO which were added to each 
well in the larval motility assay were also injected onto the HPLC system and the levels of 
ABZ, ABSX and ABSO in these standards was calculated. The concentration of benzimidazoles 
analysed by HPLC in the samples from the larval motility test is shown in Table 2.17. 
Discussion
Albendazole is oxidised in vivo to form the metabolites ABSX and ABSO (Gyurik eta/., 
1981). The sulphide form (ABZ) and the sulphoxide (ABSX) are both thought to have 
anthelmintic activity in ^ (M a r r ln e r  and Bogan, 1980 ) but the sulphone form (ABSO) 
is thought to be inactive (Averkin at at, 1975). This group of benzimidazoles are 
available commercially as netobimin the pro-drug which is metabolised to ABZ 
(McDougall eta/, 1985), the parent sulphide ABZ and ricobendazole which is ABSX. The 
activity of these compounds against various stages of O.circumcincta was studied in vitro 
Egg hatch assays were carried out on eggs of the Bearsden benzimidazole susceptible 
strain of O.circumcincta using netobimin , ABZ, ABSX and ABSO (Table 2.15). ABZ was 
shown to be ovicidal preventing egg development at all concentrations tested and this drug 
was used in routine egg hatch assays to measure the level of resistance in eggs of 
O.circumcincta (see previous experiments). When ABZ was administered orally to sheep 
it was converted to ABSX and this compound was thought to have anthelmintic activity 
(Marriner and Bogan, 1980). When ABSX was used in the egg hatch assays at 
concentrations of 10ug/ml and 5ug/ml egg development was not Inhibited and there was no 
significant difference between egg development in controls and eggs exposed to ABSX. 
Similar results were obtained with ABSO and netobimin with neither of these drugs 
reducing egg development. Therefore of this group of benzimidazoles only the sulphide, 
ABZ, has ovicidal activity and the pro-drug netobimin and metabolites ABSX and ABSO have
no ovicidal activity in vitro.
Netobimin requires metabolism to ABZ in vivo in order to have anthelmintic activity
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and therefore it was not surprising that this pro-drug failed to inhibit egg development in 
egg hatch assays. The metabolites of ABZ, ABSX and ABSO were inactive against eggs of 
O.circumcincta This may be due to poor uptake of these metabolites into the parasite eggs. 
During the egg hatch assay penetration of the eggs by the benzimidazoles is thought to be 
by passive diffusion from the surrounding medium (Weston eta/., 1984; Sangster and 
Prichard, 1984) and therefore depends on the solubility of the drug, the available 
concentration of the drug and the ability to penetrate the outer coating of the egg. ABSX is 
slightly more soluble in aqueous solution than the parent ABZ. However the uptake of the 
benzimidazoles into eggs may depend on the lipid solubility of the drug and the lipid 
concentration within the egg (Weston etal, 1984, Sangster and Prichard, 1984 ). The 
partitioning coefficient for ABSX between the solution and the eggs may be disadvantageous 
with a very low concentration of ABSX entering the eggs which was insufficient to prevent 
development. The further metabolite ABSO is insoluble in aqueous solution and therefore 
for the egg hatch assays the highest concentration which could be reconstituted in methanol 
was 3ug/ml. At higher concentrations when the drug was added to the egg suspension a 
precipitate formed. This metabolite also failed to prevent development of eggs possibly 
because of its inactivity as an anthelmintic and inability to penetrate the eggs.
Incubation of ABZ, ABSX or ABSO with infective larvae of O.circumcincta for 96h 
caused a decrease in larval motility, with ABZ showing a greater effect than ABSX at a 
concentration of lOug/ml but similar activity at 5ug/ml (Table 2,16). ABSO at a 
concentration of 3ug/ml reduced larval motility after 72h and 96h incubation but at 
concentrations of 1 ug/ml and 0.5ug/ml ABSO had little effect. ABSO is insoluble therefore 
a concentration of 3ug/ml was the highest whch couid be achieved without the ABoO 
precipitating from solution. In a previous experiment to study the effect of 
benzimidazoles, ABZ, ABSX and TBZ on the motility of infective larvae of O.circumc/nctc 
(Table 2 13) there was little reduction in larval motility after incubations ot 24h, 48h
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and 72h. After 120h incubation in ABZ and ABSX there was a reduction in larval motility. 
In the present experiment the observed reduction in larval motility xcurred more 
rapidly with significant reduction in motility in ABZ and ABSX after 24h. With ABSO a 
reduction in larval motility was not observed until the larvae had been incubated in the 
drug at a concentration of 3ug/ml for 48h. With ABZ and ABSX the reduction in larval 
motility was similar after 72h and 96h incubation at drug concentrations of 10ug/ml and 
5ug/ml (Table 2.16 ) and this reduction in motility was much greater than that observed 
with ABZ and ABSX in the previous experiment (Table 2.13). These discrepancies in the 
effect of ABZ and ABSX on the larvae may be due to differences in the ages of larvae tested. 
For the present experiment the infective larvae had been stored at 4°C for a longer period 
of time prior to their incubation with the anthelmintics than larvae used in the previous 
experiment. The differences in age of the larvae may affect the metabolic stores of the 
larvae and the partially depleted stores in older larvae may make them more susceptible 
to the effects of benzimidazoles.
The metabolite of ABZ , ABSX was inactive against eggs of O.circumcincta (Table 2.15) 
but appeared to have similar activity in vitroio the parent compound against infective 
larvae of O.circumcincta This differential activity against the various stages of
O.circumcincta suggested that the ABSX has nematocidal activity but is prevented from 
exerting this effect in eggs because of poor uptake of the drug by the eggs. The other 
metabolite of ABZ, ABSO is thought to have poor activity as an anthelmintic (Averkin e t 
a/., 1975). From the above experiments it had no effect against O.circumcinctaeggs but 
caused a reduction in larval motility when incubated at a concentration of 3ug/ml with 
infective larvae for >72h. After oral administration of ABZ at a dose rate of 1 Omg/kg to 
sheep the peak concentrations of ABZ, ABSX and ABSO in the abomasum were 6ug/ml, 
26ug/ml and 4ug/ml respectively (Marriner and Bogan, 1980). The concentrations of 
ABSX obtainable in vivo are therefore higher than the concentrations of ABZ. From
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results of in vitro  larval motility tests (Tables 2.13 and 2.16) both the parent compound 
ABZ and ABSX have anthelmintic activity which appears to be comparable. However, in 
displacement assays using tubulin extracts from H.contortus and tritiated ABZ to compare 
the tubulin binding ability of ABZ, ABSX and ABSO (see later) the binding of the 
metabolites ABSX and ABSO to tubulin was lower than the binding of the parent ABZ. These 
results would suggest that if  the mode of action of the benzimidazoles was due to tubulin 
binding the metabolites ABSX and ABSO should have much poorer activity than the parent 
sulphide, ABZ.
These conflicting results of in vitro  tests to measure the activity of ABZ and its 
metabolites ABSX and ABSO confirm that many factors play a role in determining the 
anthelmintic effect of this group of drugs. The concentration of the drug which is achieved 
in the host and therefore the availability of the drug to the parasites is important. Aligned 
to this is the solubility of the drug which influences its kinetics within the host and also 
the ability of the parasites to absorb the drug. The exact mode of action of the 
benzimidazoles is also important with ABZ binding more strongly to nematode tubulin than 
ABSX but ABSX may have other effects on the parasites e.g. effect on parasite metabolism.
Within the host the ABZ is converted to ABSX and this oxidation reaction is reversible. 
The possibility that parasites could convert ABZ to ABSX and ABSO or vice versa was 
investigated by measuring the concentration of ABZ and its metabolites in the sample 
medium surrounding the larvae after incubation for 96h, Comparison of the proportions 
of each of the metabolites in the original standard solutions with the proportions of each of 
the metabolites in the samples indicated that there was negligible interconversion of the 
metabolites over the period of incubation of the O.circumcincta larvae (Table 2.17). 
These results suggested that the larvae cannot convert ABZ to its metabolites ABSX and 
ABSO. The reduction in larval motility observed in the previous experiments (Tables 2.13 
and 2.16) was therefore due to the compound which was added originally. The solution of
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ABSX contained a low level of ABZ (0.49& which equates with 0.049ug/ml in a lOug/ml 
solution) and at this low concentration it is unlikely that the ABZ was responsible for the 
reduction in motility, The metabolite ABSX therefore has anthelmintic activity.
From results of the larval motility assays ABZ and ABSX had similar efficacy against 
infective larvae of O.circumcincta with ABSO having lower efficacy. The larvae do not 
appear to convert ABZ to ABSX or ABSO and therefore an increased rate of drug 
metabolism to the less active metabolite ABSO is not likely to be a mechanism by which the 
parasites have become resistant to the effects of benzimidazoles.
Detection of Benzimidazole Resistance in 0.circumcincta using a Larval 
Paralysis Assay with Infective Larvae Incubated in Physostigmine 
(Eserine) (Methodfrom Sutherland etal, 1988) 
Materials and Method
Materials.
Larvae - O.circumcincta infective larvae of the Bearsden benzimidazole susceptible 
strain and HFRO benzimidazole resistant strain.
Physostigmine (Eserine) -  Obtained from Sigma and used at a concentration of 1 mM. The 
solution was made up freshly for each assay by dissolving 28g of physostigmine in 0.5ml 
I00£ aqueous acetone + 0.5ml distilled water and the volume was made up to 100ml 
using distilled water.
Sterilin 16 well plastic plates 
Method.
1. Approximately 30 infective larvae of the appropriate strain were placed in each well of 
the plastic plate and excess water was removed with a fine glass pipette. The experiment 
was carried out in triplicate or quadruplicate.
2. To each well was added 1ml of the ImM physostigmine solution and plates were
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maintained at room temperature.
3. The motility of the larvae was assessed at 15 min intervals for Ih using a binocular 
microscope.
4. The percentage of larvae motile in each well was calculated at each interval and the 
replicates were meaned. The mean percentage of larvae which were motile in the two 
strains of O.circumcincta was compared at each time interval using the Student's t-test. 
Results
Larval paralysis assays using physostigmine were carried out on four occasions with 
infective larvae of the Bearsden and HFRO strains of O.circumcincta and the motility of 
infective larvae after incubation in ImM physostigmine was calculated at 15min 
intervals and results are shown in Table 2.18. Using a Student's t-test the percentage 
motility for each strain of O.circumcincta was compared in Assays 1-4 at each time 
interval and those assays where the difference in motility was significant are shown in 
Table 2.18. Two assays were carried out using infective larvae of O.circumcincta 
Bearsden and HFRO strain which had been exsheathed (for method see General Materials 
and Methods) and results are shown in Table 2.19.
Discussion
Bixhemical tests carried out on infective larvae of strains of H.contortus have revealed 
differences in the non-specific esterase activity between benzimidazole resistant and 
susceptible strains of the parasites (Sutherland at a/., 1988). During studies with 
isoelectric focussing of larval homogenates bands for esterases were found for resistant 
strains which were absent in susceptible strains and therefore there was a quantitative 
increase in the overall esterase staining in the resistant strain. A simple colorimetric 
assay (Ellman at a/., 1961) was modified to measure quantitative differences in the 
esterase activity of strains of parasites and differences were found to correlate with 
resistance levels in strains of H.contortus (Sutherland et al, 1988). The larval
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Table 2.18
M otility  of larvae measured during larval paralysis assays with infective 
larvae of O.cfrcumcrnctobearsten and HFRO strains incubated in 
physostigmine at a concentration of 1 mM
Incubation Time % of Infective Larvae Motile
(m in) Bearsden Strain HFRO Strain
Assay No. 1  2 3 4 1  2 3 4
15 100 97.9 100 99.3 100 100 100 97.7
30 97.2 97.8 94.3 99.2 100 100 100 90.6
45 69.1 88.6 70.3 58.1 88.5* 87.8 91.3* 75.7*
60 53.6 55.1 48.6 46.5 77.4* 62.9 77.3* 78.0*
*  Motility significantly different (p<0.01) from value obtained for susceptible larvae in 
the comparable assay at the same time interval.
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Table 2.19
M otility of larvae measured during larval paralysis assays using 
exsheathed infective larvae of O.circumcincta Bearsden and HFRO strains 
in the presence of ImM physostigmine.
Incubation Time % of Infective Larvae Motile
(m in) Bearsden Strain HFRO Strain
Assay No. 1  2  1 2
15 100 80.5 100 91.4
30 98.0 50.7 97.0 44.7
45 69.5 27.2 58.5 21.6
60 29.5 25.2 30.6 29.9
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paralysis test developed for the detection of resistance to levamisole and morantel ( Martin 
and Le Jambre,1979) was modified to detect differences in the level of 
acetylcholinesterase activity between benzimidazole resistant and susceptible parasites by 
incubating infective larvae in the presence of physostigmine (Sutherland eta/., 1988).
Physostigmine is an alkaloid which can be extracted from the Calabar or Ordeal bean, the 
dried ripe seed of Physostigma venosum Balfour, a perennial plant grown in West Africa. 
The pure alkaloid physostigmine was isolated from the plant by Jobst and Hesse in 1864 
and the same alkaloid was isolated by Vee and Leven in 1865 and named eserine. 
Physostigmine has a carbamyl ester linkage which can be hydrolysed by 
acetylcholinesterase and acts as an alternative substrate to acetylcholine for 
acetylcholinesterase. When physostigmine interacts with the enzyme 
acetylecholInesterase it produces the carbamylated form of the enzyme which is much 
more stable than the acetyl form of the enzyme and therefore sequestration of the enzyme 
in its carbamylated form prevents the enzyme acting to hydrolyse acetylcholine for 
periods of up to 3-4h. Consequently, there is accumulation of acetylcholine at receptors in 
the nervous system with resulting overstimulation at receptor sites. In nematode 
parasites this accumulation of acetylcholine causes paralysis.
Physostigmine can be used to detect differences in the esterase activity between 
benzimidazole resistant and susceptible parasites because resistant parasites which 
contain higher levels of esterases are capable of withstanding the effects of physostigmine 
for a longer period than susceptible parasites. Reduction in the levels of esterase after 
physostigmine treatment causing paralysis of the larvae due to a build up of acetylcholine 
will be greater in the susceptible parasites than in the resistant parasites.
Results for the larval paralysis assays with physostigmine using the Bearsden and HFRO 
strains of O.circumcincta showed significant differences between the two strains 
( p<0.01) in Assays 1, 3 and 4 after 45min and 60min incubation in the drug (Table
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2.18). In Assay 2 there was a reduction in the motility of the susceptible strain compared 
with motility of the resistant strain at 60min incubation but this was not significant. The 
test was therefore not reproducible on all occasions with Assay 2 giving different results 
from the other three assays. From results of egg hatch assays using eggs of these strains of 
O.circumcincta the HFRO strain was found to be highly resistant to the effects of 
benzimidazoles. In the larval paralysis test using infective larvae of these strains of 
Ocircumcincta incubated in physostigmine there were significant differences between 
motility of benzimidazole resistant parasites and benzimidazole susceptible parasites but 
the magnitude of variation was not large. The difference in motility between a partially 
resistant strain of O.circumcincta and the susceptible strain may be small and therefore 
not significant when trying to detect resistance using the larval paralysis assay with 
physostigmine. Similar problems were encountered when incubating infective larvae with 
benzimidazoles and measuring motility after 24,48 and 72h (see Tables 2.13 and 2.14). 
However, the larval paralysis assay with physostigmine can be performed using low 
numbers of larvae, down to 10 larvae per well, but there may be a reduction in the 
reproducibility of the assays with very low numbers of larvae.
In an effort to try to increase the difference between motility of the resistant and 
susceptible larvae in the presence of physostigmine, the assay was repeated using a higher 
concentration of physostigmine. At a physostigmine concentration of 5mh larvae of both 
the resistant and susceptible strains of O.circumcincta were paralysed within 15min. 
Therefore, for the larval paralysis test with physostigmine to differentiate between 
resistant and susceptible strains of O.circumcincta the concentration of physostigmine in 
the assay appeared to be critical with the test functioning optimally when physostigmine
was used at a concentration of 1 mM.
Exsheathment of the infective larvae prior to their use in the larval paralysis assay 
with physostigmine reduced the ability of larvae of both the resistant and susceptible
1 5 3
strains to withstand the paralysing effect of physostigmine (Table 2.19). For exsheathed 
larvae there was no significant difference between the motility of larvae of the susceptible 
and the resistant strains of O.circumcincta The sheath may therefore play a protective 
role In preventing the uptake of physostigmine by the larvae and this effect may be more 
pronounced in the resistant strain. Alternatively the sheath may contain esterases which 
are capable of binding to physostigmine and also degrading acetylcholine. A higher level of 
esterases in the sheath of the resistant larvae compared with the susceptible larvae would 
lead to a decreased effect of physostigmine on motility of the resistant larvae compared 
with the susceptible larvae.
Although the larval paralysis assay using physostigmine was found to differentiate 
between benzimidazole resistant and susceptible strains of O.circumcincta on most 
occasions the rational behind using this assay to detect benzimidazole resistance in 
nematode parasites is not clear. Measurement of the level of esterases using a colorimetric 
assay with alpha-naphthyl acetate has been used as a method to detect resistance to 
organophosphorous compounds in arthropods. The organophosphorous compounds which 
are used as insecticides act as anti-cholinesterases causing accumulation of acetylecholine 
in the insects. Resistance to organophosphorous compounds by development of higher 
esterase activity in strains of arthropods and measurement of the higher esterase levels in 
resistant insects seems a logical approach to detection of resistance to organophosphorous 
compounds In insects. However in nematode parasites the role of increased esterase 
activity which was detected in strains of parasites which are benzimidazole resistant is 
unclear. Kelly etal.X  1978) using H.contortus found that in strains where resistance to 
anthelmintics had developed there was a concomitant rise in the 'fitness' of the parasites 
as measured by increased infectivity and pathogenicity . This alteration in the 'fitness' of 
the benzimidazole resistant parasites could be due to intense selection pressure altering 
the genetic characteristics of the population resulting in a resistant phenotype which has
1 5 4
similar or superior 'fitness' to the susceptible parasites even in the absence of the 
sjl&jtinp agent. This phenomenon has been noted in studies on insecticide resistance 
(Georgniou and Taylor, 1976; McKenzie and Purvis, 1984). The possible alteration in 
the 'fitness' of benzimidazole resistant nematodes may be expressed as increased levels of 
enzymes, among other changes in the parasites. Therefore, the detection of increased 
levels of esterases in larvae of benzimidazole resistant parasites could be a measure of the 
increased 'fitness' of the parasites rather than a direct measurement of the level of 
benzimidazole resistance developed by the strain of parasites.
Alternatively, the increase in esterases in benzimidazole resistant O.circumcincta may 
be an early biochemical mechanism along the pathway of development of resistance to 
benzimidazoles. Studies on a CBZ resistant strain of Hcontortus{Rew et a/., 1982) 
showed that in the presence of benzimidazoles adult parasites were able to increase their 
metabolism of glucose to volatile end-products whereas catabolism of glucose was 
unaffected in a benzimidazole susceptible strain of Hcontortus It is possible that 
increased metabolism in resistant parasites is linked with increased levels of enzymes 
including esterases and these may play some role in the development of resistance to 
benzimidazoles in addition to the possible changes in affinity of tubulin in resistant 
p'arasites for benzimidazoles ( Lacey and Prichard, 1986).
Studies on the Uptake of Trttlated ABZ or Trlttated FBZ by Infective Larvae 
of the Bearsden Benzimidazole Susceptible and HFRO Benzimidazole 
Resistant Strains of O.circumcincta.
N&terials.
Tfttlated ABZ - 3.77uM, specific activity 360dpm/pmole
Tritiated FBZ - 8.36uM, specific activity 1 lOdpm/pmole
Infective larvae of HFRO and Bearsden strains of O.circumcincta cultured as described
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previously (see General Materials and Methods).
Sterilin 16 well plastic plates 
Method.
1. Approximately 100 larvae of the appropriate strain were placed in each well of the 
plate.
2. There were two control wells containing drug without larvae and two blank wells with 
larvae and no drug.
3. Drug was added to the plates with triplicates of each strain of O.circumcincta exposed to 
either ABZ or FBZ added at a rate of 1 Oul or 20ul.
4. The volume in each well was made up to 1 ml using distilled water.
5. Plates were incubated at 37°C for 24h.
6. On removal from the Incubator the contents of each well of the plate, except the 
controls, were placed in glass tubes and the wells washed thoroughly with water and 
washings collected in the tubes.
7. The tubes were centrifuged at 2,000g for 5mins and the supernatant removed. The 
larvae remaining were washed with water, centrifuged and supernatant removed 3 times 
to ensure that any radioactive counts were associated with the larvae and that all unbound 
drug was removed.
8. The larvae were transferred into vials containing 10ml Ecoscint. The contents of the 
control wells were placed in vials with Ecoscint. The vials were counted in a Packard 
counter for 1min.
9. The amount of drug taken up by the larvae, expressed as cpm/100 larvae, was 
calculated by subtracting the value for the blanks from each of ttie samples and calculating 
the mean of the results. _
Results
Infective larvae of both strains of O.circumcinctaww* incubated with tritiated ABZ or
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tritiated FBZ for 24h and the uptake of each of the drugs by the larvae was measured by 
counting the radioactivity in the larvae. Results expressed as cpm/100 infective larvae 
are shown in Table 2.20.
Discussion
The uptake of the benzimidazoles ABZ and FBZ by infective larvae of the two strains of 
O.circumcincta was studied to determine if there was a significant difference in the 
amount of the anthelmintics absorbed by benzimidazole resistant or benzimidazole 
susceptible parasites. From results in Table 2.20 the O.circumcincta infective larvae of 
the resistant strain retained a significantly higher concentration of ABZ and FBZ after 
incubation with the drugs for 24h compared with infective larvae of the Bearsden 
benzimidazole susceptible strain. With both ABZ and FBZ the larvae of the benzimidazole 
resistant strain of O.circumcinctacmXmzti approximately two times the level of drug 
than larvae of the susceptible strain. A two fold increase in the amount of drug added to the 
larvae resulted in a 2.5-3 fold increase in the amount of drug taken up by the infective 
larvae of both strains of parasites. This suggests that the amount of drug absorbed by the 
parasites was related to the drug concentration to which the larvae were exposed during 
incubation. Weston at a/., (1984) found the uptake of TBZ into H.contortus eggs was 
related to the concentration of the drug in the culture medium. The uptake of 
benzimidazoles into nematode eggs was believed to be by passive diffusion from the 
surrounding medium (Weston atal, 1984; Sangster and Prichard, 1984). The uptake of 
benzimidazoles into adult nematode parasites has been studied with various species. 
Sangster and Prichard (1984 ) studied the uptake of [ 14C]TBZ by adult T.coiubriformis 
using benzimidazole resistant and susceptible strains. These authors found that uptake of 
the drug was rapid with maximium levels achieved after 30mins. The parasites 
accumulated TBZ to a concentration approximately 4-5 times that in the surrounding 
medium. Similar results were found by Kohler and Bachman (1980) who studied the
1 5 7
Table 2.20
Uptake of tritiated ABZ or FBZ expressed as cpm /100 larvae by 
O.circumcincta infective larvae of the Bearsden benzimidazole susceptible 
and HFRO benzimidazole resistant strains
S tra in . com/lOO larvae
Tritiated Drug Added ABZ FBZ
Bearsden 1 Oul 53.5±2.5 359.5±30.5
Bearsden 20ul 133.5±22.5 910.5±26.5
HFRO 1 Oul 92.5±19.5 625.0*41.2
HFRO 20ul 283.0±12.6 1841.0±8.5
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uptake of MBZ in adult A sum  Sangster and Prichard (1984) compared uptake of TBZ in 
parasites and red blood cells and found the levels to be similar. These authors concluded 
that uptake of the drug was by passive diffusion from the surrounding medium and 
therefore the differential toxicity of benzimidazoles to nematode parasites compared with 
host toxicity was not due to higher uptake of the benzimidazoles by nematodes.
The possibility that an alteration in the uptake of the benzimidazoles could be 
responsible for development of resistance to benzimidazoles by nematodes has been 
investigated. Sangster and Prichard (1984) found that eggs of benzimidazole resistant and 
benzimidazole susceptible strains of T.coiubriformis contained similar levels of TBZ 
after incubation in the drug. Comparison of uptake of TBZ into adults of the resistant and 
susceptible strains of T.coJubriformis showed that the rate of uptake of TBZ measured 
over 30mins was greater in the resistant strain but this difference between the resistant 
and susceptible strains was not significant. However, the final concentration of TBZ which 
accumulated in the adult parasites over 22h incubation was significantly greater in the 
resistant worms compared with the susceptibles. These results were similar to those 
found with infective larvae of the benzimidazole resistant and susceptible strains of
O.circumcincta (Table 2.20). Rew eta l, (1982) measured the uptake of TBZ by adult 
parasites of a CBZ resistant strain of H.contortus and found the resistant parasites 
accumulated 158 less TBZ than a benzimidazole susceptible strain of H.contortus These 
results were at variance with those of Sangster and Prichard (1984) and results given in 
Table 2.20. However, all these results indicated that a reduction in the uptake of 
benzimidazoles by parasites is unlikely to be the mechanism by which these parasites 
have developed resistance to the effects of benzimidazoles.
The increase in the uptake of benzimidazoles observed for the resistant strain of
O.circumcincta (Table 2.20) was unexpected. The significant difference in uptake of both 
ABZ and FBZ by the resistant and susceptible larvae may have been due to differences in
1 5 9
the age of the larvae. The larvae which were used in the experiment were stored at 4°C 
after collection from faecal culture over a similar time period but there could have been a 
small difference in the age of the larvae. The age of the larvae may affect the levels of 
stored metabolites within the larvae which could affect the uptake of benzimidazoles. 
Weston et al., (1984) suggested that the uptake of TBZ into H.contortus eggs was 
proportional to the lipid content of the eggs. There could be a similar effect in larval 
forms with larvae containing a higher level of lipid absorbing a greater quantity of 
benzimidazoles. The differences in uptake of benzimidazoles between the two strains may 
be due to biological variation which could be a reflection of the differing sources and 
characteristics of the two strains of parasites. The Bearsden strain of O.circumcincta has 
been a laboratory strain for many years whereas the HFRO strain has been selected in the 
laboratory for 3 years. Because of their different sources the strains could contain totally 
different gene pools and therefore they may differ in many biological characteristics in 
addition to the differences in susceptibility to benzimidazoles. This in turn may account 
for marked differences in the uptake of benzimidazoles by the two strains.
The mode of action of the benzimidazoles is thought to involve binding to tubulin 
( Friedman and Platzer, 1978) and a reduction in the binding of benzimidazoles to tubulin 
from resistant nematodes has been suggested as a possible mechanism for development of 
resistance to the effects of benzimidazoles ( Lacey and Prichard, 1986). From Table 2.20 
larvae of the benzimidazole resistant strain of O.circumcincta contained a higher 
concentration of ABZ and FBZ. However, this may not relate to the capacity of the nematode 
tubulin to bind benzimidazoles because tubulin constitutes a very small percentage of the 
total protein in the parasite. Differences in the binding of benzimidazoles to tubulin 
extracts from the Bearsden and HFRO strains of O.circumcincta were observed (see 
later). The observed alteration in drug uptake in resistant larvae was probably due to 
differences in other proteins or lipids present in the larvae which may have no relevance
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to the level of benzimidazole resistance of the parasites.
GENETICS OF RESISTANCE 
Studies on Genetic Material Extracted from Benzimidazole Resistant and 
Susceptible Strains of O.circumcincta 
Materials and Methods
Extraction of DNA from O.circumcincta infective larvae.
Materials.
Larvae -  Infective larvae of the Bearsden susceptible strain of O.circumcincta were 
cultured from the faeces of an experimentally infected lamb. Infective larvae of the HFRO 
benzimidazole resistant strain of O.circumcincta were cultured from the faeces of Lamb 
DB3 and during the period of culture the faeces were exposed to TBZ at a concentration of
0.01.g/ml to ensure that the eggs which hatched were resistant to the effects of 
benzimidazoles. Larvae were isolated from faecal culture by Baermanisation (see General 
Materials and Methods).
Washing buffer - Tris-HCl 5mM, EDTA lOOmM, pH8 Lauryl sarcosyl 0.51
TE buffer -  Tris-HCl 10mM, EDTA 0.5mM , pH8
Method.
1. Larval suspensions were centrifuged and excess water removed. Larvae were washed 
twice in washing buffer and centrifuged with removal of excess buffer.
2. Larvae were weighed and approximately 0.5g of each strain were used in the extraction 
procedure.
3. The larvae were ground in a mortar and pestle in the presence of liquid nitrogen 
producing a fine white powder which was resuspended In 15m 1 of washing buffer.
4. Proteinase K was added at a rate of 50ug/ml and the samples were incubated at 50°C for 
2h.
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5. The samples were cooled on ice and an equal volume of phenol was added and the samples 
were mixed gently on a roller for 15min.
6. The samples were centrifuged for iOmin at 7,000 r.p.m. (MSE High speed 25 
centrifuge).
7. The aqueous phase was removed gently using a wide-mouthed pipette and steps 5 and 6 
were repeated using this fraction.
8. Approximately Mml of aqueous phase was obtained for each sample. To this was added 
1.4ml 3M salt solution (final concentration of salt solution 10£v/v) and 2 volumes of 
absolute alcohol. The samples were mixed gently.
9. The DNA in the samples formed clumped strands which were removed carefully using a 
glass rod. The strands were washed in 70£ethanol/TE buffer (70£v/v ethanol in 
30Sv/v TE buffer).
10. The washed DNA was redissolved in 500ul of TE buffer and rolled gently.
11 ,PNA-ase( 10ug/ml) was added to the extracted DNA and incubated at 37°C for 30min.
12. Proteinase K (1 part Proteinase to 200 parts DNA extract) was added and incubated at 
37°C for 30mins.
13. An equal volume of phenol was added and mixed gently on a roller for 15min, Samples 
were centrifuged for 2 min at low speed (< 500r.p.m.) in an Eppendorf bench top 
centrifuge.
14. The aqueous layer was removed carefully using a wide mouthed pipette and to this was 
added 1 /10 the volume of 3M salt solution and 2 volumes of absolute alcohol.
15. The DNA formed clumped strands and was removed carefully using a glass rod. The DNA 
was resuspended in 500ul TE buffer and mixed gently.
16. The extract was stored at 4°C.
17. The purity of the DNA extract was assessed by agarose gel electrophoresis.
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Segmentation of DNA Extracted from O.circumcincta Bearsden and HFRO 
Strains using Restriction Endonucleases.
Materials.
Restriction endonucleases - Pst I , Hind 111 and EcoR I.
Core Buffer -  50mM Tris HC1, pH 8, 10mM MgCl and 50mM NaCl (B.R.L.- React 2 
Buffer) diluted 1 in 10 with distilled water for use.
Sterile distil led water 
Method.
1. DNA extracts prepared by the method described above from infective larvae of the HFRO 
and Bearsden strains of O.circumcincta were used. With each restriction endonuclease 
used 20ul of DNA extract from Bearsden susceptible strain and 25ul of DNA extract from 
HFRO strain.
2. The tubes were set up as follows; Tubes 1, 3 and 5 contained 20ul DNA from the 
Bearsden strain and Tubes 2, 4 and 6, 25ul of DNA from the HFRO strain. To tubes 1 and 2 
added 2ul Pst I, tubes 3 and 4 , 2ul Hind III and to tubes 5 and 6, 2ul EcoR I. Core buffer 
3.5u1 was added to each tube and the volume in the tubes was made up to 35ul using sterile 
distilled water. Two standard tubes containing standard DNA plus Hind III were also used. 
The material in the tubes was mixed, centrifuged at low speed in an Eppendorf bench-top 
centrifuge for 1 min and incubated overnight at 37°C.
3. The tubes were removed from the Incubator and heated to 70°C for 1 Omln then stored at 
4°C.
4. The DNA fragments were separated using agarose gel electrophoresis.
Agarose gel electrophoresis
Materials./
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Materials.
Ethidium bromide -  Stxk solution lOmg/ml
TBE buffer -  0.089 M Tris borate, 0.089M Boric acid, 0.008M EDTA.
FSB -  Final sample buffer -  15* ficoll, 0.25* bromophenol blue, 0.25* xylene cyanol
S.F. and 0.25* orange G in TBE buffer.
Agarose.
Method.
1. A solution of 0.8*w/v agarose was constituted in TBE buffer and microwaved for 2 min 
to boil the solution. The agarose was allowed to cool, ethidium bromide (0.5mg/ml) was 
added and then the material was poured into the gel apparatus. The end of the gel was left to 
seal and then the remainder of the solution was added and the gel allowed to set.
2. To asses the purity of DNA isolated from O.circumcincta (see above) the gel was loaded 
with Sul DNA sample plus 3ul FSB and the gel was surrounded by TBE buffer containing 
ethidium bromide (0.5mg/ml). For assessment of DNA fragments after digestion with 
restriction endonucleases 25ul of each sample with 5ul FSB was loaded onto the gel and it 
was surrounded by TBE buffer containing ethidium bromide ( 0/5mg/ml). The gels were 
connected to the power supply and run at 150 volts for 15-30 min then 20 -30 volts 
overnight.
3. The gels were examined under ultra violet light.
Characteristics of DNA Extracted from Infective Larvae of O.circumcincta 
Bearsden and HFRO Strains 
Results
Gel electrophoresis carried out on DNA extracts from infective larvae of O.circumcincta, 
Bearsden and HFRO strains, revealed that the DNA was pure with no contaminating RNA 
present and no other bands were identified on the gel. The purified DNA of each strain was
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subjected to restriction enzyme digestion and the resulting DNA fragments were separated 
using agarose gel electrophoresis. Figure 2.21 shows the separation of DNA fragments in 
the gel. Marker DNA which divided into fragments with known numbers of base pairs after 
incubation with Hind 111 was used In the experiment to ensure that the restriction enzymes 
were functioning and there was adequate separation of the DNA fragments in the gel. A 
graph of the number of bases in each DNA fragment against the distance travelled by the 
fragments in the gel for the marker DNA was constructed ( Fig. 2.22)
Discussion
Pure samples of DNA were isolated from infective larvae of O.circumcincta Bearsden 
and HFRO strains. To ensure that all the larvae cultured from the faeces of Lamb DB3 were 
resistant to the effects of benzimidazoles the faeces were cultured in the presence of TBZ 
at a concentration of 0.0lug/ml. Initial studies to culture larvae in the presence of TBZ 
were carried out. During egg hatch assays on the eggs of the HFRO strain of O.circumcincta 
greater than 90£ of the eggs hatched in the presence of TBZ at a concentration of 
0 .lug/ml. However, when faeces containing eggs of the HFRO strain of O.circumcincta 
were cultured in the presence of TBZ at a concentration of 0.1 ug/ml and the larvae were 
collected after 12 days of culture at 28°C less than 2% of the eggs had hatched and 
developed to infective larvae compared with control cultures not exposed to the TBZ. There 
was a significant difference between hatchability of eggs of the resistant strain of 
O.circumcincta when exposed to TBZ at a concentration of 0.1 ug/ml in the egg hatch 
assays for 48h and the ability of eggs of the same strain to develop to infective larvae in 
the same concentration of TBZ when incubated for 12 days. These differences could be due 
to differences in the susceptibility of the different stages of larvae to the effects of
benzimidazoles. During development the infective larvae, larvae and adult parasites are 
subjected to anthelmintics in the host animal. However the L j and L2 forms of the parasite
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Results of agarose gel electrophoresis of DNA from Bearsden and HFRO 
strains of O.circumcincta Lanes 1 and 8 contained marker DNA, Lanes 2 
and 3 DNA from Bearsden and HFRO strains respectively after incubation 
with Pst I ,  Lanes 4 and 5 DNA from Bearsden and HFRO strains 
respectively after incubation with Hind HI and Lanes 6 and 7 DNA from 
Bearsden and HFRO strains respectively after incubation with EcoR L
167
Figure 2.22
Graph of distance travelled during agarose gel electrophoresis by DNA 
fragments containing a known number of bases.
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are present on the pasture and are therefore not subjected to the effects of anthelmintics. 
These stages of the parasite may be less resistant to the effects of the benzimidazole 
anthelmintics and therefore they are unable to develop to infective larvae when cultured 
in the presence of high levels of TBZ. Alternatively the resistance to benzimidazoles 
exhibited by the HFRO strain of O.circumcincta may be because these parasites can 
overcome the effects of the benzimidazoles for a short period of time but long term 
exposure to the drug can be effective in killing the parasites. Within the host the parasites 
are exposed to the benzimidazoles for a short period of time (approximately 72h for the 
modern benzimidazoles) and if they can remain in situ  during this period of exposure 
they w ill resist the effects of the drug. However, these parasites may be unable to 
maintain their position if exposure to the drug was more prolonged. Culture of faeces in 
TBZ at a concentration of 0,0lug/ml yielded sufficient Infective larvae for extraction of 
DNA to carry out the experiments.
Organisms are able to resist the effect of drugs by various mechanisms including 
reduction in the uptake of the drug, increased excretion of the drug, increased metabolism 
of the drug and decreased effect of the drug at the site of action by e.g. changes in the drug 
receptor sensitivity. All these changes in the phenotype of the organisms occur due to 
alterations in the genetic characteristics of the organism. Mutations occur within 
populations and these can be advantageous to the particular organism or detrimental to its 
survival. Within a population there will be a range of genes any of which can be selected 
depending on the advantages which they confer on their offspring. Most resistance in 
organisms to the effects of drug is thought to be due to mutations and the mutant forms 
become dominant in the population after selection with the particular drug. These 
mutations can take several forms e.g. change of a single base or several bases on the DNA, 
deletion or insertion of a portion of the DNA, gene amplification or uptake of 
extrachromosomal DNA. Benzimidazoles are thought to act by binding to nematode tubulin
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(Friedman and Platzer, 1978) and tubulin plays a role in formation of the mitotic 
spindle. Benzimidazoles have been shown to be teratogenic in some species (Schreiner and 
Holden, 1983) but there is conflicting evidence relating to the mutagenic effect of the 
benzimidazoles (Seiler, 1972; Kappas eta!., 1976; Carere atal, 1978; Weir, 1987). If 
benzimidazoles have a mutagenic effect this could have played a part in stimulating 
changes in the genetic code of the parasites with a possible influence on the development of 
resistance.
In some cancer cells resistance of these cells to the effects of chemotherapeutic agents 
was found to be due to amplification of the genes responsible for the production of the 
enzyme against which the drug was targeted ( Bostock, 1986). Therefore, the cancer cells 
produced high levels of this enzyme and were able to evade the action of the 
chemotherapeutic agents. This gene amplification occurred in stepped increments with the 
base sequences involved in production of the relevant proteins multiplied several times 
within the one strand of DNA. This type of resistance was found to vary in its stability 
(Schimke, 1984). Instability of the resistant phenotype can often be linked with cases 
where there is gene amplification but the gene amplification can remain stable in some 
cases. The possibility that resistance in nematodes to the effects of benzimidazoles could be 
due to gene amplification was investigated in studies on O.circumcincta DNA from 
benzimidazole resistant and susceptible strains.
Nematode endoparasites in animals can show a high level of genetic variability within 
the population (Nadler, 1987). The degree of variability is high for field strains of 
nematode parasites because of the large population and therefore the large available gene 
pool. In strains of parasites which have been maintained in a laboratory there is less 
genetic variability because the gene pool Is conserved from one generation to the next. Also 
new genetic material is not usually introduced into the strain and the genetic pool in 
parasites used to initiate the strain may represent only a portion of the available genetic
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pool. Parasites maintained in a laboratory have a tendency to adapt to the prevailing 
situation with loss of genetic variability in the strain. Therefore studies on DNA from 
laboratory maintained strains of parasites may give some indication of the genetic make 
up of the parasites but cannot reflect the full spectrum of genes available in the entire 
population of the parasites.
In order to investigate possible differences in the DNA derived from benzimidazole 
resistant and susceptible strains of O.circumcincta the DNA from each strain was 
fragmented using restriction endonucleases. Each of these restriction enzymes, which are 
derived from bacteria, bind to a specific sequence of bases found on the DNA strand which 
is termed the recognition sequence. The enzyme then lyses the DNA at a cleavage site which 
is usually located within the recognition sequence. In the experiments with DNA from 0 
circumcinctatf the Bearsden and HFRO strains restriction enzymes termed 6-cutters 
were used. These recognise a sequence of 6 base pairs and in a strand of DNA cut randomly 
using one of these enzymes fragments containing 46 bases , 4096 bases, w ill be produced. 
The enzymes which were used in the experiments are listed in Fig. 2.23 along with the 
recognition sequences and cleavage sites for each of the enzymes. When the DNA is digested 
by the endonuclease, fragments of DNA are produced which can be separated by agarose gel 
electrophoresis with the rate of migration on the gel inversely proportional to the log of 
the weight of the fragment.
The DNA from the Bearsden and HFRO strains of O.circumcincta was divided by 3 
individual nucleases and the resulting fragments were examined. In order to detect 
differences in the fragments between the two strains there would have to be a change at one 
of the recognition sites for the endonuclease. Detection of a point mutation using this 
method is very unlikely because the statistical chance of this type of mutation occurring at 
the recognition site is very low. However, gross changes in the DNA e.g. gene amplification 
may be recognised. With gene amplification an area of the DNA is repeated and therefore
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Figure 2.23
Recognition sequences and cleavage sites for restriction endonucleases.
Restriction Endonucleases
Pst I  recognises C-T-G-C-A-G
t
Hind 111 recognises A-A-G-C-T-T
tEcoR I-----------recognises G-A-A-T-T-C
^  bond lysed by restriction endonuclease
after cleavage with restriction enzymes there will be a large number of identical 
fragments from the amplified area. This increase in production of a particular fragment 
can be recognised as a darker staining band after agarose gel electrophoresis.
Agarose gel electrophoresis was used to separate the fragments produced after cleavage 
of the DNA from O.circumcincta Bearsden and HFRO strains. Examination of the agarose 
gel (Fig. 2.21) revealed that there were no differences in the DNA fragments obtained 
from the two strains of O.circumcincta This suggested that gross differences in the DNA 
between benzimidazole resistant and benzimidazole susceptible strains of O.circumcincta 
do not exist. Gene amplification as a mechanism for the development of resistance is 
therefore unlikely. Mutation of a short sequence of bases would not be identified using this 
method except in the extreme situation where a change occurred at an endonuclease 
recognition site. Resistance to benzimidazole in H.contortus\z thought to be polygenic (Le 
Jambre eta/J  979; Herlich eta/., 1981). If resistance was polygenic in O.circumcincta 
the DNA of the resistant parasites may be modified at several sites but these areas of 
change or mutation may not be recognised by the method described above.
Lacey (1985) described a reduction in the binding of benzimidazoles to tubulin from 
resistant nematodes compared with the level of binding to tubulin of susceptible parasites 
as the possible biochemical basis for resistance to benzimidazoles. This would imply that 
an alteration has taken place in the genes of the resistant parasites which are responsible 
for the production of tubulin molecules. Foster eta/, (1987) found a mutant strain of 
Phy'sarium po/ycepha/um which was resistant to benzimidazoles and produced a 
tubulin molecule with altered electrophoretic mobility compared with p  tubulin from a 
non-resistant strain. In addition to thep  tubulin with altered electrophoretic behaviour 
normal p  tubulin was produced by the resistant organism. The mechanism controlling the 
production of the different forms of p  tubulin and the genetic basis for development of 
these tubulin molecules is unknown.
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In order to identify components of the genome of O.circumcincta the DNA fragments on 
the agarose gel were used to make a Southern blot. To try to identify components of the 
genome, DNA probing for known gene sequences e.g. the tubulin gene would be required. 
Suitable probes are becoming available but further investigation on the DNA from the 
Bearsden and HFRO strains of O.circumcincta has not yet been carried out.
General Discussion and Conclusions
Resistance in sheep nematodes to the effects of benzimidazole and other anthelmintics is 
of economic importance in Australia, New Zealand, South Africa and countries in South 
America. However, the incidence of benzimidazole resistance is low in the U.K. Reports of 
anthelmintic resistance in sheep parasites in the U.K. tend to be from research 
establishments and in Southern England where Hcontortusinlections occur (Michel eta/., 
1982). A strain of O.circumcincta from premises owned by the HFRO was isolated and 
studied. Management and climatic differences between the U.K and Australia, New Zealand, 
South Africa and countries in South America may be important influencing the incidence 
and the development of nematode resistance to the effects of anthelmintics (Waller, 
1987). Also, the prevalence and economic effects produced by H.contortus in Australia, 
New Zealand, South Africa and some countries in South America are of significantly 
greater importance than in the U.K where H.contortus occurs only in the southern parts 
of the country. Early identification and prevention of widespread development of 
resistance to a range of anthelmintics is important to ensure that anthelmintic resistance 
does not become a major problem to the sheep industry in the U.K.
Various tests are available to detect resistance including the egg hatch assay ( Le Jambre, 
1976; Coles and Simpkin, 1977), the faecal egg count reduction test, larval motility 
assays for levamisole and morantel (Martin and Le Jambre, 1979), tubulin binding 
assays (Lacey and Snowdon, 1988) and the controlled anthelmintic efficiency test
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(Powers eta/, 1982), Each of these tests has various drawbacks, however, the in vitro 
egg hatch assay is used most commonly to test for resistance against benzimidazoles. In egg 
hatch assays using TBZ and ABZ results were paralleled with resistance levels for ABZ 
higher than with TBZ in most cases. This suggested that TBZ penetrated the eggs better and 
lower concentrations were required to exert an ovicidal effect on the eggs. However, 
differences in the resistance levels measured in the eggs of parasites may not reflect 
differences in the resistance of adult parasites ( Le Jambre et el, 1979). This may be due 
to differences in the genetic control of resistance at different stages in the development of 
the parasites. In the dose titration trial selection of adult parasites using high dose rates of 
fenbendazole failed to increase the resistance in the eggs produced by these adult parasites. 
Also, during 14 generations of the HFRO strain of O.circumcincta with 12 treatments 
using FBZ the level of resistance measured by egg hatch assays showed a negligible 
increase. Similar results have been found (Waller et al, 1985; Borgsteede, personal 
communication, 1987) with failure to show a rise in resistance in egg hatch assays after 
selection of parasites. With the HFRO strain of O.circumcincta although variations in the 
level of resistance found in parasite eggs were detected during an infection the results of 
the dose titration trial and the egg hatch assays suggested that the strain was highly 
resistant to the effects of benzimidazoles and the population appeared to be relatively 
homogeneous.
During tests with infective larvae of O.circumcincta incubated in the presence of 
benzimidazoles differences in the motility of larvae of the susceptible and resistant 
strains were detected. Because of the mode of action of the benzimidazoles a long period of 
incubation was required before motility of the larvae was affected and differences between 
resistant and susceptible strains of parasites were small. Low numbers of infective larvae 
can be used for a larval motility test with physostigmine to detect differences in the 
acetylcholinesterase activity between benzimidazole resistant and susceptible strains of
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nematodes (Sutherland at at, 1988). The relationship between acetylcholinesterase 
activity and resistance to benzimidazoles has not been elucidated and therefore this test 
may not be suitable to detect low levels of resistance in populations of nematode parasites.
There have been reports of reduction in the level of resistance in populations of 
T.colubriformis and H.contortuson withdrawal of anthelmintic selection (Simpkin and 
Coles, 1978) but later reports (Hall et al, 1978b) suggested that withdrawal of 
selection pressure failed to reduce resistance in T. colubriformis and H.contortus to TBZ. 
In studies with the HFRO strain of O.circumcincta removal of pressurisation with FBZ 
over four generations did not alter the level of resistance measured in egg hatch assays. 
Counterselection using levamisole can reduce the level of benzimidazole resistance in 
strains of O.circumcincta (Donald etaL 1980; Waller eta/., 1983; Martin etaL 1988) 
but resistance levels rose rapidly on reintroduction of the benzimidazoles.
In studies on 'clones' of the HFRO strain of O.circumcincta established after 
transplantation of a pair of adult parasites into the abomasum of a lamb there was loss of 
resistance in the eggs produced by the second generation after transplantation. However, 
selection with benzimidazole anthelmintics caused a rapid rise in the level of resistance 
which suggested that genes conferring resistance were present in the parasites and could 
be selected readily by pressurisation with benzimidazole anthelmintics. Results of these 
studies suggested that resistance could be a polygenic trait but controlled by a small 
number of genes
The main problem with genetic studies in parasites is that breeding experiments using 
single adult parasites in vitro are very difficult to perform (Douvres and Malakatis, 
1977) and backcrosses to the original parents are impossible because of the short 
lifespan of the adult parasites. Some breeding experiments using benzimidazole resistant 
and susceptible T.colubriformis have been carried out (Martin etaL in press) using a 
guinea pig model. Resistance was controlled by more than one gene and inherited as a
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semi-dominant character with a strong maternal influence. A similar mechanism of 
inheritance possibly could occur in O.circumcincta
Another problem with studies on the genetic inheritance of resistance was testing the 
level of resistance when small numbers of parasites were available, in order to carry out 
egg hatch assays for benzimidazole resistance with O.circumcincta a faecal egg count of 
> 100 eggs per gram was necessary.
Changes in the level of resistance in strains of nematodes maintained in the laboratory 
and used in experimental infections may not reflect changes in field strains of parasites. 
In the field parasites on the pasture which are not exposed to the effects of anthelmintics 
play a role in the development of resistance within the whole population. The number of 
parasites in refugia was found to influence the rate of development of resistance in 
benzimidazole resistant strains of H.contortus ( Martin otal, 1981).
The frequency of anthelmintic treatment and the dose rate of anthelmintics used have 
been implicated as factors which influence the development of anthelmintic resistance in 
nematodes (Martin et a/, 1982; Martin, 1987). In the dose titration experiment 
treatment of adults of the HFRO strain of O.circumcincta with increasing doses of 
fenbendazole failed to increase the level of resistance measured by egg hatch assays. 
Resistance in a population of parasites may reach a high level and further selection with 
anthelmintics cannot increase the level of resistance. In areas of Australia for parasite 
control schemes implemented on sheep farms it is recommended that an adequate dose of 
anthelmintic should be used to remove a high proportion of the parasite burden within the 
animals and therefore the low numbers of parasites surviving anthelmintic treatment are 
not allowed to predominate in the parasite population ( Dash eta ly 1985).
Side -  resistance with benzimidazoles is found and egg hatch assays using TBZ and ABZ 
produced similar patterns of results. The metabolites of ABZ, ABSX and ABSO and the 
pro-drug netobimin were not ovicidal when used in egg hatch assays. However, ABSX was
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effective in reducing larval motility when infective larvae of O.circumcincta were 
incubated in this metabolite. Within the host the modern benzimidazole anthelmintics 
exist in a chemical equilibrium with the suphoxide form of the drug predominating and 
low levels of the sulphide form found in plasma and tissues (Marriner and Bogan, 1980, 
1981a and 1981b). The close relationship between the sulphide and sulphoxide 
structures may allow both forms to bind to parasites and have an anthelmintic action and 
the failure of ABSX to exert an ovicidal effect in egg hatch assays may be due to its 
inability to penetrate the egg shell of O.circumcincta For egg hatch assays TBZ, which has 
greater water solubility than the modern benzimidazoles, is the drug used most commonly.
Isolation of DNA from O.circumcincta HFRO and Bearsden strains was achieved and there 
were no obvious differences in the DNA after separation with some restriction enzymes. 
This implied that gene amplification was not Involved in the development of resistance to 
benzimidazoles but examination of the DNA using this method would not identify small 
changes in the genetic code unless they occurred at an area where the restriction enzymes 
had their action.
The mechanism of action of the benzimidazole anthelmintics has not been described fully 
and therefore it is difficult to identify the mechanisms by which parasites can become 
resistant to the effects of these anthelmintics. Exposure to the benzimidazoles over a 
prolonged period is necessary to kill the parasites. Therefore, parasites which have the 
ability to withstand the effects of the benzimidazoles for the short period of time of 
exposure to the drug in the host are resistant. This may be achieved by alterations in 
binding of the drug or parasite metabolism. An increase in the uptake of ABZ and FBZ into 
resistant compared with susceptible infective larvae of O.circumcincta ( HFRO and 
Bearsden strains) was found. Similar differences in drug uptake were described for 
benzimidazole resistant and susceptible Tcoiubriformis adults (Sangster and Prichard,
1984) but adults of a resistant strain of H.contortus accumulated a lower concentration
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of benzimidazoles than a susceptible strain (Rew etal, 1982). The significance of these 
differences in drug uptake by resistant and susceptible parasites is unknown as is the 
importance of these differences to the ability of the parasites to resist the effects of the 
benzimidazole anthelmintics. Some of these differences could be due to population 
variation in the strains of O.circumcincta which were obtained from different sources 
and therefore would have little or no relevance to the mechanisms of development of 
resistance to benzimidazoles.
The genetic pool in a population may influence the rate of development of resistance to 
different classes of drugs. H.contortus populations in Australia developed resistance to 
benzimidazoles rapidly but resistance to levamisole and morantel was slower to develop 
(Waller, 1985). With T.colubriformis and O.circumcincta resistance to levamisole and 
morantel along with benzimidazole resistance developed rapidly (Waller, 1985; Waller 
1987). Before resistance to an anthelmintic is identified in the field a high level of 
resistance to the appropriate drug has developed (Waller, 1986). From results in the 
dose titration trial treatment with increased doses of benzimidazoles did not increase the 
level of resistance in eggs of the surviving parasites but equally once a population of 
parasites resistant to anthelmintics is established removal of selection pressure does not 
guarantee a return to anthelmintic susceptibility even after a prolonged period. These 
findings have important implications for parasite control in the sheep industry especially 
in areas of Australia where parasite populations showing multiple resistance to 
anthelmintics are established and livestock rearing in these areas is now dependent on the 
use of ivermectin and closantel with benzimidazoles and levamisole/ morantel proving 
useless for the control of nematode parasites. In the U.K. the situation regarding 
anthelmintic resistance is much less serious possibly due to differences in the 
predominance of parasite species, climate and management systems but the genetic ability 
to develop resistance to anthelmintics is present in some populations of parasites.
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SUMMARY
A benzimidazole resistant strain ( HFRO strain) and a benzimidazole susceptible strain 
(Bearsden strain) of the sheep abomasal parasite Osier iagia circumcincta were obtained 
and passaged through parasite naive lambs. Using egg hatch assays to detect resistance day 
to day changes in the susceptibility of the eggs from adult O.circumcincta of these strains 
to the effects of the benzimidazoles, thiabendazole and albendazole were noted. Treatment of 
the lambs which were parasitised with the HFRO strain with fenbendazole at the normal 
dose rate caused a temporary increase in the resistance level measured by egg hatch 
assays. However, 12 treatments with fenbendazole over a 14 generation period with the 
HFRO strain produced a negligible rise in benzimidazole resistance for this strain.
A dose titration trial to determine the effectiveness of fenbendazole against adult 
parasites of the HFRO strain of O.circumcincta confirmed that the parasites were highly 
resistant to the effects of the benzimidazole anthelmintics. Treatment with increasing 
doses of fenbendazole used in the dose titration trial failed to increase the level of 
resistance in the eggs produced by the adult parasites remaining after treatment.
The establishment of 'clones' of the HFRO strain of O.circumcinctaby implantation of 
pairs of adult parasites into the abomasa of lambs was investigated. The offspring of these 
parents showed a reduced level of resistance to the benzimidazoles measured by egg hatch 
assays but after treatment with fenbendazole selection for resistance occurred rapidly.
The DNA from the two strains of O.circumcincta was isolated and compared after 
sectioning with restriction endonucleases. The banding obtained after gel electrophoresis 
was similar for the two strains.
Studies were carried out on the motility of infective larvae of the HFRO and Bearsden 
strains of O.circumcincta in the presence of benzimidazole anthelmintics, their 
metabolites and physostigmine. Prolonged incubation in the presence of benzimidazoles 
was required to reduce motility. Differences in the motility in the presence of
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physostigmine between benzimidazole resistant and benzimidazole susceptible strains of 
parasites were found. The activity of the benzimidazole metabolites against larval stages 
and eggs of O.circumcincta was studied and discussed.
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TUBULIN AND MICROTUBULES
INTRODUCTION
Microtubules are tubular structured polymers of protein which form part of the 
cytoskeleton within cells composed of subunits of the protein tubulin . They are associated 
with the mitotic spindle, centrioles, neurotubules , cilia and flagella and are necessary for 
the maintenance of cell shape, transport of material within cells and mitosis (Dustin, 
1984). Tubulin has been isolated from all groups of vertebrates and many invertebrates 
e.g. fungi, helminths and plants. The tubulin molecules isolated from these diverse sources 
are closely related but not identical.
The tubulin molecule is a dimer composed of two closely related subunits a  and p  
tubulin. These subunits have approximate molecular weights of 50,000 (Valenzuela eta/,
1981). The a  and p  peptides are thought to have derived from a common protein because 
of close similarities in their amino acid sequences with approximately 42-50$ homology 
of bases (Krauhs et al, 1981; Ponstingl et a/., 1981). Slight differences in the 
structure of the tubulin molecules have been found among species and also within a single 
animal e.g. in the mouse 7 a  tubulin and 14p  tubulin isotypes of the subunits have been 
identified which are produced in varying quantities during development ( Denoulet eta/,
1982). However, antibodies prepared against tubulin in the rabbit can be used in 
immunological techniques to identify tubulin in a wide range of species indicating that the 
antigenic determinants are similar (Dales ,1972)
The tubulin dimer binds two molecules of guanosme nucleotide either 6DP or GTP In the 
dimer form one molecule of the nucleotide is fixed but the nucleotide attached to the p  
tubulin unit can exchange with GTP in solution and the presence of GTP is thought to play a 
fundamental role in the assembly of dimers into the microtubule structure (Geahlen and 
Haley, 1979) Other proteins are associated with microtubules including enzymes 
necessary for assembly, high molecular weight microtubule associated proteins (MAPs)
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and tau proteins. MAPs and proteins play a role in the assembly of tubulin into 
microtubules and the stability of the formed polymer ( Murphy etal, 1 977).
Tubulin molecules can assemble into microtubules both in vivo and in vitro and an 
equilibrium can be set up between tubulin dimer and microtubules. The concentration of 
tubulin dimer in the cell in vivo may have a regulatory effect on the rate of formation of 
microtubules and the rate of production of tubulin mRNA (Cleveland and Kirschner, 
1981). In vertebrate cells about 50% of the tubulin in cells is present in the free dimer 
form (Hiller and Weber, 1978).
There are many conditions which are necessary to facilitate assembly of microtubules 
in vitro ( Weisenberg, 1972) including presence of GTP, adequate concentration of 
tubulin, a low level of calcium ions, presence of magnesium ions (Lee and Timasheff, 
1977), presence of glycerol (Shelansky eta/.,)913) and suitable temperature.
Studies on the assembly of microtubules suggest that the helical structure which is 
produced has polarity. The microtubule is in a dynamic relationship with free tubulin 
dimers and assembly and disassembly occurs at either end of the microtubule but at 
differing rates. "Treadmilling" occurs with an overall predominance of addition of tubulin 
and GTP to one end of the helical structure and loss of tubulin and GDP at the other end. In 
addition to assembly into microtubules other polymer forms can be identified including 
rings, ribbons, sheets, stacks of rings, cylinders and arrays ( Burton, 1981).
in vitro the process of tubulin assembly into microtubules under suitable conditions 
can be measured spectrophotometrically as an increase in turbidity (Gaskin eta/., 1974). 
This effect can be utilised in the study of inhibitors of microtubule formation. Many drugs 
are known to act as inhibitors with the cytotoxic drug colchicine the firs t to be discovered 
and its inhibitory actions described (Borisy and Taylor, 1967). Distinct binding sites 
have been identified on the tubulin molecule where inhibitors are thought to bind. The 
colchicine binding site is shared by podophyllotoxin (Cortese et s/,,1977) and the
1 8 5
benzimidazoles (Hoebeke etel, 1976). A wide range of benzimidazoles has been tested as 
inhibitors of tubulin polymerisation and is thought to bind to the same site on the tubulin 
molecule ( Barrowman et e l, 1984). The vinca alkaloids bind at a different site ( Bryan, 
1972).
Binding of colchicine to tubulin and the incorporation of this complex into the growing 
microtubule decrease the rate of assembly of the microtubule by blxking further addition 
of tubulin dimers to the microtubule. The colchicine tubulin complex was shown to xcur 
at a ratio of 1 molecule of colchicine to 1 tubulin dimer (Bryan, 1972). Work with pure 
mammalian tubulin and parbendazole suggested that the benzimidazoles bind to the tubulin 
dimer in a ratio of 1:1 ( Havercroft etel, 1981). It was suggested that colchicine binding 
to mammalian tubulin is not easily reversible whereas that of benzimidazoles is more 
readily reversible (Wilson etel, 1974)
One of the possible modes of action of the benzimidazole anthelmintics is binding to 
tubulin and preventing the formation of microtubules in helminths (Hoebeke etel.,\976; 
Friedman and Platzer, 1978). Using elxtron micrxcopy ultrastructural changes in the 
microtubular network in cells in nematodes and cestodes have been identified ( Borgers and 
De Nollin, 1975; Verheyen etel, 1976). In addition to ultrastructural studies, because 
xlchicine and benzimidazoles bind to tubulin at the same site, the amount of benzimidazole 
binding to tubulin can be measured ind irxtly  by competition with colchicine binding 
(Friedman and Platzer, 1978)
Like xlchicine the benzimidazoles bind to tubulin from a wide variety of sourxs 
including mammalian, fungal and helminth tubulin. This widespread activity dxs not 
explain the selective toxicity of the benzimidazoles to helminths and fungi.
Isolation of mammalian tubulin to study inhibition of assembly into microtubules in 
the presence of the benzimidazoles is relatively simple because of the high level of tubulin 
in the extrxts from mammalian brain. This tissue xntains about 20-40 % of tubulin in
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the soluble protein fraction. In helminths tubulin constitutes a low proportion of the 
soluble protein fraction and therefore isolation and purification of sufficient quantities of 
tubulin is difficult (Gull e/al, 1987). Several methods have been used to isolate and 
purify tubulin from mammalian brain with the principle methods being ammonium 
sulphate precipitation followed by DEAE chromatography (Weisenberg eta/, 1968) and 
cycles of assembly and disassembly (Shelansky et si, 1973). To isolate tubulin from 
helminths crude tubulin extracts can be prepared by ultracentrifugation (Barrowman ei 
ah, 1984) and purified by ammonium sulphate fractionation or prepared by rapid bench 
top centrifugation (Lacey and Snowdon, 1988). Preparation of pure extracts from 
helminths using column chromatography has been described (Gull eta/.,\ 987, Lacey and 
Snowdon , in preparation).
Studies on the inhibition of tubulin polymerisation using nematode and mammalian 
tubulin showed that one group of benzimidazole anthelmintics including FBZ, PBZ and MBZ 
had equal potency against both types of tubulin whereas OFZ and TBZ had greater efficacy 
as inhibitors of polymerisation of nematode tubulin with little effect on mammalian 
tubulin (Gull eta/, 1987)
Further studies on microtubules in helminths ( Davis and Gull, 1983) revealed that the 
number of protofilaments in microtubules in helminth cells differed from the number 
predominating in mammalian cells. There are usually 13 protofilaments in microtubules 
in mammalian cells and microtubules with 11, 12 and 14 protofilaments were identified 
in helminth cells.These ultrastructural differences may play a role in the differential 
toxicity of benzimidazoles to helminths.
The synthesis of tritiated benzimidazoles allowed the direct measurement of binding of 
these compounds to tubulin extracts in vitro (Lacey and Prichard, 1986). Binding of 
benzimidazoles to mammalian tubulin was unstable to charcoal extraction (Lacey, 
personal communication, 1988) unlike binding of benzimidazoles to tubulin extracted
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from nematodes which was stable to charcoal extraction (Lacey and Prichard, 1986). 
Using tubulin extracts from the nematode parasite Hcontortusthe benzimidazoles were 
ranked on the affinity of the interaction to tubulin and ABZ had the strongest affinity 
followed by FBZ, PBZ, OBZ, MBZ and OFZ. This does not seem to reflect the efficacy of 
these drugs as anthelmintics when used in vivo.. Lacey and Prichard (1986) suggested 
that resistance in parasites to the effect of benzimidazoles was due to alteration in the 
degree of binding of benzimidazoles to tubulin in these strains. These authors showed that 
tubulin extracted from benzimidazole resistant strains of H.contortusXmxti significantly 
less benzimidazole than extracts from benzimidazole susceptible strains. The differential 
binding of benzimidazoles to tubulin extracts from nematodes was suggested as a 
biochemical method to detect resistance to benzimidazoles in nematode parasites (Lacey 
and Snowdon, 1988)
PREPARATION OF TUBULIN EXTRACTS 
Materials and Method
Preparation of Tubulin Extracts from Ascaris suum
( Method modified from Barrowman eta/., 1984)
Reaoents.
Parasites - Adult Ascaris suum were obtained from the gastrointestinal tract of pigs 
slaughtered at the Glasgow abattoir.
Homogenisation Buffer -IO uM potassium dihydrogen orthophosphate/di potassium 
hydrogen orthophosphate (KH2P04/K2HP04) containing ImM magnesium sulphate
(MgS04), O.ImM guanosine 5'-triphosphate (GTP), 25£(v/v) glycerol and luM
phenylmethane sulphonyl fluoride (PMSF), pH 7.
Method.
1. Intestines were isolated from A suum by dissection.
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2. Intestinal material was homogenised in homogenisation buffer for 5 min using a 
hand-held glass homogeniser.
3. The homogenate was centrifuged at 1 OO.OOOg for 1 h using a SW 41 rotor and Beckman 
ultracentrifuge (L8-55).
4. Supernatant was retained as the crude tubulin extract and was stored at -20°C.
5. An aliquot of the crude tubulin extract was assayed for protein using a Lowry protein 
assay (see later).
6. Purity of the crude extract was assessed using sodium dodecylsulphate-poly acrylamide 
gel electrophoresis (SDS-PA6E) (see later).
Further purification of Crude Tubulin Extract.
1. Crude extract was adjusted to a final concentration of 200g/1 ammonium sulphate added 
over 15 min at room temperature.
2. Precipitate was allowed to collect for 30 min at room temperature.
3. The mixture was centrifuged at 2,000g for Ih and pellet discarded.
4. Supernatant was dialysed overnight against 3 changes of modified homogenising buffer 
( OTP added at a concentration of 1 u ll)
5. Purified extract was stored at -20°C.
6. The purity of the extract was checked using SDS-PAGE (see later).
Preparation of Tubulin Extracts from Infective larvae of Ostertagia 
circumcincta and Haemonctws contortus{.W%\)M!A A).
Reaoents.
Washing buffer -  0.025M 2(N-morpholino)ethanesulphonic acid (MES) buffer pH6.5 
containing ImM ethylene glycol bis-(/-aminoethyl etherjN.N.N'.N'-tetraacetic acid
(E6TA) and 0.5mM MgS04
Homogenising buffer -  Washing buffer plus 0.1M OTP.
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Method.
1. Infective larvae were obtained after Baermanisation and counted. The larvae were 
washed in distilled water and centrifuged at 1 ,OOOg for 5min and the supernatant 
removed.
2. The larvae were washed in 10ml washing buffer, centrifuged as above and supernatant 
removed.
3. This was followed by a wash in homogenising buffer, centrifugation as above and 
removal of the supernatant.
4. The pellet of larvae was transferred to a glass hand-held homogeniser in a small volume 
of homogenising buffer (approximately 0.5ml per 100,000 larvae).
5. The larvae were homogenised for 3min and an aliquot was checked under a dissecting 
microscope to ensure thorough disintegration of the larvae.
6. The homogenate was transferred to a 1.5ml Eppendorf tube and the homogeniser was 
rinsed using a small volume of homogenising buffer and rinsings combined with the 
homogenate. The overall volume in the Eppendorf tube was adjusted to approximately
0.7ml for 100,000 larvae up to 1 5ml for 400,000 larvae.
7. Tubes were placed in a bench-top Eppendorf centrifuge and centrifuged at 10,000 
r.p.m. for lOmin.
8. After centrifugation the supernatant was removed and stored on ice. This fraction 
contained the crude tubulin extract.
9. A protein assay was carried out on an aliquot of the crude extract using either a Lowry 
protein assay (see later) or a BioRad protein assay (see later).
Alternative Method for the Preparation of Tubulin Extracts from Infective 
Larvae of 0. circumcincta( Method B).
Reaoents./
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Reaoenti
Buffer - 10uM KH2P04/K2HP04 containing ImM MgS04, 0 ImM OTP, 25$ (v/ vj
glycerol and 1 uM PMSF, pH 7.
Method.
1. Infective larvae of O.circumcincta were obtained after Baermanisation and counted 
under a dissecting microscope. A known number of larvae were washed in distilled water 
and centrifuged at 2,000g for 5min and the supernatant removed.
2. The larvae were homogenised in a small volume of buffer in a glass hand-held 
homogeniser for 3min and an aliquot examined under a dissecting microscope to ensure 
adequate homogenisation.
3. The homogenate was transferred to a 0.8ml ultracentrifuge tube making up the volume 
to 0.8ml using buffer
4. Tubes were centrifuged in a Beckman ultracentrifuge (L8-55) using a SW 50 rotor at 
4°Cand 100,000g for lh.
5. The supernatant was retained as the crude tubulin extract and an aliquot used in a 
Lowry protein assay t see later)
Preparation of Tubulin Extracts from eggs of 0. circumcincta
Reagents.
Buffer - IOuM KH2P04/K2HP04 containing ImM MgSO , O.ImM GTP, 2Z% (v /v)
glycerol and I uM PMSF, pH 7.
Method.
1. Eggs were collected from fresh faeces using salt flotation (see previously) and washed 
on a 38micron sieve The egg suspension was centrifuged, the supernatant removed and the 
eggs resuspended in buffer. Aliquots of the egg suspension were counted under a dissecting
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microscope and an estimate of the total egg number was made.
2. The eggs were homogenised for approximately 5min in a hand-held glass homogeniser 
and an aliquot was examined under a dissecting microscope to ensure thorough 
disintegration of the eggs.
3. The homogenate was transferred to a 0.8ml ultracentrifuge tube and ultracentrifuged at 
4°Cfor I hat 100, OOOg (SW 50 rotor, Beckman ultracentrifuge - L8-55).
4. The supernatant was retained and a Lowry protein assay (see later) carried out on an 
aliquot of the extract. The extract was used in a tubulin binding assay (see later)
Lowry Protein Assay (from Lowry eta/., 1951)
This protein detection method emplcys the principle that a copper-tartrate complex 
reacts with the protein in alkaline solution and this complex reduces phosphomolybdate to 
form a blue substance which can be measured quantitatively by measuring its absorbance 
at 500 or 750nm.
Reaoents.
Solution A -2% (w /v) Sodium carbonate in 0.1 M NaOH
Solution B -1 % (w /v) Copper sulphate ,5H20.
Solution C - 2£(w/v)Sodium potassium tartrate.
Solution D - Equal volumes of solutions A and B mixed.
Solution E -  1 ml of solution D mixed with 50ml solution C.
Solution F -  Folin and Ciocalteu's phenol reagent diluted 1:1 ( v/v) with deionised water.
Standard protein solutions - A range of concentrations of bovine serum albumin (BSA) in 
distilled water from 0.05-2mg/ml.
Method.
1. Duplicates of 0.1ml of each sample, standard or water (blank) were placed in glass 
test tubes.
1 9 2
2. To each was added 1 m 1 solution E vortexed and allowed to stand for 10 min at room 
temperature.
3. Added 0.1 ml solution F whilst vortexing and allowed to stand for 30 min at room 
temperature.
4. Absorbance was measured at 500nm (or 750nm) in a spectrophotometer (Pye Unicam 
SP8-500 UV/VIS Spectrophotometer)
5. A standard curve for protein concentration against absorbance was plotted using the 
results obtained with the BSA standard solutions and from this the protein concentration 
in the test samples was calculated after correction using the blank.
BioRad Protein Assay
This is a dye-binding assay based on the colour change of an acidic solution of Coomassie 
Brilliant Blue 6-250 in response to binding of different protein concentrations, measured 
spectrophotometrically at 595nm.
Reaoents.
BioRad dye reagent concentrate - Solution of dye, phosphoric acid and methanol.
Buffer -  0.025M MES buffer, pH 6.5 containing 1 mM EGTA, 0.5mM MgS04 and 0.1M GTP.
Standard solutions - A range of solutions of BSA 5-50 ug/ml in distilled water 
Method.
1. The dye reagent was diluted 1 in 5 ( v/v) using distilled water.
2. Duplicates of a known volume( 0.02-0.05) of sample, standard or buffer (blank) were 
placed in a glass test tube.
3. 5ml of the diluted dye reagent was added to each tube whilst vortexing and allowed to 
stand at room temperature for at least 5 min.
4. The absorbance was measured at 595nm.
5. A standard curve of protein concentration against absorbance at 595nm was drawn
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using results of the BSA standards. From this standard curve the protein in the samples 
was estimated after correction using the aosorhance value of the blank
Sodium Dodecylsulphate Poly Acrylamide Gel Electrophoresis (SDS-PAGE) 
with Discontinuous Buffers (Discgel system described by Laemmli, 1970)
Reagents.
Acrylamide stock solution -  30g acrylamide and 0.8g N’ -N methylenebisacrylamide made 
up to 100ml with distilled water Stored in dark at 4°C
Resolving gel buffer - 0.25M Tris-SDS stock solution, pH6.8 (39.4g Trizma-HCl and 2g 
SDS, pH adjusted to 6.8 and made up to 1,000ml with distilled water).
Stacking gel buffer -  0.75M Tris-SDS stock solution, pH8.8 (71 g Trizma base, 47.2g 
Trizma -HC1 and 2g SDS, pH adjusted to 8.8 and made up to 1,000ml with distilled 
water).
Electrode buffer - 0.025M Tris, 0 .192M glycine buffer (15.15g Trizma base, 72g 
glycine and 5g SDS adjusted to pH8.8 and made up to 5,000ml with distilled water)
Sample buffer - 0 0625M Tris-SDS buffer! 25ml resolving gel buffer, 2g SDS. i0ml 
glycerol, 5ml 2-mercaptoethanol, 0.1ml 1 gbromophenol blue made up to 100ml with 
distilled water).
Ammonium persulphate solution -  1 8(w /v) ammonium sulphate in distilled water. Made 
up freshly
Staining solution -  0.1 % Coomassie Brilliant Blue in methanol/acetic acid/ water 5 4:1 
by volume.
Destaining solution - Methanol/acetic acid/water 1:1:8 by volume.
Method
1. Glass plates 8cm by 8cm were sealed at the sides using plastic tape and placed in an 
oven overnight at 60°C to ensure adequate sealing.
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2. Resolving gel was prepared using 19.8ml acrylamide stock solution and 15ml 
separating gel buffer made up to 60ml with distilled water and degassed thoroughly. To 
this was added 25ul N,N, N'.N’ -  tetramethyl-ethylenediamine (TEMED). This mixture 
was divided into two equal portions.
3. To half of the resolving gel mixture was added 0.75ml ammonium persulphate solution 
and this mixture was poured between the prepared plates and allowed to set for 15min to 
seal the base of the gel.
4. 0.75 ml ammonium persulphate solution was added to the remainder of the resolving 
gel and this was introduced between the plates.
5. On the top of the gel was placed a layer of 20$ methanol to ensure a flat surface was 
maintained during setting of the gel for 15-20 mins. The methanol was poured from the 
gel surface and the gel stored at 4°C overnight.
6. Stacking gel was prepared using 3m 1 stock acrylamide and 5m 1 stacking gel buffer made 
up to 20ml with distilled water and degassed thoroughly. To this was added 20u1 TEMED 
and 0.5m 1 ammonium persulphate solution. This was poured onto the surface of the 
resolving gel and allowed to set.
7. Sample preparation involved mixing 50ul sample with 50ul sample buffer and boiling 
for 5min. A mixture of standard proteins of molecular weights 12,300-78,000 was 
boiled in sample buffer. After boiling the mixtures were left to cool for 10min.
8. Duplicates of 30ul of each sample or standard were loaded onto the top of the stacking 
gel.
9. The gel was placed in a Pharmacia gel electrophoresis system surrounded by 
electrophoresis buffer. The gel was run at 60 volts and 30 amps for 15 min then 120 
volts and 65 amps with circulation of the buffer for approximately 2h.
10. The gel was removed from the plates and stained in staining solution for 1 h followed 
by overnight destaining in the destaining solution.
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11. The gel was examined and a graph of molecular weight against distance travelled in the
gel by proteins was constructed for the protein standards.
Results and Discussion 
Results of SDS-PAGE of Tubulin Extracts from Ascuris suum
A crude tubulin extract from A. suum which contained 15.3mg/ml protein and a
purified crude extract with protein content 10.7 mg/ml were prepared. Results of 
SDS-PAGE using these samples are shown in Fig. 3.1. The distance travelled by the 
standards and their molecular weights is shown in Table 3.1 and a standard graph drawn of 
distance travelled against the log of molecular weight (Fig. 3.2). The distance travelled by 
bands in the tubulin samples is shown in Table 3.2 and their approximate weights 
calculated using the standard graph ( Fig. 3.2).
Preparation of Tubulin Extracts -  Discussion 
Analysis of extracts from A.suum by SDS-PAGE produced a wide protein band of 
approximately 52,000 molecular weight corresponding to tubulin (Fig. 3.1) Molecular 
weights of a  and f t  tubulin were found to be approximately 53,000 and 56,000 ( Dentler 
eta/., 1975). In the SDS-PAGE of extracts from A suum the wide band at approximately
52.000 molecular weight could incorporate the combined bands of the a  and p  tubulin 
molecules which have failed to separate on the gel. There was no evidence of a band at
100.000 molecular weight corresponding to the molecular weight of the tubulin dimer. 
Other lower molecular weight constituents, possibly smaller enzyme molecules, were 
present on the gel (Fig. 3.1 and Table 3.2) but they were not identified accurately. The 
band at approximately 67,000 molecular weight may correspond to tau proteins which 
are low molecular weight microtubule associated proteins with molecular weights 
55,000-70,000 (Weingarten et a/, 1975) There was no difference on SDS-PAGE 
between the crude tubulin extract and the purified crude extract. Ammonium sulphate 
fractionation failed to remove contaminating small proteins. However, for both extracts
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□ flMIP 3 ,1
Diagram of SDS PA6E showing separation of protein standards, crude 
tubulin extract and partially purified extract from A. suum Intestinal 
material in columns 1,2 and 3 respectively.
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Table 5.1
Distance travelled and molecular weights of standard proteins used 1n
SDS-PAGE
Protein Molecular weight Distance Travelled
from base of oel
(mm)
Phosphorylase b 94,000 11
Albumin 67,000 17
Ovalbumin 43,000 26
Trypsin Inhibitor 20,100 38
Table 3.2
Distance travelled from the base of the gel and molecular weights of 
proteins in tubulin extracts from Ascaris suum
Band Distance Travelled Molecular Weight*
from base of gel 
(mm)
A 17 67,000
B 22 52,000
C 27 39,000
D 31 32,000
♦Values calculated using standard graph plotting distance travelled against log molecular 
weight of proteins (Fig 3.2)
Figure 3.2
Graph of distance travelled by protein standards in SDS PA6E against log
molecular weight.
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the tubulin band was darker staining than other bands suggesting that relatively high 
concentrations of tubulin were available after extraction from the parasites. For binding 
assarvs the crude tubulin extract without further ammonium sulphate fractionation to try 
to purify the extract was considered suitable.
Extracts of tubulin prepared from mammalian brain tissue contain much higher 
concentrations of tubulin at 25-405? of the total soluble protein as compared with 
nematodes where the tubulin fraction is less than 1 % of the total soluble protein content. 
For A suum the use of intestinal material to prepare extracts enhances the amount of 
available tubulin but with smaller nematode species e.g. O.circumcincta and H.contortus 
whole parasites are used because of the difficulty of extracting intestinal material. For the 
tubulin extracts approximately Z% of the protein in the crude extract is tubulin and this 
could predispose to variations in results of binding assays ( see later).
Other methods to prepare highly purified tubulin extracts from parasites are available 
(Gull et el, 1987) involving separation on a DEAE Sephadex column followed by 
temperature dependent cycles of assembly and disassembly of tubulin into microtubules 
combined with separation using ultracentrifugation. This method requires very large 
numbers of parasites 50g wet weight of A suum yields aproximately 0.75mg purified 
tubulin. This method therefore is impractical for studies on tubulin binding where low 
numbers of parasite larvae are available for testing resistance.
Lacey and Snowdon (in preparation) have described a method for purifying tubulin 
from mammalian brain using amino-activated gel chromatography. This method has been 
evaluated for purification of tubulin from nematodes, cestodes and trematodes (Lacey and 
Gill, personal communication) but again this method is limited because large numbers of 
parasites are required. Also purification of tubulin from nematodes using this method is 
less successful than with other groups of helminths because of the presence of 
contaminating proteins which cannot be separated in the extract. Tubulin extracted using
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temperature dependent assembly of microtubules isolates the tubulin which polymerises 
and depolymerises readily whereas gel chromatography isolates a greater proportion of 
the tubulin. The importance of the different types of tubulin and the possible effect they 
have on the binding characteristics of the extract has not been established.
For the tubulin binding assays to compare the binding of benzimidazoles to tubulin 
extracts from resistant and susceptible parasites it is impractical to use highly purified 
tubulin extracts. The extraction method used to obtain tubulin from A suum which was 
shown to be successful using SDS-PAGE was modified for use with 0. circumcincta and 
Hcontortus larvae and eggs. The preparation of extracts from homogenised nematode 
parasites for use in tubulin binding assays using ultracentrifugation or centrifugation in a 
bench top Eppendorf centrifuge has been described (Lacey and Prichard, 1986; Lacey and 
Snowdon, 1988). Both methods yielded crude extracts with suitable protein 
concentrations when sufficient larvae were used (>50,000) and the volume of the 
homogenate was maintained at a low level (< 1 ml). Using bench-top centrifugation was 
quicker and ensured that the tubulin extract was collected rapidly reducing the overall 
time taken to perform the binding assay and therefore may reduce the denaturation and 
loss of protein from the sample.
TUBULIN BINDING ASSAYS 
Displacement of Colchicine Binding Assay using Crude Tubulin Extracts 
Prepared from Ascaris suum
This assay utilises the principle that colchicine binds to tubulin in a similar way to the 
benzimidazoles and therefore after incubation with benzimidazoles there is a reduction in 
the amount of tritiated colchicine which can subsequently bind to the tubulin extract. The 
reduction in binding of tritiated colchicine in the presence of benzimidazoles can be 
measured by comparing the final counts bound with those in a control sample, i.e. tubulin 
extract with tritiated colchicine alone. This method was modified from Sherline et at.,
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(1974) and Barrowman etal.,(1984).
Materials and Methods
Reagents.
Buffer -  10mM KH2P04/K2HP04 containing ImM MgS04,0.ImM GTP and luM PMSF, pH
7.
Radiolabelled colchicine - (ringA-4-3H) colchicine obtained from Amersham 
International. Stock solution IOuM in ethanol/buffer 1:10, 5-15Ci/mmol 
( 185-550GBq/mmol).
Benzimidazoles -  Stock solutions of MBZ and ABZ 0.4mM( lOOug/ml) in ethanol were 
diluted 1 in 10 with buffer for use.
Charcoal suspension -  2mg/m1 activated charcoal (Norit-A activated charcoal -  Sigma
Chemical Co. Ltd) in 1 £(w /v) BSA
Method.
1. One ml of crude tubulin extract from Asuum (see previously) was incubated with 
lOul MBZ or ABZ (0.4uM) for 3h at 37°C in a glass tube (control was prepared by 
incubating 1 ml tubulin extract with 10ul buffer and blank by incubating 1 ml buffer with 
10ul buffer).
2. To each tube was added 10Oul tritiated colchicine and tubes were incubated for 1,5h at 
37°C.
3. Separation of tubulin bound tritiated colchicine and unbound tritiated colchicine was 
carried out using a gel filtration column (method A) or activated charcoal extraction 
(method B).
Method A
4A. The gel filtration column (see below) was run to almost dryness and the sample or 
control was loaded onto the column.
5A. The sample was eluted from the column using buffer and 1 ml fractions were collected
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from the base of the column. A I OOul aliquot of each fraction was added to 10ml Optiphase 
X and counted in a Packard counter for 1 min.
6A. The tritiated colchicine bound to tubulin is eluted in the void volume. The counts from 
the fractions 6-10 contained the tubulin bound fractions. The total counts bound to tubulin 
were calculated in each of the samples and the inhibition of binding of tritiated colchicine 
to tubulin for MBZ or ABZ was calculated by subtracting the values of binding in these 
samples from the control.
Method B
4B. To each sample, control or blank was added 10ml charcoal suspension, mixed and 
allowed to stand for lOmin.
5B. Charcoal mixtures were centrifuged at 2,200g for lOmin. A 10Oul aliquot of the
supernatant was placed in 10ml Optiphase X and counted in a Packard counter for 1 min.
6B. The percentage inhibition of binding of tritiated colchicine to tubulin by MBZ or ABZ
was calculated using the following equation; cpm control-com blank XI00
cpm sample-cpm blank
Preparation and calibration of gel filtration column
A gel filtration column was prepared for use in tubulin binding assays to separate drug 
bound to tubulin from unbound drug. The gel filtration column works on the principle that 
as a solution passes down the column the molecules within the solution have different 
abilities to enter the pores formed in the column which contain the stationary phase of the 
solution. Smaller molecules which can enter the gel pores move more slowly through the 
column because they spend a proportion of their time in the stationary phase whereas 
larger molecules cannot enter the pores and pass down the column in the mobile phase 
Therefore molecules are eluted from the column in order of decreasing molecular size.
The material used in the gel filtration column was Sephadex 6-100 which has a
205
fractionation range of 4,000-150,000 molecular weight for proteins.
Reaoents.
Sephadex G -100 -  bead size 40-120microns ( Sigma Chemical Co.Ltd.)
Eluting buffer -  10mM KH2P04/K2HP04 containing ImM Mg$04> 0.1 mM GTP and luM 
PMSF, pH 7.
Method.
1. Sephadex G-100 ( 2g) was placed in excess buffer for 48-72 h at room temperature to 
swell and was degassed thoroughly.
2. A 20 cm gel filtration column was prepared in a sintered glass column 30cm X 1.4 cm.
3. The column was allowed to settle and flushed several times with eluting buffer.
4. The column was calibrated using dextran blue (0.5ml dextran blue in 50$(v/v) 
glycerol) and potassium dichromate (10£ ( w/v)). The void volume was 9-10 ml. 
Results
Crude tubulin extract prepared from intestinal material of Asuum with protein 
concentration of 15.3mg/m1 was used in the assay. The assay was carried out initially 
using method A to separate colchicine bound to tubulin and unbound drug. Binding of 
tritiated colchicine to the tubulin extract was inhibited by MBZ and ABZ and inhibition of 
colchicine binding is given in Table 3.3. The assay was repeated on three occasions using 
method B to separated bound and unbound tritiated colchicine after incubation with an 
inhibitor MBZ or ABZ. Results of the three assays were combined and are shown in Table 
3.3.
Discussion
Colchicine an antimitotic compound has been shown to bind irreversibly to tubulin from 
mammalian brain, fungi and helminths (Dustin,1984). The benzimidazoles are thought to 
bind to the same site on the tubulin molecule as colchicine (Friedman and Platzer, 1978) 
and therefore the binding of benzimidazoles to tubulin can be measured indirectly by
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Table 5.5
.. . jjiHjjipg 0f  tritiated colchicine to tubulin extracts from 
A.suum in the presence of mebendazole or albendazole
Inhibitor % Inhibition of Colchicine
Binding
*0.40uM MBZ 92.8
*0.40uM ABZ 48.4
**0.40uM MBZ 32.4±7.4
**0.40uM ABZ 46.8±11 3
*  Tritiated colchicine bound to tubulin extract separated from unbound drug using 
Sephadex column (Method A)
**Tritiated colchicine bound to tubulin extract separated from unbound drug by charcoal 
extraction ( Method B)
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measuring the inhibition of binding of tritiated colchicine by the benzimidazole compound. 
Separation of bound from free tritiated colchicine in the assay can be achieved using a gel 
filtration column (Borisy and Taylor, 1967) or charcoal extraction (Sherline et aJ., 
1974) and both these methods were investigated. An alternative method of separation 
using DEAE cellulose filter paper (Borisy, 1972) was not investigated because values for 
binding are on average 15-2Q£ lower than with the gel filtration column method. The gel 
filtration column method of separation is time consuming and is not suitable for multiple 
determinations which prompted the development of the charcoal extraction method 
(Sherline eta l, 1974).
Results for inhibition of binding of tritiated colchicine with column separation (Table 
3.3) are similar to those obtained by Barrowman et al ,(1984) who found that ABZ 
inhibited binding by 42.6£ and MBZ by 88.2£. These results indicate that MBZ has a 
greater affinity for nematode tubulin than ABZ. Repeats of the inhibition of colchicine 
binding assay using charcoal extraction showed similar results for ABZ (Table 3.3) but 
inhibition of binding was much less with MBZ. Several problems were encountered with 
the charcoal extraction method. The standard deviation of the mean is quite high indicating 
a problem with reproducibilty in the assay. The type of charcoal used in the extraction has 
an effect on the assay (Sherline etal., 1974) and Sigma activated charcoal was used to try 
to minimise variation caused by differences in stability of the tubulin-colchicine complex 
to types of charcoal.
The indirect measurement of benzimidazole binding by competition with tritiated 
colchicine is affected by the affinity of both the benzimidazole and colchicine for the 
binding sites on tubulin. Where the benzimidazole has a high affinity for the tubulin 
binding site the specific activity of the tritiated colchicine can be a limiting factor in the 
assay. With MBZ where inhibition of colchicine binding is high a low concentration of 
colchicine and therefore a low level of radioactive counts binds to the tubulin
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subsequently. This low level of radioactivity can cause variability in the assay because any 
variation in the background counts can have a significant effect on the results. To 
overcome this problem binding of benzimidazoles to tubulin should be measured directly 
using radiolabelled benzimidazole compounds. The significance of the inhibition of binding 
of tritiated colchicine by a benzimidazole as a measure of the activity of the benzimidazole 
in vivo is questionable. Barrowman et al, (1984) found that inhibition of colchicine 
binding was similar with ABZ, ABSX and ABSO even although ABSO has little anthelmintic 
activity in vivo and for the other benzimidazoles tested degree of inhibition of colchicine 
binding did not reflect known efficacy of the compounds in vivo The direct measurement 
of binding of benzimidazoles to nematode tubulin therefore may be of greater significance 
for measuring efficacy of the individual benzimidazole compounds (see later).
Another limiting factor in measuring binding of benzimidazoles to nematode tubulin 
extracts by this indirect method with tritiated colchicine is the low soluble protein 
content in the extracts and the fact that tubulin constitutes a small percentage ( <5£) of 
the soluble protein component. In order to investigate binding of benzimidazoles to tubulin 
extracts of O.circumcincta or Hcontorti/s,w\\zre the protein concentration is ten fold less 
than extracts from A.suum intestine, a more sensitive method is required.
TRITIATION OF BENZIMIDAZOLES 
Labelling of some of the benzimidazole drugs with tritium was investigated in order that 
binding of the benzimidazoles to tubulin could be measured directly by combining the 
drugs with tubulin extracts, removing unbound drug residues and then counting the 
labelled material bound to the tubulin fraction (see later). Two methods with various 
modifications were investigated.
Materials and Methods
Method 1 for the Preparation of Tritiated Benzimidazoles
Reagents./
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Reagents.
Albendazole, Fenbendazole and Thiabendazole -  donated by the appropriate drug company 
Sodium boro(3H) hydride - Amersham International 5-20 Ci/mmol 
(185-740GBq/mmol)
Other compounds were obtained from Sigma Chemical Co Ltd or BDH Chemicals Ltd.
Method.
Method 1 was modified from the method of Lacey (1985), involving bromination of the 
benzimidazole followed by debromination in the presence of tritium labelled sodium 
borohydride and a palladium chloride catalyst.
1. The pure benzimidazole compound, ABZ, FBZ or TBZ, 0.5g (2.5 x 10“3 moles), was 
dissolved in 10ml glacial acetic acid. To this was added 1.5 molar equivalents ( 600mg) of 
bromine and the reaction was stirred for 1 h.
2. The precipitate which formed was collected and air dried overnight. This brominated 
product was then recrystallised from methoxyethanol over a 24-48h period.
3. A quantity of the recrystallised material was dissolved in methanol ( lOOug/ml) and 
purity assessed using high performance liquid chromatography ( HPLC).
4. Ten umoles (0.003g) of the brominated benzimidazole was dissolved in 400ul 20% 
DMSO in methanol. To this was added 30umoles of palladium chloride as a 0.4$ solution in 
methanol (1 .33ml of a 0A% solution). Then added 50 umoles of sodium boro(3H)hydride 
dissolved in 30ul of water and the reaction was stirred for 30 min.
5. The reaction mixture was diluted to 2ml with methanol and filtered through a sintered 
glass funnel. The funnel was washed 5 times with 2ml aliquots of methanol.
6. The washings were collected, combined and evaporated to dryness under a stream of air 
for approx. 36h.
7. The product was then purified using method A or B
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Purification Method A
7A. The residue was dissolved in 10ml chloroform and applied to a silica Sep-Pak 
(Waters) pre-washed with chloroform. The material passing through the column during 
loading was retained, evaporated to dryness under a stream of air and the residue was 
redissolved in 0.5ml methanol.
8A. The loaded Sep-Pak was washed with 20ml chloroform and washings were collected, 
evaporated to dryness under air and the residue was redissolved in 0.5ml methanol.
9A. The product was eluted from the column using 2 x 10ml 1055 methanol in chloroform 
and the eluate collected, evaporated to dryness and the residue redissolved in 0.5ml 
methanol.
10A. All the fractions eluted from the Sep-Pak column were tested for purity by HPLC. 
Purification Method B
7B. The residue was dissolved in 3m 1 dichloromethane (DCM) and loaded onto a silica Bond 
Elut (Analytichem International) pre-conditioned with 2ml DCM and allowed to run by 
gravity flow. The material passing through the column during loading was collected, 
evaporated to dryness under air and redissolved in 0.5ml methanol.
8B. The flask containing the benzimidazole sample was rinsed with 2 x 3ml DCM and 
material passing through the column was collected, evaporated to dryness under air and 
redissolved in 0.5ml methanol.
9B. The column was washed with 5ml DCM and washings collected , evaporated to dryness 
under air and redissolved in 0.5ml methanol.
10B. The product was eluted from the column using 5m! 25£methanol/ DCM and eluate 
collected, evaporated to dryness in air and redissolved in 0.5ml methanol.
11B. All the fractions collected from the Bond Elut column were assessed for drug purity 
using HPLC.
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Quantitative and Qualitative Analysis of Products of Bromination and 
Tritiation of Benzimidazoles
High-performance liquid chromatography (HPLC) was used to test the purity of the 
products of the bromination and tritiation of the benzimidazoles using the method of 
Marriner and Bogan,(1980).
Materials.
Pump- Gilson model 302
Detector- Cecil CE2012 variable wavelength ultra violet spectrophotometer 
Column- 100mm x 5mm (Shandon Southern) packed with ODS-Hypersil 5 micron. 
Wavelength- 292nm 
Absorbance- 0.05 A.u.f.s
Solvent A-Methanol: Ammonium carbonate (0.05M) 75:25 - used to detect ABZ, 3HABZ, 
brominated ABZ, FBZ, 3HFBZ, brominated FBZ, TBZ and brominated TBZ.
Solvent B - Methanol: water 65:35 + 0.5ul perchloric acid (1.18v/v) per ml of solvent 
- used to detect oxidised metabolites of the benzimidazoles - ABSX, ABSO, OFZ and 
5 hydroxy TBZ.
Flow rate- Iml/min
Standard concentrations of the individual pure benzimidazole compounds and their 
metabolites were reconstituted in methanol over a range of concentrations lOuq/ml, 
20ug/ml, 50ug/ml and 1 OOug/ml to allow quantitation of the tritiated benzimidazole 
compounds.
During HPLC analysis fractions were collected from the base of the column corresponding 
to each peak obtained spectrophotometrically. A 10ul aliquot of each of these samples was 
placed in 10ml Optiphase X scintillation fluid and counted for 1 min in a Packard counter
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Thin Layer Chromatography of Tritiated Albendazole
( Method modified from Gyurik eta l, 1981)
Reaoents.
Solvent -  chloroform: methanol: concentrated ammonium hvdroxide 90:10:1 
Silica gel -  silica gel 250 microns containing inorganic phosphor (OF Analtech)
Method.
1. Glass plates were coated with silica gel. The plates were dried and heated overnight at 
50°C to activate the gel
2. Test compounds- ABZ C1 OOug/ml) and 3HABZ (315ug/ml) 1 OOul were spotted in 
duplicate onto the plate and allowed to dry.
3. Plate was placed in solvent for 1 h then allowed to dry.
4 Plate was examined under U V light ( 254nm.)
5. The silica gel at the area of the spots was scraped from the plate and either placed in 
10ml Optiphase X and counted in a Packard counter or shaken in methanol, centrifuged to 
remove the silica and iniected onto an HPLC system to detect ABZ.
Method II for the Preparation of Tritiated Benzimidazoles
Reagents.
Tritium labelled MBZ and ABZ were obtained from Dr.E.Lacey (CSIRO Division of Animal 
Health, McMaster Laboratory, Bydney) Labelling of the drugs was carried out by catalvtic 
exchange using palladium on calcium carbonate in pure dioxane at 60°C under tritium gas 
( Lacey etal, to be published). Using HPLC and mass spectrometry the -:,HMBZ and °HABZ 
were analysed and quantified into aliquots of 29.5uq which were stored in 2ml methanol in 
glass vials
Buffer - 0.025 MES buffer pH 6.5 containing I mM EGTA and 0.5mM MqS04 
Method./
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Method.
1. To prepare the tritiated benzimidazoles for use in the tubulin binding assays vials 
containing 29.5ug of the compounds in methanol were evaporated to dryness under a 
stream of nitrogen.
2. The residue was redissolved in 2m 1 DMSO and made up to 10ml with MES buffer 
producing a 10uM solution.
4. Calculation of specific activity of tritiated benzimidazole was carried out. Six lOul 
aliquots of IOuM 3HMBZ or 3HABZ In DMSO/MES buffer mixture were placed in 5ml 
Biofluor and counted for 1 min. The specific activity (dpm/pmole) for each compound was 
calculated.
Results and Discussion 
Tritiation of Albendazole
Using method I , ABZ was brominated then reacted with tritiated sodium borohydride in 
the presence of a palladium chloride catalyst to form tritiated ABZ. The reaction is shown 
in Fig. 3.3. with bromination at the C-5 position followed by debromination at this 
position and substitution by tritium.
Results of HPLC Analysis of Products of the Bromination and Tritiation of 
Albendazole
The product of the bromination reaction was recrystallised and a 10Oug/ml solution in 
methanol was injected onto an HPLC column and comparisons made with Injections of pure 
ABZ. A small peak corresponding to that of ABZ was found and the concentration of ABZ in 
the sample was calculated as 1 ug/ml and the remaining peak, showing a longer retention 
time than pure ABZ was assumed to correspond to the brominated compound (Table 3.4). 
A pure brominated ABZ standard was not available and therefore the exact concentration of 
this compound could not be calculated by HPLC. Measurement of ABZ in the product of the 
bromination reaction showed that approximately 1 % of the ABZ had failed to brominate.
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Fioure 5.3
Mechanism of bromination and tritiation of albendazole.
HC—OCH
NH
HC—OCH
Debromi nation 
and Tritiation
O
HC—OCH
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After reaction of the brominated ABZ with tritiated sodium borohydride the product was 
purified initially using a Sep-Pak (Method A) and fractions collected from the base of the 
column during loading, washing and elution. An aliquot of each of these fractions was tested 
by HPLC. Injection of the loading sample produced a high peak with retention time 
identical to ABZ, tritiated ABZ, and a smaller peak corresponding to the brominated 
compound. The sample contained contaminants which could have been free sodium 
borohydride. The major part of the loaded material failed to adhere to the silica in the 
Sep-Pak column and passed out in the void volume. Washings collected from the Sep-Pak 
also contained tritiated ABZ and a small amount of unconverted brominated ABZ. The eluted 
fraction contained 2.5ug/ml tritiated ABZ. No brominated ABZ was detected in this sample.
The poor loading and separation achieved with the Sep-Pak column prompted further 
investigation into the use of an alternative system. Method B was developed using a Bond 
elut with dichloromethane as the solvent. The products collected from the Sep-Pak 
separation (loading, washing and elution samples) were combined and evaporated to 
dryness in a stream of air then the residue was redissolved in dichloromethane and loaded 
onto a Bond elut column. HPLC analysis was carried out on an aliquot of each fraction 
collected from the base of the Bond elut column during loading, rinsing, washing and 
elution. Samples collected during loading, rinsing and washing of the column contained no 
detectable levels of ABZ. The eluate produced a large peak with retention time identical to 
pure ABZ and this was assumed to be tritiated ABZ. There was also a peak with a greater 
retention time which corresponded to brominated ABZ. A 1 in 20 dilution of the eluate 
contained 31.54 ug/ml tritiated ABZ (119uM). Injection of this tritiated ABZ sample on a 
methanol/perchloric acid column to detect ABSX and ABSO confirmed the presence of these 
oxidised products but at low concentrations, less than \% of the overall tritiated ABZ 
concentration.
During HPLC analysis fractions were collected from the base of the column and an aliquot
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was counted to determine the presence of the tritiated compound. The fractions taken 
before the ABZ peak gave a mean of 533cpm, those taken at the time of the ABZ peak 
30,360cpm and fractions after the peak 307cpm.
Results of Thin Layer Chromatography of Albendazole and Tritiated 
Albendazole
Thin layer chromatography with ABZ and the tritiated ABZ produced detectable spots 
under UY light and the distance travelled by each of the compounds was identical (Fig. 
3.4). The spot for tritiated ABZ was more prominent than the ABZ spot reflecting the 
higher concentration of tritiated ABZ added to the plate. The silica was scraped from the 
plate at the area of the spots and the presence of pure ABZ confirmed by HPLC. For the 
duplicate samples the silica scraped from the area of the spot was placed in Optiphase X 
and counted. The spot from the tritiated ABZ sample gave 8 )689,832cpm.
Tritiation of Fenbendazole
Fenbenda2ole was brominated then tritiated using method I. The chemical reaction is 
similar to that given for ABZ (Fig. 3.3).
Results of HPLC Analysis of the Products of Bromination and Tritiation of 
Fenbendazole
The recrystallised product of the bromination reaction was dissolved in methanol 
( lOOug/ml) and injected on HPLC and compared with a standard solution of pure FBZ. The 
bromination product did not show a peak corresponding to FBZ but there was a large peak 
indicating the presence of a compound with a longer retention time than FBZ which 
probably corresponds to the brominated FBZ (Table 3.4).
After reaction of the brominated FBZ with tritiated sodium borohydride the product was 
purified (Using a Bond-elut column and fractions collected from the base of the column 
were analysed. The load sample contained a high peak corresponding to FBZ , tritiated FBZ, 
and a smaller peak for the brominated FBZ. The rinse sample contained both tritiated FBZ
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Figure 5.4
Thin layer chromatogram of albendazole standard and tritiated albendazole.
HABZ
O
and brominated FBZ. There was no tritiated FBZ or brominated FBZ in the wash sample or 
eluate. The load and rinse samples were combined and evaporated to dryness, redissolved 
in dichloromethane and loaded onto another Bond-elut column to repeat the purification 
step. Again fractions were collected from the column and analysed by HPLC. The load 
sample gave a high peak corresponding to tritiated FBZ and a peak for brominated FBZ. A 1 
in 10 dilution of this load sample contained tritiated FBZ at a concentration of 25 ug/ml 
(83.6uM). None of the other fractions collected from the Bond-elut contained tritiated 
FBZ or brominated FBZ. The load sample was injected onto a column with methanol/ 
perchloric acid as the solvent. Small peaks corresponding to OFZ and FBZSO were found but 
it was calculated that less than I % of the tritiated FBZ in this fraction was in these 
oxidised forms.
During HPLC analysis fractions were collected from the base of the column and an aliquot 
was counted to determine the presence of the tritiated compound. The fractions collected 
prior to the FBZ peak showed a mean of 7,555cpm, those collected at the FBZ peak 
4,502,380cpm, those collected during the brominated FBZ peak 8,578cpm and fractions 
after the peaks 1,066cpm.
Tritiation of Thiabendazole
Thiabendazole was brominated then reacted with tritiated sodium borohydride in the 
presence of a palladium chloride catalyst using method I.
Results of HPLC Analysis of Products of the Bromination and Tritiation of 
Thiabendazole.
The recrystallised product from the bromination reaction ( lOOug/ml) was injected 
onto an HPLC column and comparisons were made using a pure TBZ standard. The sample 
produced a small peak equivalent to 5ug/ml TBZ and a larger peak for a compound with a 
longer retention time than TBZ which was assumed to correspond to the brominated TBZ 
(Table 3.4).From this result it was calculated that 5$ of the original TBZ had failed to
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brominate during the reaction.
The brominated TBZ was reacted with tritiated sodium borohydride and the product 
purified using method B through a Bond-elut column with fractions collected from the 
base of the column analysed by HPLC. The load and rinse samples produced a small peak 
corresponding to TBZ and a large peak for brominated TBZ. The wash sample did not 
contain any detectable levels of TBZ or brominated TBZ. The eluate showed a small peak for 
TBZ and a larger peak corresponding to brominated TBZ. Fractions collected from the base 
of the column were counted to detect tritiated compounds. An aliquot of the fractions 
collected during the TBZ peak showed 3,823cpm and during the brominated TBZ peak 
476cpm.
There was poor conversion of brominated TBZ to tritiated TBZ and the fractions 
collected from the Bond-elut were combined, evaporated to dryness under a stream of air 
and the residue redissolved in 20% DMSO in methanol and the tritiation reaction repeated. 
The product was purified using method B and fractions collected from the column analysed 
by HPLC. None of the fractions contained TBZ. All the fractions collected from the 
Bond-elut column had high counts for radioactivity but the counts were not associated with 
TBZ.
This experiment to tritiate TBZ by bromination followed by tritiation using tritiated 
sodium borohydride and a palladium chloride catalyst was repeated twice with similar 
results to above. The brominated compound failed to debrominate and negligible amounts of 
tritiated TBZ were formed.
Specific Activity of Tritiated Benzimidazoles
The specific activity of the tritiated ABZ and FBZ produced by method I described above 
and tritiated MBZ and ABZ produced by method II is given in Table 3.5.
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Retention times of benzimidazole compounds and brominated benzimidazole 
compounds during HPLC analysis using methanol: ammonium carbonate
(6 5 :3 5 ) as the solvent.
Compound Approximate Retention Time *
Albendazole 2.6min
Brominated Albendazole 3.4min
Thiabendazole 1.8min
Brominated Thiabendazole 3.2min
Fenbendazole 4.4min
Brominated Fenbendazole 6.2min
*  Retention times can be variable and values are approximate.
♦Albendazole (Batch 1) 
♦Albendazole ( Batch 2) 
♦Fenbendazole 
♦♦Albendazole 
♦♦Mebendazole
Table 3.5
Specific activity of radiolabelled benzimidazoles
Specific Activity 
(dpm/pmole)
265
360
110
9754
2685
♦♦ Tritiated using Method II
223
Tritiation of Benzimidazoles -  Discussion
Radiolabelling of benzimidazoles with tritium was investigated to try to produce 
compounds which could be used to investigate the binding of this class of drugs to the 
cytoskeletal protein, tubulin, in nematodes. In the past labelling of benzimidazoles with 
14C produced compounds of sufficient specific activity to investigate their metabolism, 
pharmacokinetics and biochemistry (DiCuollo et si, 1974; Prichard et si, 1981; 
Davidse and Flach, 1977). Tritiation of the benzimidazoles produces compounds with 
higher specific activity and therefore better suited for biochemical tests involving the 
binding of benzimidazoles to small amounts of nematode tubulin.
Using the method of Lacey (1985) tritiation of TBZ, ABZ and FBZ was attempted ( method 
I). Bromination of all 3 compounds was successful with 95%, 99% and 100£ of the 
original compound becoming brominated for TBZ, ABZ and FBZ respectively. The differing 
solubilities of the brominated compounds compared with the parent benzimidazole is 
reflected by the increased retention times of all the brominated compounds compared with 
the parent compounds on HPLC analysis (Table 3.4).
The purification of the products of the tritiation reaction was carried out using a 
Sep-Pak or Bond-elut column to try to remove tritium not associated with the 
benzimidazole. Purification of tritiated ABZ using a Sep-Pak was not achieved because the 
benzimidazole compound was not retained by the column. The original method described by 
Lacey (1985) used a Sep-Pak for separation, however, in the present studies a Bond-elut 
column and different solvent system achieved better results for ABZ. During the 
experiment to tritiate FBZ purification on a Bond-elut column was not achieved because 
the sample failed to load onto the column. During subsequent HPLC analysis and 
radioactivity estimation of the tritiated FBZ there was a high level of radioactivity in the 
material collected prior to the FBZ peak. This was due to non-volatile tritium not bound 
to FBZ which had not been removed during purification using the Bond-elut. The analysis
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of tritiated ABZ showed significantly lower counts for radioactivity in the sample collected 
from the HPLC column before the peak of ABZ suggesting that the unbound tritium had been 
removed successfully during the purification step through a Bond-elut for ABZ.
For both FBZ and ABZ the counts obtained in fractions collected from the HPLC column 
during the peak of the benzimidazole showed significantly higher levels than samples 
before and after the peak. This indicated that the tritium was associated with the 
benzimidazole. Thin layer chromatography of the tritiated ABZ confirmed that the tritium 
was bound to the ABZ. The calculated specific activity for tritiated ABZ therefore gives a 
good indication of the amount of tritium bound to the benzimidazole. The value for specific 
activity of FBZ was lower which suggested that there was poorer conversion of the 
brominated compound to the tritiated product and possibly replacement of the bromine by 
an untritiated hydrogen during the reaction. The value for specific activity also may be 
less accurate than for ABZ because some of the counts were not associated with the FBZ but 
were due to unbound tritium. This could affect the accuracy of calculations made during 
binding experiments and possibly lead to over estimation of the amount of drug binding to 
tubulin in binding assays (see later).
The use of bromination followed by reaction with tritiated sodium borohydride in the 
presence of a palladium chloride catalyst as a method to tritiate TBZ gave poor results. The 
yield of brominated compound was lower than with ABZ and FBZ but at approximately 
95$ should have been adequate for debromination and tritiation. Analysis of the products 
of tritiation followed by purification showed a poor yield of tritiated TBZ in all 
experiments. Further attempts to react the partially tritiated compound with tritiated 
sodium borohydride resulted in total loss of the TBZ. The products of the reaction had high 
radioactivity counts but this tritium was not associated with TBZ. Tritiation of TBZ by this 
method failed because in the presence of the palladium chloride catalyst the brominated 
TBZ was broken down rather than debrominating with replacement of the bromine by
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tritium. The chemical structure and properties of the TBZ molecule therefore prevent 
tritiation of the molecule using this method.
To improve the specific activity of the tritiated benzimidazoles they were labelled by a 
different method (Lacey et a l, in preparation) involving catalytic exchange using 
palladium on calcium carbonate in pure dioxane at 60°C in the presence of tritium gas. 
The tritium has been shown to be incorporated at position 4 of the benzimidazole nucleus 
in ABZ and is assumed to occur at this position in the other benzimidazoles. The compounds 
were purified and analysed using HPLC and thin layer chromatography. The specific 
activity found for the tritiated ABZ prepared by this method was greater than tritiated ABZ 
synthesised previously using a brominated intermediate (Table 3.5). A high specific 
activity was also obtained for MBZ produced by method II.
The production of tritiated compounds with a high specific activity facilitates the 
studies on the binding of benzimidazoles to nematode tubulin. The differences in the 
binding of benzimidazoles to tubulin extracts from anthelmintic resistant and susceptible 
parasites can be quantified more accurately using tritiated drugs with high specific 
activity. For some benzimidazole resistant strains of parasites the quantity of 
benzimidazole binding to the tubulin extracts is very low and therefore to measure binding 
the use of a compound with high specific activity is necessary (see later).
Tritium has a radioactive half life of 12.36 years (Strominger et a l. ,1958) and 
therefore the specific activity of the synthesised tritiated benzimidazoles remained 
constant over the period of use. There was evidence of oxidation of the benzimidazoles on 
storage and during preparation. During the synthesis of tritiated ABZ and FBZ by method I 
the solvents were evaporated under a stream of air rather than nitrogen as described by 
Lacey (1985). HPLC analysis of the products showed less than 1 % of the final product was 
in the oxidised form suggesting that evaporation under air had little effect on the oxidation 
of the benzimidazoles. The tritiated compounds synthesised by method I were stored in
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methanol and there was negligible oxidation over the period of storage (up to 12 monthsj. 
Tritiated ABZ and MBZ prepared by method II were stored in methanol and then prepared 
in DMSO and buffer for use in binding assays. Oxidation of the benzimidazoles was rapid in 
the presence of DMSO and compounds in DMSO and buffer were used for 3-4  weeks then 
replaced because the increasing levels of oxidised products influence the results of binding 
assays ( see later).
Tubulin Binding Assays using Tritiated Benzimidazoles 
Materials and Methods
Modified Tubulin Binding Assay using Tubulin Extracts from A. suum ,0. 
circumcincta (infective larvae and eggs) and H contortus (infective 
larvae) with Tritiated ABZ and FBZ
Reagents.
Buffer A - 10uM KH2P04/1<2HP04 containing 1 mM MgS04, 0 ImM OTP, 25% (v /v )
glycerol and luM PMSF, pH 7.
Buffer B - Buffer A without glycerol
Tritiated ABZ - Prepared by method I (see previously) and diluted to 119uM , 23.8uM or
11.9 uM in methanol. Specific activity 360dpm/pmole.
Tritiated FBZ - Prepared by method I (see previously) and diluted to 83.6uM or 8.36uM 
in methanol. Specific activity 1 lOdpm/pmole
Charcoal suspension - 2mg/ml activated charcoal (Norit-A activated charcoal, Sigma 
Chemical Co. Ltd.) in 1 £(w/v) BSA.
Method.
1 90 ul tubulin extract prepared by method A or B ( see previously) was placed in a 5ml 
plastic tube and lOul tritiated ABZ or FBZ added (blank 90ul buffer A plus 10 ul tritiated 
drug) mixed and the tubes incuDated at 3 c *^C tor 1 ^min in a waterbath.
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Unbound tritiated drug was separated from tubulin bound drug using either gel 
filtration (methodA) or charcoal extraction (method B).
Method A
3A. The gel filtration column i see previously) was allowed to run to almost dryness The 
sample or blank was loaded onto the top of the column and eluted from the column using 
buffer B.
4A. Fractions, each of 1 ml, were collected from the base of the column and a 1 OOul aliquot 
of each fraction was placed in 10ml Optiphases X and counted in a Packard counter for 
Imin.
5A. The total counts of tritiated drug bound to the tubulin which was eluted in the void 
volume was calculated and corrected using the blank. Using the specific activity of the 
tritiated drug and the protein content of the tubulin extract the binding in pmoles/mg 
protein was calculated.
Method B
3B. Charcoal extraction of the unbound tritiated drug was carried out. 0.5ml of the 
charcoal suspension was added to each tube, vortexed and incubated at 37°C for 5 min in a 
shaking water bath.
4B. The tubes were centrifuged at 3 ,500g for 10mm.
5B. An aliquot of the supernatant (0.4ml) was placed in 5ml Ecosint in a plastic 
scintillation vial and counted in a ^  counter! Packard Model 2650 Tricarb) The blanks 
and samples were counted for Imin.
6B. Adjustments were made for quenching and the results corrected by subtraction of the 
blanks then multiplied bv 15 to give the total counts in the sample. To calculate the 
binding of ABZ or FBZ to the tubulin extracts in pmoles/assay the total counts in each 
sample were divided by the specific activity of ABZ or FBZ (dpm/pmole) and then to 
calculate the binding in pmoles/mg protein this value ( pmoles/assay) was divided by the
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protein concentration in the sample.
Binding Assays using Tubulin Extracted from A.suum and Tritiated 
Albendazole 
Results
A modified tubulin binding assay using tubulin extracted from Asuum intestinal 
material was investigated. Varying concentrations of tritiated drug were used in the assay 
to try  to determine the optimum concentration for use in tubulin binding assays. The 
tubulin extract had a protein concentration of 16mg/ml measured by the Lowry protein 
assay. The tritiated drug was ABZ from batch 1 with specific activity of 265 dpm/pmole. 
The tubulin bound 3HABZ was separated from unbound drug using charcoal extraction 
( method B). The assay was repeated on three occasions and all results are shown in Table
3.6. For Assay 2 tubulin samples were incubated with tritiated drug for 15min and in 
Assay 1 and 3 incubation was for 3h prior to separation of bound and unbound drug. 
Discussion
Binding of tritiated ABZ to tubulin extracts from A.suum was related to the 
concentration of tritiated drug incubated with the extract (Table 3.6). The duration of 
incubation was not critical. Assays 2 and 3 were performed on the same day using identical 
samples and varying the incubation time from 15min in the former to 3h in the latter. 
There was no significant difference, calculated using a Students t-test, between samples 
incubated for 15min or 3h at the same concentration of tritiated drug. Saturation of 
benzimidazole binding sites on tubulin must occur rapidly and prolonging the incubation 
time did not increase the binding.
Reproducibility of the assay was good with no differences between assays 1, 2 and 3 
except for the sample incubated with 5.95 uM 3HABZ in Assay 1 where the value for drug 
binding was low possibly due to experimental error.
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Table 5.6
Binding of tritiated albendazole to tubulin extracts from A.suum
Concentration 3HABZ Binding of 5HABZ ( omoles/mq protein)
(uM ) Assav 1 Assav 2 Assav 3
23.80 11.56 12.25 12.92
11.90 8.85 7.36 8.09
5.95 1.97 5.89 6.92
3.97 5.26 5.51 4.31
1.98 1.92 2.74 1.81
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The protein concentration with tubulin extracts from A.suum was significantly higher 
than extracts from O.circumcincta and H.contortus larvae. In these assays (Assay 1, 2 and 
3) individual samples contained a constant amount of protein ( 1.44mg/tube). Binding of 
trittated benzimidazoles has been shown to vary with protein concentration (Lacey and 
Prichard, 1986) and therefore the binding of tritiated drug to tubulin is calculated taking 
protein concentration into account as pmoles per mg of protein in the tubulin extract. The 
results for this assay were consistent and higher concentrations of tritiated ABZ gave 
increased binding. It was decided that for future tubulin binding assays a concentration of 
23.8 uM or 11.9uM 3HABZ would be used to ensure a high level of binding to the tubulin 
molecules. Increasing the concentration of 3HABZ above this level could increase the error 
in the assay because the efficiency of charcoal in removing unbound tritiated drug could 
become a limiting factor ( see later)
Binding of Tritiated Albendazole to Tubulin Extracted from O. circumcincta 
(Bearsden Strain) 
Results
Using a range of numbers of infective larvae or eggs of O.circumcincta, Bearsden 
benzimidazole susceptible strain, tubulin was extracted using Method B. Protein in the 
resultant extracts was determined by the Lowry method and results are shown in Table
3.7. The extracts were used in tubulin binding assays using tritiated ABZ from batch 2 
(23.8 uM) with specific activity of 360dpm/pmole. Bound and unbound drug were 
separated using charcoal extraction or Sephadex column separation. The binding of 3HABZ 
calculated as pmoles per mg protein in the tubulin extract is shown in Table 3.7. 
Discussion
The tubulin extracts from more than 2,000 infective larvae of O.circumcinctt 
contained similar protein concentrations. Increasing the number of larvae used to make
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Table 3.7
Binding of tritiated albendazole to tubulin extracts from infective larvae 
or eggs of the Bearsden benzimidazole susceptible strain of 0. circumcincta
Tubulin Extract Protein
(m g/m l)
3.000 eggs 0.23
1.000 larvae 0.11
2.000 larvae 0.22
3.000 larvae 0.20
4.000 larvae 0.24
5.000 larvae 0.24
10.000 larvae 0.26
Binding 3HABZ (pmoles/mg protein) 
Charcoal Column
separation separation
1270.48
1263.30
4.57
41.90 1246.11
160.19 
119.91
577.35
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the extract did not produce a proportional increase in the protein concentration in the 
tubulin extract (Table 3.7). The homogenisation of the larvae could have been at fault 
causing variability in the amount of protein extracted from the larvae.
The concentration of tritiated ABZ bound to the extracts which was stable to charcoal 
extraction was much higher in the tubulin extract from eggs than larvae of 0 
circumcincta Also increasing numbers of larvae from 2,000-4,000 showed increased 
binding of tritiated ABZ although the extract made using 5,000 larvae bound less than the 
extract from 4,000 larvae. The binding of drug to the tubulin extracts was calculated 
taking protein concentration into account and therefore there should be no difference in 
the binding of benzimidazoles to extracts using different numbers of larvae. For the 
extracts using 4,000 and 5,000 larvae the protein concentrations were identical and yet 
the binding of tritiated ABZ differed. It is possible that the protein concentration is not a 
direct measure of the tubulin content of the extract from the parasites and the amount of 
tubulin as a proportion of the total protein in the extract could vary from sample to 
sample.
There could be variability in the stability of the tubulin drug complex to charcoal 
extraction leading to within-assay variation in the measurement of tubulin bound drug. 
For each sample duplicates or triplicates were tested and a mean result was taken for 
calculation of the amount of drug bound to the extract. Occasionally there were obvious 
outliers where the charcoal had failed to extract the total amount of unbound tritiated drug 
and these values were ignored when calculating the tubulin binding of benzimidazoles. 
However, if  this incomplete extraction occurs to a lesser extent it could lead to variation in 
the results for the assay. Separation of bound and unbound tritiated drug using a Sephadex 
column was examined and the results were compared with results of binding assays using 
charcoal extraction. There is no apparent reason for the higher values for binding of 
tritiated ABZ in the assays using column separation. The charcoal may extract some of the
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tubulin bound drug as well as the unbound drug but this would not account for the large 
variation in the results between the two methods. A comparison of separation of tubulin 
bound and free tritiated colchicine using charcoal or a Sephadex column (Sherline ata l, 
1974) showed no significant differences between the results in assays using the two 
methods. Because benzimidazoles are thought to bind to the same site on tubulin as 
colchicine it is likely that the benzimidazole tubulin complex w ill behave in a similar way 
to the tubulin colchicine complex in both charcoal and column separation.
The high binding of tritiated ABZ to the tubulin extracted from eggs may be due to a 
higher percentage of tubulin in this extract compared with the extracts from larvae. 
Alternatively, there may be other macromolecules in the extract capable of binding 
tritiated ABZ and therefore increasing the amount of tritiated ABZ bound through 
non-specific binding. Eggs were collected from faecal material with thorough washing of 
the sample, however, contaminating faecal material which is closely associated with the 
eggs may influence the binding of tritiated benzimidazoles in the assay. Clean larval 
samples of O.circumcincta are readily available as a suitable starting material for 
tubulin extraction and assays of binding of benzimidazoles. Using higher numbers of 
larvae and thorough homogenisation during the preparation of tubulin extracts from 
O.circumcincta larvae may aid in achieving higher concentrations of protein in the 
tubulin extract.
Comparison of Binding of Tritiated Albendazole to Tubulin Extracts from 
Benzimidazole Susceptible and Resistant Strains of O.circumcincta 
(Bearsden and HFRO Strains) 
Results
Tubulin extracts were prepared using infective larvae or eggs of O.circumcincta by 
Method B. The two strains of O.circumcincta used were the Bearsden benzimidazole
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susceptible strain and the HFRO benzimidazole resistant strain. The protein concentration 
in the tubulin extracts was calculated using a Lowry protein assay and results are shown 
in Tables 3.8 and 3.9. The tubulin extracts were used in binding assays using tritiated ABZ 
batch 2 (23.8uM) with specific activity of 360 dpm/pmole. The bound and unbound drug 
were separated using a Sephadex column or charcoal extraction. Results of binding of 
tritiated ABZ were expressed as pmoles/mg protein in the tubulin extract and are shown 
in Tables 3.8 and 3.9.
Discussion
Lacey and Prichard (1986) found that binding of tritiated benzimidazoles to 
benzimidazole resistant strains of Haemonchus contortus was significantly lower than 
binding to benzimidazole susceptible strains. Similar differences in binding of 
benzimidazoles were found between benzimidazole resistant and susceptible strains of 
O.circumcincta and TrichostrongyJuscoiubriformis (Lacey and Snowdon, 1988) and the 
binding of benzimidazoles to tubulin extracts from nematode parasites was suggested as a 
possible assay to detect benzimidazole resistance.
Results in Table 3,8 show reduced binding of tritiated ABZ to tubulin extracted from eggs 
of the benzimidazole resistant stain of O.circumcincta compared with the susceptible 
strain. However, binding of tritiated ABZ was much higher to tubulin extracts from larvae 
of the resistant strain than tubulin extracts using larvae of the susceptible strain. 
Similar results were obtained in a repeat of the binding assay (Table 3.9). The binding of 
tritiated ABZ to the tubulin extracts was inconsistent between assays. In Table 3.9 the two 
extracts using 10,000 resistant larvae bound similar amounts of tritiated ABZ but this 
differed from results of binding to an extract made with 10,000 resistant larvae in the 
previous assay (Table 3.8). Binding of tritiated ABZ to tubulin extracts from eggs of the 
two strains of O.circumcincta (Table 3.8) was much lower than binding calculated in a 
previous assay (Table 3.7). This could be due to increased care taken to ensure the
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Table 3.8
Binding of tritiated albendazole to tubulin extracts from eggs and infective 
larvae of benzimidazole susceptible and resisitant strains of 
O.circumcincta (Bearsden and HFRO strains)
Tubulin Extract Protein Binding 3HABZ (pmoles/mg protein)
(m g/m l) Charcoal Column
separation seoaratlon
6,000 eggs -  S 0.10 346.70 -
6,000 eggs -  R 0.10 112.03 -
15,000 larvae -  S 0.28 318.43 131.45
10,000 larvae -  R 0.24 4004.76 665.95
4,000 larvae -  R 0.11 - 841.32
S -  Bearsden susceptible strain of O.circumcincta 
R -  HFRO resisitant strain of O.circumcincta
Table 3.9
Binding of tritiated albendazole to tubulin extracts from Infective larvae 
of benzimidazole susceptible and resistant strains of O.circumcincta 
(Bearsden and HFRO strains)
Tubulin Extract
10.000 larvae - S
10.000 larvae -  R
10.000 larvae -  R
5.000 larvae -  R
Protein
(m g/m l)
0.39
0.18
0.21
0.09
Binding 3HABZ (pmoles/mg protein) 
Charcoal Column
separation
1233.93
5967.49
5556.87
389.03
S - Bearsden benzimidazole susceptible strain of O.circumcincta 
R - HFRO benzimidazole resistant strain of O.circumcincta
separation
322.79 
11771.43
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samples were clean and free from faecal material prior to homogenisation in preparation 
of the tubulin extracts or due to inconsistency in the assay. There was a marked variation 
in the binding measured using a column or charcoal for separation of the bound and 
unbound drug. For some tubulin extracts binding measured after charcoal extraction was 
higher than with column separation but with other extracts this trend was reversed.
Overall the results of these binding assays were extremely variable and comparisons of 
binding of benzimidazoles to resistant or susceptible strains of 0.circumcinctam\\& not 
be made because of the within assay and between assay variability in binding. The 
reproducibility of the results of binding assays was a major problem and the reasons for 
the extreme variability in the results were unknown. The protein concentration within 
the tubulin extract could have been at fault. A low level of protein and therefore tubulin in 
the extract could result in poor specific binding of benzimidazole and the contribution to 
the total binding of benzimidazole made by non-specific binding could distort the results. 
The efficiency of the charcoal at removing unbound tritiated drug also may be of great 
importance especially where low levels of drug were binding to tubulin. The contribution 
to the overall counts in the sample made by a small amount of unbound drug could be 
significant if the tubulin extract was binding a small amount of tritiated drug. According to 
Sherline et a l, (1974) activated charcoal removed 96$ of tritiated colchicine from 
samples. Calculation of the efficiency of the charcoal at removing unbound tritiated drug in 
the binding assays using tritiated ABZ described above showed results of 94.3$ and 
94.9$ which is probably as good as can be attained using this method. Efficiency of 
removal of unbound tritiated drug was greater with a column but this method has the 
disadvantage of being more time-consuming and therefore of little use for multiple sample 
assays.
The nature of the benzimidazole used in the binding assay may have an effect on the 
binding profile because of the differing affinities of the individual benzimidazoles for
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tubulin (Lacey and Pritchard, 1986). Lacey and Snowdon (1988) in their description of 
benzimidazole binding to tubulin extracts as a method of detecting resistance to 
benzimidazoles used tritiated mebendazole as their test benzimidazole. The use of different 
benzimidazole compounds in the binding assays to tubulin extracted from benzimidazole 
resistant and susceptible strains of O.circumcincta was investigated using tritiated FBZ in 
addition to tritiated ABZ to try  to establish if the nature of the benzimidazole was a reason 
for the variable results obtained in the assays.
Binding of Tritiated Fenbendazole to Tubulin Extracts from Benzimidazole 
Susceptible and Resistant Strains of O.circumcincta (Bearsden and HFRO 
Strains) 
Results
Tubulin extracts were prepared using Method B from 5,000 infective larvae of the 
Bearsden benzimidazole susceptible strain and the HFRO benzimidazole resistant strain of 
O.circumcincta. The protein concentrations in the tubulin extracts which were calculated 
using a Lowry protein assay are shown in Table 3.10. These extracts were used in a 
binding assay with tritiated FBZ ( 83.9uM, 110dpm/pmole). The bound and unbound drug 
were separated using a Sephadex column and results of binding of tritated FBZ to the 
tubulin extracts in pmoles/mg protein are given in Table 3.10. A graph was drawn of the 
counts in fractions eluted from the Sephadex column during separation of tubulin bound 
and unbound tritiated FBZ (Fig. 3.5)
Discussion
There was no significant difference in the binding of tritiated FBZ to tubulin extracts 
from the benzimidazole resistant and susceptible strains of O.circumcincta(Table 3.10). 
Lacey and Prichard, (1986) noted a higher level of binding of benzimidazoles to tubulin 
extracted from benzimidazole susceptible parasites compared with binding to
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Table 3.10
Binding of tritiated fenbendazole to tubulin extracts from benzimidazole 
susceptible and resistant strains of O.circumcincta 
(Bearsden and HFRO strains)
Extract Protein Binding 5HFBZ
(m g/m l) (pmoles/mg protein)
5.000 larvae-S 0.13 2870.94
5.000 larvae-R  0.15 2776.44
S -  Bearsden benzimidazole susceptible strain of O.circumcincta
R -  HFRO benzimidazole resistant strain of 0.circumcincta
Figure 5.5
Counts in eiuate from Sephadex column used to separate tubulin bound and 
unbound tritiated fenbendazole using tubulin extracts from O.circumcincta
HFRO and Bearsden strains.
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benzimidazole resistant strains. In previous assays (Tables 3.8 and 3.9) using tritiated 
ABZ binding to tubulin extracts from infective larvae of a benzimidazole resistant strain 
of O.circumcincta was higher than to extracts from larvae of a benzimidazole susceptible 
strain. Using tritiated FBZ there was no difference in the level of binding to extracts from 
these same resistant and susceptible strains of O.circumcincta (Table 3.10). The high 
level of binding measured in these assays to extrxts from a benzimidazole resistant strain 
of O.circumcincta conflicts with results described by Lacey and Snowdon (1988). In the 
assay described above using tritiated FBZ the unbound and tubulin bound drug were 
separated using a Sephadex column in case instability to charcoal extraction was causing 
variability in the results of the binding assays (see previously). Using column separation 
and collection of fractions from the column for counting, a graph can be drawn showing the 
elution of the tritiated drug (Fig. 3.5). The tritiated drug bound to high molecular weight 
material is eluted in the void volume (fractions 5-12) and the unbound tritiated FBZ 
which has a lower molecular weight is eluted later, in fraction 20 onwards 
approximately. The graph of counts eluted from the column during separation of the bound 
and unbound tritiated FBZ showed high counts at the period of elution of high molecular 
weight compounds (Fig 3.5) then a fall to basal levels. There was a rise in counts from 
fractions 20-30 . From these results it can be concluded that the tritiated FBZ is bound to 
material with a high molecular weight which is assumed to be tubulin. The tubulin 
extracts from benzimidazole resistant and susceptible strains of O.circumcincta X\ad 
similar protein concentrations (Table 3.10) and a similar pattern of binding of tritiated 
FBZ and therefore the binding assay in this form cannot be used as a method to detect 
resistance to benzimidazoles in strains of O.circumcincta.
The Effect of Host Treatment with Fenbendazole on the Binding of 
Benzimidazoles to Tubulin Extracted from Eggs of O.circumcincta (HFRO 
Strain)
Results
Eggs of O.circumcinta were collected from the faeces of a lamb ( DB16) which had been 
infected experimentally with the HFRO benzimidazole resistant strain of O.circumcincta 
for passage 5 (see previously). Eggs were collected prior to oral treatment of the lamb 
with FBZ at a dose rate of 5mg/kg and after treatment on 3 occasions at 24h, 48h and 8 
days post treatment. Using 20,000 eggs collected at each occasion tubulin was extracted 
and the protein concentration in the extracts determined using a Lowry protein assay. The 
protein concentration in the extracts was adjusted to give a concentration of 0.11 mg/ml in 
each extract. The extracts were used in tubulin binding assays with tritiated FBZ 
(83.6uM, llOdpm/pmole) and tritiated ABZ (119uM, 360dpm/pmole). The tubulin 
bound and unbound drug were separated using a Sephadex column.
Results of binding of tritiated ABZ and FBZ to the tubulin extracts in pmoles /mg 
protein are given in Table 3.11. The counts obtained during elution of the tubulin bound 
fraction of the samples during Sephadex column separation for each of the tubulin extracts 
with tritiated ABZ or tritiated FBZ are shown in Figs. 3.6 and 3.7 respectively. 
Discussion
Binding of benzimidazoles to tubulin extracts from O.circumcincta eggs passed in the 
faeces of a lamb treated with orally administered FBZ varied (Table 3.11). There was 
increased binding of tritiated ABZ to tubulin extracts from eggs collected 24h and 48h 
after FBZ treatment. However, in binding assays using tritiated FBZ, increased binding 
was observed at 24h and binding was reduced at 48h compared with pre-treatment levels. 
The reason for the increase in binding to tubulin extracts from eggs collected immediately 
post-treatment is unknown. It is possible that treatment of the host with FBZ reduces the
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Table 3.11
Binding of tritiated benzimidazoles to tubulin extracted from eggs of
O.circumcincta (HFRO strain) collected before and after oral treatment of
the host with fenbendazole
Extract
P re-treatment 
24h Post-treatment 
48h Post-treatment 
8dsys Post-treatment
Binding of Tritiated Benzimidazole 
(pmoles/mg protein) 
Albendazole Fenbendazole
131.21
181.53
203.51
166.95
452.53
538.02
404.52
464.67
Figure 5.6
Counts obtained during elution of tubulin bound tritiated albendazole from 
a Sephadex column with tubulin extracts from eggs of O.circumcincta HFRO 
strain collected prior to and at 24h, 48h and 8 days after treatment of the
host with fenbendazole.
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Figure 3.7
Counts obtained during elution of tubulin bound tritiated fenbendazole from 
a Sephadex column with tubulin extracts from eggs of O.circumcincta HFRO 
strain collected prior to and at 24h, 48h and 8 days after treatment of the
host with fenbendazole.
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formation of microtubules in adult parasites (Borgers eta/, 1975b) and their eggs. This 
may produce a change in the equilibrium between tubulin subunits and the microtubule 
structures with possible exposure of an increased number of benzimidazole binding sites. 
From Figs. 3.6 and 3.7 the distribution of counts bound to high molecular weight 
compounds eluted from the Sephadex column was similar for all the samples suggesting 
that any increase in binding occurred to macromolecules of similar distribution and high 
molecular weights. The tubulin extracts were prepared to contain the same amount of 
protein but the proportion of tubulin in extracts from eggs collected immediately 
post-treatment could be higher.
Alternatively, there could be an alteration in the adult population of the parasites 
leading to changes in the eggs produced by the parasites. After treatment of the host with 
FBZ there was a drop in the faecal egg count. Either fewer adults are laying eggs or the 
rate of egg laying in the same population is reduced. If the latter was the case then the eggs 
were possibly held within the female parasites for a longer period with possible increased 
accumulation of tubulin. Egg hatch assays carried out on eggs passed in faeces in the 
24-72h period after oral treatment of the host with FBZ showed elevated ED50s 
particularly when ABZ was used in the assay (see previously). The reason for these 
observed differences in the results of egg hatch assays may have a link with reasons for 
the observed changes in the binding of benzimidazoles to tubulin extracts from eggs 
collected during the same period post-treatment.
The results of this group of binding assays were fairly consistent compared with 
previous assays. The tubulin extracts were prepared using higher numbers of eggs than 
previously which may have resulted in the improved reproducibility (see later).
Binding of Tritiated Albendazole and Tritiated Fenbendazole to Tubulin 
Extracts Prepared using High Numbers of Infective Larvae of a 
Benzimidazole Susceptible and Resistant Strain of O.circumcincta 
(Bearsden and HFRO Strains)
Results
Tubulin extracts were prepared by Method A using infective larvae of HFRO and 
Bearsden strains of O.circumcincta. The protein concentration in the extracts was assessed 
using a Lowry protein assay and the results are shown in Table 3.12 The extracts were 
used in duplicate tubulin binding assays using tritiated FBZ (8.36uM, 1 lOdpm/pmole) 
and tritiated ABZ (1 1.9uM, 360dpm/pmole) with results shown in Table 3.13. Tubulin 
bound and unbound tritiated drug were separated using charcoal. The susceptibility factor, 
the concentration of drug bound to the susceptible strain divided by the concentration of 
drug bound to the resistant strain, was calculated for each assay along with the resistance 
factor, the concentration of drug bound to the resistant strain divided by the concentration 
of drug bound to the susceptible strain, and are shown in Table 3.13.
Discussion
The tubulin extracts contained a higher level of protein than any extracts used 
previously (Table 3.12) with >70ug of protein in each sample of extract used in the 
binding assays. Binding of tritiated FBZ in pmoles/mg protein was higher than binding of 
tritiated ABZ which was similar to results in the previous binding assay using tubulin 
extracts from eggs of O.circumcincta HFRO strain (Table 3.11). The binding of tritiated 
ABZ to tubulin Extracts A and B was lower than binding to Extracts C and D but levels of 
binding of tritiated FBZ did not show such a large fluctuation. In all the assavs the 
concentration of tritiated ABZ or FBZ bound was greater to the tubulin extracts from the 
susceptible strain of O.circumcincta than the resistant strain. This is contrary to results 
obtained in previous assays but similar to results of Lacey and Snowdon (1988).
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Table 3.12
Protein concentration in tubulin extracts prepared from infective larvae 
of Bearsden and HFRO strains of O.circumcincta
Extract Protein Concentration
( no. of Larvae) ( mg/ml)
A -  200,000-S  2.16
B - 150,000- R  4.55
C - 150,000- S  0.82
0 - 1 5 0 , 0 0 0 - R  1.32
S -  Bearsden benzimidazole susceptible strain of O.circumcincta 
R -  HFRO benzimidazole resistant strain of O.circumcincta
Table 3.13
Binding of Tritiated Benzimidazoles to Tubulin Extracts from Large 
Numbers of Infective Larvae of Benzimidazole Resistant and Susceptible
Strains of O.circumcincta.
Tubulin Extract Binding (pmoles/mg protein)
3habz 3hfbz
Assav 1 Assav 2 Assav 1 Assav 2
A -  200,000 larvae - S 22.20 26.39 110.50 89.74
B -  150,000 larvae - R 2.32 4.30 25.90 17.33
Resistance Factor S/R 9.57 6.14 4.27 5.18
Susceptibility Factor R/S 0.11 0.16 0.23 0.19
C -  150,000 larvae - S 117.66 50.14 149.32 64.81
D -  150,000 larvae - R 51.61 43.66 16.85 22.00
Resistance Factor S/R 2.28 1.15 8.86 2.95
Susceptibility Factor R/S 0.44 0.87 0.11 0.34
S -  Bearsden benzimidazole susceptible strain of O.circumcincta 
R -  HFRO benzimidazole resistant strain of O.circumcincta
However, the reproducibility of results from one assay to another is poor (Table 3.13). 
When measuring resistance a susceptibility factor or resistance factor is calculated to 
draw comparisons between various resistant and susceptible strains of nematodes. From 
the results in Table 3.13 these factors show great between assay variation. For tritiated 
ABZ the resistance factors range from 1.15 to 9.57 and for tritiated FBZ from 2.95 to 
8.86 for the same resistant and susceptible strains. The quantification of resistance from 
the results of this assay is therefore very unreliable. From egg hatch assay results (see 
previously) a ratio for resistant/ susceptible of about 6 is expected with these strains. 
Further discussion on the reproducibility of results in binding assays is included later.
Binding of Tritiated Albendazole or Fenbendazole to Tubulin Extracts from 
Haemonchus contortus (McMaster and VRSG Strains) 
Results
Tubulin extracts were prepared by Method A using various numbers of infective larvae 
of the two strains. The protein concentration in the extracts was assessed using a Lowry 
protein assay and results are shown in Table 3.14. The extracts were used in binding 
assays with tritiated FBZ (8.36uM, 1 lOdpm/pmole) and tritiated ABZ ( 10.8uM, 360 
dpm/pmole). Separation of the tubulin bound and unbound benzimidazole was carried out 
using charcoal extraction. A Sephadex column was used to separate bound and unbound 
tritiated ABZ in repeat assays. Results of these binding assays are shown in Table 3.15. 
Discussion
Differences in the binding of tritiated benzimidazoles to tubulin extracts from 
benzimidazole susceptible and resistant strains of H.contortus were found (Table 3.15). 
With tubulin Extracts A and B and tritiated ABZ there was an approximate three fold 
increase in binding to the extract from the susceptible strain compared with the extract 
from the resistrant strain. However, with tritiated FBZ the overall binding of drug was
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Table 5.14
Protein concentration in tubulin extracts prepared from infective larvae 
of Haemonchus contortus (McMaster and VRSG strains)
Tubulin Extract Protein Concentration
(no. of Larvae) (m g/m l)
A -  100,000 -  McMaster -  S 0.62
B - 100 ,000 -VRSG-R  0.55
C -  120,000 -  McMaster -  S 0.98
D -  5 5 ,0 0 0 -VRSG-R  0.27
S -  Benzimidazole susceptible strain 
R -  Benzimidazole resistant strain
• '  ■
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Table 5.15
Binding of tritiated ABZ or tritiated FBZ to tubulin extracts from
H. con tort us (McMaster and YRSG strains)
Tubulin Extract * Binding of Benzimida?nle
(pmoles/mg protein)
5HABZ *  5HABZ**  3HFBZ*
McMaster -  A 65.55 58.23 117.13
VRSG-B 20.49 21.36 99.07
Resistance Factor 3.20 2.73 1.18
Susceptibility Factor 0.31 0.37 0.85
McMaster-C 56.06 40.85 165.65
VRS0-D 64.80 76.64 308.35
Resistance Factor 0.87 0.53 0.54
Susceptibility Factor 1.16 1.88 1.86
1 Number of larvae used to prepare tubulin extracts and protein concentration of the 
extracts given in Table 3.14.
*Bound and unbound drug separated using charcoal extraction 
**Bound and unbound drug separated using a Sephadex column
greater but the difference between binding to the resistant strain and binding to the 
susceptible strain was much lower. For tritiated ABZ separation of bound and unbound 
drug using a Sephadex column gave similar results to assays where charcoal extraction 
was used. With tubulin Extracts C and D comparison of binding of tritiated ABZ or FBZ to 
the susceptible strain with binding to the resistant strain gave the opposite results. The 
extract derived from the resistant strain bound a higher level of drug than the extract 
from the susceptible strain. Extract D was prepared using 55,000 infective larvae 
compared with 120,000 larvae used for Extract C. The lower resulting protein 
concentration in Extract D could be important in influencing the results of the tubulin 
binding assays. The effect of protein concentration in the tubulin extract on the binding of 
tritiated benzimidazoles is discussed in more detail later.
Lacey and Prichard (1986) used these strains of H.contortus in their work on 
identification of benzimidazole resistant strains of nematodes using the tubulin binding 
assay. These authors calculated the ratios of binding of drug to the susceptible strain 
(McMaster) as compared with binding to the resistant strain ( VRSG) for individual 
benzimidazole compounds. For ABZ the ratio was 60.8± 18.9 and for FBZ 10.2± 1.4. These 
ratios do not correspond with results (resistance factors) shown in Table 3.15 from 
binding assays using identical strains of H.contortus These gross differences in results 
using the tubulin binding assay required further investigation to try to elucidate if 
consistent, reliable results could be obtained with this method.
Tubulin Binding Assay using Tubulin Extracts from Benzimidazole 
Resistant or Susceptible H.contortus 0. circumcrnctoInfective Larvae 
and Tritiated ABZ or MBZ. (Method from Lacey and Prichard ,1986) 
Materials and Method
Reagents./
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Reagents.
Tritiated ABZ and MBZ - Tritiated drugs prepared by method It (see previously) as 10 uM 
solution in DMSO /  MES buffer. Specific activity ABZ -  9754 dpm/pmole and MBZ - 
2685 dpm/pmole
Buffer- 0.025M MES pH6.5 containing 0.1 mM EGTA, 1,5mM MgS04 and 0.1M GTP.
Charcoal suspension - 2mg/ml charcoal ( Norit-A activated charcoal - Sigma Chemical Co. 
Ltd.) in 1 % (w/v)BSA.
Method
1. Duplicates of 90ul of tubulin extracts prepared by method A (see previously) and 
dilutions of the extracts giving a range of protein concentrations from approx. 
10-120ug/ml were placed in 1,5ml Eppendorf tubes ( blanks 90ul buffer).
2. To each tube was added 10ul tritiated ABZ or MBZ vort.exed and the tubes were incubated 
for 30 min at 37°C in a shaking waterbath.
3. 0.5ml of the charcoal suspension was added to each tube, vortexed and incubated at 37°C 
for 5 min in a shaking waterbath.
4 The tubes were centrifuged at 10,000 r p m. in an Eppenaorf bench-top centrifuge for 
lOmin.
5. An aliquot of the supernatant (0.4ml) was placed in 5ml Biofluor in a glass 
scintillation vial and counted in a /  counter (Packard Model 2650 Tricarb). The blanks 
were counted for 10mm and the samples for 1 min
6. Adjustments were made for quenching and the results corrected by subtraction of the 
blanks then multiplied by 1.5 to give the total counts in the sample. To calculate the 
binding of ABZ or MBZ to the tubulin extracts in pmoles/'assav the total counts in each 
sample was divided by the specific activity of ABZ or MBZ (dpm/pmole) and then to 
calculate the binding in pmoles/mg protein this value (pmoles/assay) was divided by the 
protein concentration in the sample.
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7. Graphs of binding, pmoles/assay or pmoles/mg protein, against protein concentration 
in the tubulin extract were drawn and the mean value for binding of 3HABZ or 3HMBZ to 
each individual strain calculated using values from the linear portion of the graphs.
Tubulin Binding Assays using Tubulin Extracts from H.contortus McMaster 
and YRSG Strains with Tritiated Mebendazole and Tritiated Albendazole 
Results
Tubulin extracts were prepared from infective larvae of H.contortusY\cY\e%\&r and 
VRSG strains. The protein concentrations in the extracts were determined using the BioRad 
assay and results are shown in Table 3.16. These extracts were used in tubulin binding 
assays with tritiated MBZ or tritiated ABZ. A range of protein concentrations was used for 
each extract in the assays (Table 3.16). Graphs of protein concentration against binding of 
tritiated drug for Assays 4 and 5 with MBZ are shown in Figs. 3.8 and 3.9 and for Assays 
3 and 4 with ABZ in Figs. 3.10 and 3.11 The mean and standard deviation for binding of 
tritiated MBZ or ABZ for each assay are shown in Tables 3.17 and 3.18. For tritiated MBZ 
curves of binding to tubulin extracted from the McMaster strain (Fig. 3.12) or VRSG 
strain (Fig. 3.13) for each assay against protein concentration were drawn. Similar 
curves were drawn for assays using tritiated ABZ (Figs. 3.14 and 3.15).
Discussion
The tubulin extracts were prepared using high numbers of H.contortus infective larvae 
(>100,000 larvae) producing protein concentrations in the extracts over the range 
0.69-2.96 mg/ml. Using the BioRad protein assay was less time consuming than the 
Lowry assay and gave comparable results for protein concentrations in the extracts. Lacey 
and Snowdon (1988) found a linear relationship betweeen protein concentration in the 
extract and number of larvae with a yield of 6.5 ug protein per 1,000 larvae. The range
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Table 5.16
Tubulin extracts prepared from H.contortus McMaster and YRSG strains
Assav Number of Protein concentration Protein in Assay
Number Larvae (mg/ml) (ug)
1 400,000 -S 2.88 2 2 - 9 8
400,000 -  R 2.96 2 6 -  119
2 100,000 -S 0.87 3 5 -6 1
100,000- R 0.89 4 4 - 8 0
3 450,000- S 1.88 9 -  169
450,000- R 2.01 5 -  181
4 400,000- S 1.61 8 -  144
400,000 -  R 1.69 8 -  153
5 300,000- S 1.46 4 -  131
300,000- R 1.56 4 -  141
6 200,000 -S 1.82 9 -  163
200,000- S 0.69 3 - 6 2
S -  McMaster benzimidazole susceptible strain of H.contortus 
R -  VRSG benzimidazole resistant strain of H.contortus
Figure 3.8
Binding of tritiated mebendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus VRSG and McMaster strains in Assay 4.
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Figure 5.9
Binding of tritiated mebendazole ( pmoles/mg protein) to tubulin extracted 
from H.contortus YRSG and McMaster strains in Assay 5.
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Figure 3.10
Binding of tritiated albendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus YRSG and McMaster strains in Assay 3.
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Figure 3.11
Binding of tritiated albendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus YRSG and McMaster strains in Assay 4.
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Table 3.17
Results of tubulin binding assays using tubulin extracts from H.contortus 
McMaster and VRSG strains with tritiated mebendazole
Assay Number Binding of 3HMBZ Resistance Susceptibility
(pmoles/mg protein) Factor Factor
McMaster VRSG
1 83.90±3.65 22.28±2.21 3.77 0.27
2 96.10±5.32 24.05± 1.97 4.00 0.25
4 84.33±5.79 26.00±3.51 3.24 0.31
5 77.34±4.15 24.06± 1.91 3.21 0.31
6 94.35±4.58 - - -
6 97.13±6.84 - _
( Results are mean values ± standard deviation of the mean)
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Results of tubulin binding assays using tubulin extracts from H.contortus 
McMaster and YRSG strains with tritiated albendazole
Assay Number Binding of 3HABZ Resistance Susceptibility
(pmples/mg protein) Factor Factor
McMaster VRSG
108.73±9.78 16.28±6.00 6.68 0.15
94.73±9.97 13 49±5.88 7.02 0.14
92.34±5.90 14.16±5.44 6.52 0.15
88.40±7.0 - - -
(Results are mean values ± standard deviation of the mean)
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Figure 5.12
Binding of tritiated mebendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus McMaster strain in Assays! , 2 , 4  and 5.
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Figure 3.15
Binding of tritiated mebendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus YRSG strain in Assays 1, 2 , 4 and 5.
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Figure 3.14
Binding of tritiated albendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus McMaster strain in Assays 2, 3 , 4 and 5.
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Figure 5.15
Binding of tritiated albendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus VRSG strain in Assays 2 , 3 and 4 .
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for protein extracts in the current experiments was approximately 7-9ug per 1,000 
larvae.
The effect of protein concentration in the extracts on the binding of benzimidazoles was 
studied by using a wide range of protein concentrations for each tubulin extract in the 
binding assays. The binding of benzimidazoles to tubulin extracts is expressed in 
pmoles/mg protein in the extract to take account of the variation in binding with 
increasing protein concentrations. However from Figs. 3.12-3.15 where binding is 
plotted against protein concentration there is increasing binding of benzimidazoles with 
increasing protein concentration. Lacey and Snowdon (1988) found binding of 
benzimidazoles to be linear with respect to protein concentration down to 5ug/assay with 
deviation from linearity occurring below lOug/assay. These workers observed both 
increases and decreases in binding below this level of protein. From Figs. 3.12-3.15 the 
relationship between binding of benzimidazoles and protein concentration for both ABZ and 
MBZ was not linear. Curve fitting with exponential curves produced good correlations 
R>0.97. When linear calculations were calculated they were poorer with a range of 
0.62-0.96 for R values. The lim it of detection of the assay, i.e. the protein concentration 
below which Lacey and Snowdon (1988) expected deviation from linearity was defined as 
20ug protein per assay. From Figs. 3.12-3.15 there was a sharp rise or fall (Fig. 3.14) 
in the level of benzimidazoles around a protein concentration of 30ug with deviation at 
higher protein concentration in assays using the resistant strain of H.contortus Taking 
35ug of protein per assay as the limit of detection and discarding figures for binding using 
protein values below this level curves of binding against protein concentration were 
redrawn for binding of ABZ to extracts from the YRSG strain (Fig. 3.16) and MBZ to 
extracts from the YRSG strain ( Fig. 3.17). Again the best fit curves were drawn and were 
shown to be exponential curves rather than the linear relationship shown by Lacey and 
Snowdon (1988).
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Figure 3.16
Binding of tritiated albendazole (pmoles/mg protein) to tubulin extracted 
from H.contortus YRSG strain in Assays 2 , 3 and 4 using data for samples
containing >35 ug protein.
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Figure 3.17
Binding of tritiated mebendazole ( pmoles/mg protein) to tubulin extracted 
from Hcontortus VRSG strain in Assays 2 , 3 and 4 using data for samples
containing >35 ug protein.
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The curves for individual assays were similar showing consistent results among the 
assays. Using values tor binding to tubulin extracts containing >35ug protein per assay a 
mean value and standard deviation for the binding of MBZ or ABZ for each assay was 
calculated ( Tables 3 17 and 3 18) In the binding assays using ABZ the standard deviation 
of the mean was greater than when MBZ was used in the assays, Between assay variation 
was less in assays using MBZ compared with assays using ABZ. However, with both ABZ 
and MBZ results of binding assays showed reduced binding to benzimidazole resistant 
strains of H.contorius However, the difference in binding of benzimidazole to tubulin 
extracts from benzimidazole resistant and susceptible strains is greater when ABZ was 
used as the ligand rather than MBZ. Lacey and Prichard (1986) noted that resistance 
factors were higher when benzimidazoles which are alkyl derivatives e.g. ABZ were used 
in the assays compared with phenyl derivatives e g MBZ, The differences in the resistance 
factors were less marked in the current study than results shown by Lacey and Prichard 
(1986). In order to define the level of resistance of a particular stain of Hcontortus a 
range of different strains would need to be used and their binding compared with a single 
susceptible strain using one of the benzimidazoles. Lacey and Prichard (1986) 
recommended MBZ as the ligand of first choice because of the increased consistency of 
results with this benzimidazole compared with the others.
Binding of Trltlated Mebendazole or Albendazole to Tubulin Extracts from 
Various Strains of O.circumcincta 
Results
Tubulin extracts were prepared by Method A using > 100,000 infective larvae of each of 
the strains of Ocircumcincta shown in Table 3.19 Binding assays were carried out using 
tritiated ABZ and MBZ on a range of protein concentrations of each tubulin extract. The 
mean binding for each of the benzimidazoles was calculated tor the individual assays using
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Table 3.19
Strains of Ostertogiacircumcincta used in tubulin binding assays
Source
Lamb R94 (Glasgow)
Lamb DB34 (Glasgow)
Lamb FR61 (Glasgow)
C.S.I.R.O. (Sydney)
C.S.I.R.O. (Melbourne)
C.S.I.R.O. (Melbourne)
C.S.I.R.O. (Melbourne)
Strain
Bearsden
HFRO
Resistance Status
Susceptible
Resistant
HFRO transplant-F3 Generation Resistant ( partially)
McMaster
KS
KR
KSXKR (40:60)
Susceptible
Susceptible
Resistant
Resistant (partially)
results for the binding to tubulin extracts with >35 ug protein in the assay. The mean 
binding of tritiated MBZ and tritiated ABZ to tubulin extracts are shown in Tables 3.20 
and 3.21 respectively. For some of the strains 2 or 3 assays were performed using the 
same batch of larvae but different tubulin extracts were prepared for each individual 
assay.
Discussion
The sources of the strains of 0.circumcincta used in the binding assays are shown in 
Table 3.19. The resistant strain obtained from C.S.I.R.O., Melbourne (KR strain) had been 
maintained in a laboratory situation with pressurisation using benzimidazoles to produce 
a highly resistant strain. The KS X KR strain was produced by combining KS and KR 
infective larvae in the ratio of 40:60 and using this mixture to infect lambs. The progeny 
of the cross were collected by culturing faeces of the infected lambs. The binding assays 
were performed on strains of O.circumcincta with varying benzimidazole resistance 
status in order to try to validate the use of the tubulin binding assay as a test for the 
detection of benzimidazole resistance and to draw comparisons of the resistance level 
among the different strains of O.circumcincta .
As in previous binding assays the protein concentration of the tubulin extract used in the 
assay had an effect on the binding of benzimidazoles. The results for binding (Tables 3.20 
and 3.21) were calculated over a narrow range of protein concentrations, 35-100 ug 
protein per assay, in order to minimise any variation in binding due to changes in protein 
concentration.
For some of the strains binding assays were carried out on several occasions and results 
showed marked between assay variation e.g. for the KR strain binding varied from 46.23 
pmoles MBZ/mg protein on occasion one to 18 57pmoles MBZ/mg protein on occasion 2 
which is a 60% drop in binding. Similarly on occasion 3 the binding for each strain was 
significantly different from results on the previous 2 occasions both in assays using MBZ
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Table 5.20
Binding of tritiated mebendazole to tubulin extracts from
0. circumcincta
Strain Binding of 3HMBZ ( pmoles/mg protein)
_L _2_ _3_
Bearsden 102.50±4,09 73.30±4 10
HFRO 34.13±4.10 25.40±1.37
HFRO transplant 82.14±2.35 
McMaster 92.09±2.41
KS 77.83±3.58
KR 46.23±3.35 18.57±2.06 32.18±3.17
KS X KR 71.53±4.31 46.5U3.57 62.76±4.05
( Results are mean values ± standard deviation of the mean)
Table 3.21
Binding of tritiated albendazole to tubulin extracts from
O.circumcincta
Strain Binding 3HABZ (pmoles/mg protein)
_L _2_ JL
Bearsden 105.88±5.71
HFRO 18.56±3.06
HFRO transplant 74.79±4.52 
McMaster 140.84±6.14
KS 112.50±4.38
KR 39.38±4.25 18.23±2.20 31.46±4.77
KS X KR 101.17±6.1 1 57.43±4.20 84.99±5.90
( Results are mean values ± standard deviation of the mean)
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and in assays with ABZ. Lacey and Snowdon 11988) found between experiment variation to 
be trom v^-^5/1 over a 12 month period usinQ strains ot T.coiubriformis, Hcontortus. 
and O.circumcincta In previous assays (Tables 3.17 and 3.18) with Hcontortus day to 
day variation in binding of benzimidazoles to tubulin extracts was of this order. However 
variation in binding with strains of O.circumcincta in the present experiments was much 
greater.
A possible reason for variability in the results of binding assays was changes in the 
protein content of the tubulin extracts or changes in the percentage or availability of 
tubulin in the extracts. Using the same number of larvae of the same strain of
0.circum cincta \\m ^\\^\tx\ was carried out using separate homogenisers because this 
step is the most likely to produce variability in the tubulin extraction (Lacey, personal 
communication, 1988). However, there was no significant difference in binding to tubulin 
extracts prepared using different homogenisers. Another problem with the assay is that 
total protein is measured in the extracts rather than the tubulin content. Tubulin 
constitutes <5% of the total protein in the tubulin extract and therefore it is unlikely that 
any change in the tubulin content in the extract would be reflected by a change in the 
overall protein concentration. Assay of the tubulin content would be more satisfactory 
using e.g. an ELISA for tubulin (see later). Standardisation of the ELISA assay is difficult 
because slight differences exist between the binding of anti-tubulin antibody to tubulin 
from resistant and susceptible strains. There could be day to day variation in the 
metabolism of infective larvae causing alteration in the amount of extractable protein and 
tubulin. However it would be surprising if these changes could account for differences in 
binding to O.circumcincta when they do not occur to such an extent in Hcontortus where
binding is less variable.
These changes in binding observed for the Bearsden, HFRO, KR and KS X KR strains 
assayed on different occasions confirm that in order to make any comparisons among
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different strains of O.circumcinctd the assays need to be carried out on the same day using 
exactly the same method and equipment. Comparison of the ratio of binding of MBZ to KR 
with KS X KR gave values of 0.64, 0.40 and 0.51 on the 3 xcasions and therefore the 
validity of the assay as a method of quantitating benzimidazole resistance accurately in 
strains of O.circumcincta is questionable.
There were also differences in the level of resistance measured in the strains when ABZ 
was used as the ligand in the assays rather than MBZ. The strains were ranked in order of 
susceptibility ( most susceptible= 1) according to results of binding assays using MBZ and 
ABZ (Table 3.22). The only strains which retain the same order with both benzimidazoles 
are the highly resistant strains KR and HFRO. The HFRO transplant strain which has been 
shown to be partially resistant was ranked above the susceptible strain KS using results 
for binding assays with MBZ. The HFRO transplant strain from lamb FR61 was tested for 
resistance using egg hatch assays and results were compared with those from egg hatch 
assays on the HFRO and Bearsden strains (see previously). The HFRO transplant strain 
was resistant with results from egg hatch assays showing resistance slighltly less than the 
HFRO strain. However, results from binding assays (Tables 3.20 and 3.21) suggest that 
the HFRO transplant strain was fairly susceptible. Similarly the resistance of the KS X KR 
strain should lie about midway between that of the KS and KR strains according to results 
of egg hatch assays (Martin, personal communication, 1988) and again results of binding 
assays show the KS X KR strain to be fairly susceptible. Differences between results of egg 
hatch assays and binding assays could be due to the influence of the stage of development of 
the parasite being tested. For tubulin binding assays tubulin is extracted from infective 
larvae whereas egg hatch assays are carried out using undeveloped parasite eggs. There 
could be differences in the level of resistance which can be measured at different stages of 
the life cycle of the parasites, which could in turn be linked to dependence on tubulin 
during that particular phase of the life cycle.
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Table 3.22
Susceptibility to benzimidazole anthelmintics of strains of O.circumcincta 
ranked using result from tubulin binding assays with mebendazole or
albendazole
Strain
Bearsden 
McMaster 
HFRO transplant 
KS
KSXKR
KR
HFRO
Order of Susceptibility 
Assays with MBZ Assays with ABZ
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In order to detect resistance using egg hatch assays the population of parasites has to 
have a high level of resistance (Martin, personal communication, 1988). The tubulin 
binding assay appears to have similar drawbacks with highly resistant strains detectable 
but identification and quantitation of benzimidazole resistance in less resistant strains 
appears to give much less reliable results.
Competitive Binding Assay with Tritiated Albendazole using Tubulin 
Extracted from O.circumcincta with Albendazole, Albendazole sulphoxide, 
Albendazole sulphone and Colchicine 
Materials and Method
Reaoents.
Tritiated ABZ - prepared by method I (see previously) and diluted to 10 8uM in 
methanol. Specific activity 360dpm/pmole
Buffer - 0.025M MES buffer containing 0.1 mM E6TA, 0.5mM MgSO^  and 0 1M GTIJ pH 6.5.
Charcoal suspension - 2mg/ml activated charcoal (Norit-A activated charcoal -  Sigma 
Chemical Co. Ltd.) in 1B(w/v) BSA.
Stock solutions of inhibitors -  solutions of ABSX and ABSO and colchicine were prepared
( 10.8uM) in methanol
Method.
1. Tubulin extracts prepared by method A ( see previously) from Ocircumcinctd infective 
larvae of Bearsden strain, benzimidazole susceptible, adjusted to a protein concentration 
of 2-3mg/ml.
2. 90u1 tubulin extract (or 90ul buffer-blank) was placed in 5ml plastic tubes. lOul of 
one of the inhibitors (or lOul methanol in the blank and standard) was added The tubes 
were vortexed and incubated at 37°C for 20min in a waterbath. The samples were earned 
out in triplicate.
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3. 1 Oul o f3HABZ was added to each tube (10ul methanol to blank), vortexed and incubated 
for 15min at 37°C in a waterbath.
4. 0.5ml charcoal suspension was added to all the tubes, mixed and incubated for 1 Omin at 
37°C in a waterbath
5. All tubes were centrifuged at 3,500g for 1 Omin.
6. A 0.4ml aliquot of the supernatant in each tube was added to IOml Ecoscint in a 
scintillation vial and counted for I min in a Packard counter.
7. The counts for the standards and samples were corrected by subtracting the average 
counts obtained for the blanks. These results were divided by the specific activity of 
3HABZ and the protein concentration of the tubulin extract to give the binding of 3HABZ in 
pmoles/mgprotein. The effect of the inhibitor was measured by comparing the binding of 
3HABZ in the standard with binding of 3HABZ in the presence of an inhibitor The results 
were expressed as a percentage inhibition of binding.
Results
The amount of tritiated ABZ bound to tubulin extracts after pre-incubation with the 
inhibitors is shown in Table 3 23 
Discussion
Colchicine and the benzimidazoles are thought to bind to the tubulin molecule at the 
same binding site (Friedman and Platzer, 1980b). The benzimidazoles and colchicine 
therefore compete for the binding site. Prior incubation with one of these molecules 
should reduce subsequent binding of tritiated ABZ to the tubulin molecule. This 
competition for binding sites was exploited in the original binding assays (see previously) 
when binding of benzimidazoles was measured indirectly by displacement of colchicine 
(Sherline eta/, 1974 ; Barrowman eta!., 1984) The low counts for radioactivity of the 
tritiated colchicine were a limiting factor in the use of this assay. With tritiated 
benzimidazoles inhibition of binding of the drug can be measured using a modification of
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Table 5.25
Binding of tritiated ABZ (pmoles/mg protein) to tubulin extracted from
O.circumcincta after incubation with a range of inhibitors (ABZ, ABSX,
ABSO and Colchicine)
Assay Number Inhibitor
Blank ABZ ABSX ABSO Colchicine
1 49.77 -  50.20 58.30
2 22.87 19.96 63.17 36.49
3 27.29 22.52 24.67 20.43 42.19
- ft
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the tubulin binding assay by adding a step, pre-incubation of the tubulin extract with an 
inhibitor, before addition of the tritiated ABZ.
Barrowman et a/,{ 1984) found that ABSX and ABSO acted as inhibitors of colchicine 
binding. From the results given in Table 3.23 they did not inhibit binding of tritiated ABZ 
in Assays 1 and 2 and inhibited binding to a slight extent in Assay 3. Pre-incubation with 
ABZ caused a low level of inhibition in Assays 2 and 3 but the values for binding of 
tritiated ABZ were not significantly different from the blanks. In Assay 3 pre-incubation 
with colchicine caused an increase in binding of tritiated ABZ to the extract which is 
contrary to the expected result.
The reason for the increase in binding of tritiated ABZ in Assay 3 after pre-incubation 
with ABSX or ABSO and in Assay 3 after pre-incubation with colchicine was unknown. 
There may be a high level of non-specific binding which masks the inhibitory effect of the 
pre-incubated substances but this would not explain the enhancement of binding of 
tritiated ABZ which was observed in some cases. From previous tubulin binding assays 
using a Sephadex column to separate the bound and unbound tritiated drug the high counts 
corresponded to drug bound to a high molecular weight component which was assumed to be 
tubulin. However, this may not be the case and binding to some other component of the 
crude extract could be influencing the results of the assays.
Previous tubulin binding assays using tubulin extracted from Q.circumcincia^misA 
variability in results. This may account for some of the discrepancies in results between 
assays in the present competitive binding assay. A similar type of assay using H. contortus 
tubulin was investigated using a range of concentrations of the inhibitor substances ABZ, 
ABSX and ABSO.
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Displacement Assay using Tubulin Extracts from M.co/itortuswMU Tritiated 
Albendazole and the Inhibitors Albendazole, Albendazole Sulphoxide and 
Albendazole Sulphone.
Materials and Method
Reagents.
Stock solutions ot Inhibitors - Stock solutions of ABZ, ABSX and ABSO at a concentration of 
5,000uM were made up in DMSO. Serial dilutions 1:2 in DMSO were made and a range of 
solutions was used in the assay to give final concentrations of 0.025-3.125uM for ABZ 
and 0.39-50uf1 for ABSX and ABSO.
Buffer -  0.025 MES buffer, pH 6.5 containing 0 1 mM EGTA, 0 5mM MgS04 and 0 1M GTP
Tritiated ABZ prepared by method II with specific activity of 9754 dpm/pmole.
Charcoal suspension - 2mg/ml activated charcoal (Norit-A activated charcoal- Sigma 
Chemical Co. Ltd) in 1 £(w /v) BSA.
Method.
1. Crude tubulin extract prepared by method A (see previously) from Hcontortus 
McMaster strain ( Benzimidazole susceptible) was adjusted to a protein concentration of 
80-1 OOug/1 OOul using buffer. 90ul of tubulin extract was placed in each 1.5ml 
Eppendorf tube (Blank 90ul buffer).
2. To each tube 2ul of inhibitor was added - duplicates of each concentration of the 
inhibitor solutions were used (blank and standard 2u1 DMSO added) vortexed and 
incubated for 30 min at 37°C in a shaking water bath.
3. lOul of 3HABZ was added to each tube, vortexed and incubated for 30min at 37°C in a 
shaking water bath.
4 Added 0.5ml charcoal suspension to each tube, vortexed and incubated for 5min at 37°C 
in a shaking water bath then the tubes were centrifuged at 10,000 r.p.m. in an tDpendorf 
Dench-top centrifuge for lOmin.
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5. A 0.4ml aliquot of the supernatant from each tube was placed in 5ml Biofluor in a glass 
scintillation vial and counted in a ^  counter (Packard Model 2650 Tricarb).
6. The blank was counted for 10 min and the average dpm subtracted from the counts of all 
the other samples and standards.
7. The standards and samples with inhibitor substances were counted for I min. After 
correction for quenching, the final concentration of 3HABZ binding in each sample and 
standard was calculated in pmoles/mg protein by dividing the counts in each by the 
specific activity of the 3HABZ and the protein concentration of the tubulin extracts
8. The reduction in binding caused by each of the inhibitors was calculated by comparing 
the H3ABZ binding in the standards with that found in the samples. This reduction was 
expressed as percentage inhibition.
Results
Binding of tritiated ABZ to the tubulin extracts after prior incubation with buffer or 
increasing concentrations of ABZ, ABSX or ABSO was calculated. The percentage inhibition 
of binding of tritiated ABZ was calculated for each concentration of the inhibitors and a 
graph of percentage inhibition against log concentration of inhibitor was drawn (Fig. 
3.18). The best-fit straight line plot was drawn for each inhibitor and from this the 
LD50, the concentration of inhibitor at which binding of tritiated ABZ was reduced by 
50£ was calculated. The LD50 for each of the inhibitors is shown in Table 3.24. 
Discussion
Pre-incubation of tubulin extracts with ABZ, ABSX or ABSO reduced the subsequent 
binding of tritiated ABZ. The potency of the compounds as inhibitors differed with ABZ 
being more potent than ABSX and ABSO. Barrowman eta/., (1984) using inhibition of 
colchicine binding assays found ABSX and ABSO bound almost as strongly as ABZ to tubulin 
extracted from Asuum. However, in the present study the inhibition of binding of 
tritiated ABZ is less with the metabolites ABSX and ABSO than with the parent compound
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Table 3.24
Inhibition of binding of tritiated ABZ to tubulin extracted from H.contortusSn
the presence of ABZ, ABSX and ABSO
Inhibitor *  LD 50 (uM)
Albendazole 0.48
Albendazole sulphoxide 2.35
Albendazole sulphone 11.13
♦Concentration of inhibitor which reduced binding of tritiated albendazole by 50£
Fioure 5.18
Percentage inhibition of binding of tritiated albendazole to tubulin 
extracted from Hcontortus YRSG strain in the presence of albendazole, 
albendazole sulphoxide and albendazole sulphone.
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The relationship between strength of binding of a benzimidazole to tubulin and efficacy 
as an anthelmintic is probably not simple. The benzimidazoles have several possible modes 
of action (see Introduction) and some of these may not be linked with tubulin binding. 
Therefore conclusions drawn from data on the ability to displace tritiated ABZ from the 
tubulin binding site as a measure of the strength of tubulin binding may be misleading. 
Lacey and Prichard (1986) found that binding to tubulin differed from one benzimidazole 
compound to another with greater binding found with MBZ and OFZ than with ABZ, FBZ, 
PBZ and OBZ. However, this does not reflect the known in vivo efficacy of these drugs. The 
efficacy of ABSO as an anthelmintic is negligible but from studies by Barrowman eta/., 
(1984) and the present studies ABSO binds to tubulin.
Another important factor is the concentration of drug available in the host animal. 
After oral administration of ABZ to ruminant animals high levels of ABSX are found and 
negligible levels of ABZ. Even if ABSX were poorer at binding to tubulin than ABZ and 
therefore had poorer activity than the parent compound the higher available 
concentrations of ABSX would more than compensate for the poorer binding of this 
metabolite to tubulin.
In the previous competitive binding assay using O.circumcincta tubulin ABZ at a 
concentration of 1,08uM inhibited binding of tritiated ABZ to a slight extent and ABSX and 
ABSO at the same concentration had a variable effect on binding. The use of Hcontortus 
tubulin and tritiated ABZ with a higher specific activity in the present assay produced 
greater differences in binding in the presence of lower concentrations of the inhibitors. 
This may be due to the reduction in the importance of non-specific binding because of the 
higher counts associated with the tritiated ABZ or the possible influence of the parasite 
species used to prepare tubulin extracts for the binding assays (see previously).
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General Discussion and Conclusions
The mechanism of action of the benzimidazole anthelmintics is thought to include 
inhibition of formation of microtubules in cells (Borgers and De Nollin, 1975) 
Benzimidazoles have been shown to bind to tubulin and inhibit the assembly of tubulin into 
microtubules in vitro  (Friedman and Platzer, 1978; Ireland eta/. A979). The binding 
of benzimidazoles to tubulin is thought to occur at the same site as colchicine binds 
(Hoebeke et at, 1976). Studies with tubulin extracted from Asuum confirmed that 
benzimidazoles compete with colchicine for binding sites in tubulin extracts and this 
competitive binding could be used as a method to measure the binding of benzimidazoles to 
tubulin. Binding of benzimidazoles was also measured directly using tritiated 
benzimidazoles but the results from a range of assays using nematode tubulin were 
variable
The protein content in tubulin extracts exerted a strong influence on the binding of 
benzimidazoles. The initial studies using the tubulin binding assay involved tubulin 
extracts with low protein concentrations and results were very variable. Latterly with 
higher protein concentrations in the tubulin extracts the assay appeared more robust but 
reproducibility of results especially with extracts from O.circumcincta was poor. 
Various factors could be implicated including tubulin content in the extract, specific 
activity of the tritiated benzimidazole used and method of separation of the tubulin bound 
and unbound drug.
The differences in binding of benzimidazoles to tubulin extracts from benzimidazole 
susceptible and resistant strains was inconsistent. Lacey and Snowdon (1988) have 
advocated tubulin binding of benzimidazoles as a routine diagnostic assay for detection of 
benzimidazole resistance in nematode parasites. From the results presented above it was 
obvious that the test has various disadvantages. Early work showed that the test was of no 
value to differentiate between strains of parasites with tubulin extracts using low
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numbers of infective larvae. Results were of some value when extracts were prepared 
using >100,000 infective larvae but this places limitations on the test for diagnosis of 
resistance because availability of infective larvae may be a problem.
Alteration in the binding of benzimidazoles may not be the entire mechanism by which 
parasites have evolved resistance. In studies on the mechanism of action of benzimidazoles 
and their effect on microtubule assembly, (Gull et a l, 1987) differences in the 
supramolecular structure of microtubules between mammals and helminth species were 
described. These authors found differences between groups of cells within nematode 
parasites. This is shown as differences in the arrangement and number of protofilaments 
in microtubules in cells. The selective action of benzimidazoles on helminth microtubule 
formation is likely to involve differences in tubulin, changes in the molecular structure 
of microtubules and possibly different mechanisms of microtubule assembly. Resistance to 
benzimidazoles may be acquired by an alteration in any one of these constituents.
Tubulin has been highly conserved throughout evolutionary development of species and 
there is little variation in the component O'and p  tubulin molecules. However, there is 
species variation in the molecular structure of helminth microtubules (Davis and 
Gull, 1983; Gull etaL 1987). In the tubulin binding assays the binding of benzimidazoles 
to a crude extract of tubulin was measured. Differences in binding could reflect 
differences in the binding site for benzimidazoles. However, at low protein concentrations 
binding of benzimidazoles was extremely variable. This suggested that changes were 
occurring in the binding site when a low concentration of tubulin was present in the 
extract. At low levels of tubulin the assembly of microtubules or their component parts 
may be affected with changes in the tertiary structure of the tubulin molecules causing 
variation in benzimidazole binding. The differences in benzimidazole binding to 
benzimidazole susceptible and resistant strains may reflect differences in tertiary 
structure of tubulin or possibly other macromolecules in the extracts. Reliability of the
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tubulin binding assay with tubulin extracts from Hcontortus was greater than with 
extracts from O.circumcincta This may be due to species differences in the structure of 
microtubules and their method of assembly. A similar mechanism could account for 
differences in binding between extracts from infective larvae or eggs of the same species 
of nematode.
When parasites develop resistance to benzimidazoles there is side-resistance to other 
members of the group of anthelmintics. In the tubulin binding assays there is 
benzimidazole dependent variation in results for binding. Lacey and Prichard (1986) 
recommended MBZ as the benzimidazole of choice in tubulin binding assays because results 
using this compound are more consistent than with other benzimidazole compounds. From 
Table 3.22 the level of resistance measured in strains of O.circumcincta differed with the 
benzimidazole compound used in the assay. To use the tubulin binding assay as a method to 
diagnose resistance accurately, results require to be consistent and from the above trials 
this has not been shown.
Other factors may be involved in the development of resistance to anthelmintics 
including change in uptake of the drug, changes in drug metabolism (Sutherland et at, 
1988), and physiological changes (Kelly e ta l, 1978). The use of the tubulin binding 
assay to detect resistance to benzimidazoles is a highly specific biochemical test directed 
at one area possibly involved in the mode of action of the benzimidazoles and therefore in 
changes associated with drug resistance.
The above studies involved experimental infections with a single species of nematode 
parasite. In the field situation infections are mixed and preparing a tubulin extract from a 
mixed population for the binding assays makes detection of resistance in a single species of 
nematode impossible. Other methods are therefore more appropriate where mixed 
infections predominate e.g. faecal egg count reduction test, egg hatch assay with culture of 
larvae to allow identification of species or inhibition of larval development
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DEVELOPMENT OF AN ENZVME LINKED IMMUNOSORBANT ASSAY (ELISA) FOR 
THE DETECTION OFa AND p  TUBULIN IN NEMATODES
Materials
Parasites -  Infective larvae and first stage (L I ) larvae of O.circumcincta, Bearsden and 
HFRO strains were prepared by the method given previously (see General Materials and 
Methods). Infective larvae were exsheathed (see General Materials and Methods). Adult
O.circumcincta of the HFRO strain were obtained at necropsy of lambs in Experiment 2 of 
the Dose Titration Trial (see previously).
Antibodies - Monxlonal anti-c t tubulin - mouse monoclonal antibody in ascites fluid, 
Monoclonal anti-/? tubulin -  mouse monxlonal antibody in ascites fluid and anti-mouse 
immunoglobulin horseradish peroxidase linked whole antibody (from sheep) affinity 
purified in buffered aqueous solution were obtained from Amersham International pic.
Phosphate buffered saline (PBS) - Prepared with 1.07g Na^ HP04 (anhydrous),039g
NaH2P04.2H20 and 8.5g NaCl in 1 litre of distilled water, pH7.2.
BSA-PBS -  3fc(w/v) bovine serum albumin in PBS 
Tween-PBS- 0.05£(v/v) Tween 20 in PBS.
BSA-Tween-PBS - 3£(w/v) bovine serum albumin in Tween-PBS.
Carbonate/bicarbonate buffer -  N a ^  (anhydrous) 10.6g/l and NaHCOj 8.401g/l were 
mixed in proportions of 29.3ml Na2C03 with 70.7ml NaHC03 to produce a solution with 
pH 9.6.
Sodium acetate/citric x id  buffer - 0.1M sodium acetate (anhydrous) and 0.1M citric acid 
were mixed in proportions of approximately 99ml sodium acetate and 1ml citric acid to
produce a solution with pH 6 0.
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Enzyme substrate -  250ug 33'-diaminobenzidine-4HC1 per ml, 0.5ul 308 Ho0o per ml 
in 0.05M trisHCl buffer, pH7.6.
TMB enzyme substrate -  iOOmg 3 )3\5,5 ’-tetramethylbenzidine (TMB) dissolved in 
1 Oml DMSO. Iml of this was added to 100ml of 0.1M sodium acetate/ citric acid buffer,
pH6 and H202 was added to a final concentration of 1.3mh/l.
MES buffer -  0.025M MES buffer containing 0.1 mM EGTA and 0.5mM MgS04, pH 6.5.
MES +GTP buffer -  MES buffer plus 0.1M GTP.
Nitrocellulose membrane.
96 well ELISA plates (Nunc)
Immunological Detection by Protein Blotting of Alpha Tubulin in Extracts 
from Infective Larvae of O.circumcincta Bearsden Benzimidazole 
Susceptible and HFRO Benzimidazole Resistant Strains. ( Method modified from 
Ogata at a/, 1983)
Method.
1. Samples containing 10,000 or 100,000 infective larvae of the Bearsden or HFRO 
strain of O.circumcincta were washed in MES buffer and centrifuged on 3 occasions.
2. The larvae were homogenised in MES +GTP buffer. With 10,000 larvae the total 
volume was 0.5ml and with 100,000 larvae the volume was 1ml.
3. The homogenates were placed in Eppendorf plastic centrifuge tubes and centrifuged at 
12,500r.p.m. in an Eppendorf benchtop centrifuge for 15min.
4. The supernatant was removed as the tubulin extract and a Lowry protein Assay (see 
previously) was carried out on all the extracts.
5. Nitrocellulose membranes were soaked in MES buffer
6. Separate nitrocellulose membranes were loaded with tubulin extracts. The volume of
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extract loaded onto the membrane was adjusted to add 4ug of protein for the extracts from 
10,000 larvae and 19.8 ug of protein for the extracts from 100,000 larvae. A blank was 
prepared using MES +GTP spotted onto the membrane. The membranes were placed in an 
incubator at 37°C to dry the spots.
7. The nitrocellulose strips were soaked in BSA - PBS for 1 h at 37°C.
8. The nitrocellulose membranes were incubated for !h at 37°C surrounded by anti- 
tubulin antibocV (antibody diluted 0.02ml in 100ml BSA -  Tween-PBS).
9. The membranes were washed 4 times with Tween-PBS with agitation over a period of 
30min.
10. The membranes were incubated for 1h at 37°C surrounded by anti-mouse antibody 
peroxidase linked (diluted 1:400 in BSA -Tween -PBS).
11. The membranes were washed 4 times with Tween -PBS with agitation over a period of 
30min.
12. The membranes were soaked in enzyme substrate for 5min and the reaction was 
stopped by the addition of distilled water.
13. The membranes were dried in the incubator at 37°C and examined for development of a 
brown colour.
Results
The nitrocellulose strips were examined after the addition of substrate and a small 
brown circular spot was detected in the area where extracts from 100,000 infective 
larvae of both strains were loaded (see Fig.3.19). There was no colour change detected in 
the blank and on the nitrocellulose strips loaded with extracts from 10,000 infective 
larvae. The protein blots using extracts from 100,000 larvae contained 19.8ug protein 
and a n ti-a  tubulin antibody bound to the protein blot. However, the blots from extracts 
from 10,000 larvae which contained 4ug protein were not detected with an ti-a  tubulin
antibody.
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Figure 3.19
Results of a protein blot onto nitrocellulose with tubulin extracts from 
infective larvae of the Bearsden and HFRO strains of O.circumcincta with 
detection of a  tubulin using an immunological technique.

Discussion
The binding of anti-cttubulin antibody to extracts from 100,000 infective larvae which 
were blotted onto nitrocellulose strips was assumed to be due to binding to tubulin in the 
extracts. The nitrocellulose strips with buffer blotted onto the strip (blank) showed no 
change in colour after the addition of antf-a tubulin antibody , peroxidase linked second 
antibody and substrate which suggested that antibody was binding to a constituent of the 
extract from the 100,000 larvae and this was assumed to be tubulin. For the protein blot 
using extracts from 10,000 infective larvae the protein concentration added to the 
nitrocellulose strip was much lower and binding of anti-or tubulin antibody was not 
detected by examining the nitrocellulose strip with the naked eye. Using the protein 
blotting technique the full volume of extract loaded onto the nitrocellulose membrane may 
not have become bound to the membrane. The higher protein concentration in the extracts 
from 100,000 infective larvae may be necessary in order to ensure that sufficient 
tubulin bound to the strips.
In this experiment a constant protein concentration of the extracts from 100,000 
infective larvae of each strain of O.circumcincta was added to the nitrocellulose 
membrane. However, because of the the diffuse nature of the colour spot on the 
nitrocellulose membrane it was impossible to measure the colour change quantitatively. 
Differences in the binding of anti - ct tubulin antibody to the extracts from benzimidazole 
resistant and benzimidazole susceptible parasites could not be measured accurately using 
this method. To make the assay quantitative the peroxidase induced colour reaction would 
need to be eluted from the nitrocellulose strip and colour changes measured in a 
spectrophotom eter. Alternatively, a similar rextion using ELISA plates would allow
colorimetric analysis of the end products of the rextion.
These initial studies using nitrocellulose strips were useful to establish that tubulin 
extrxts bound to the surface of the nitrocellulose membrane and binding of anti-atubulin
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antibody could be detected. This method was modified and used in an ELISA with anti-ar 
tubulin antibody and an ti-^  tubulin antibody using 96 well plastic plates.
Development of an ELISA to Detectatubulln and p  tubulin in Extracts from
0.circumcinctaBearsden and HFRO Strains
Method.
1. Tubulin extracts were made from infective larvae of the Bearsden and HFRO strains of 
O.circumcincta by the method described previously (see steps 1 -4  in above method)
2. Using adult parasites, exsheathed infective larvae or first stage larvae the parasites 
were counted and a known number were sonicated in MES +6TP buffer. The parasites were 
exposed to several cycles of sonic waves( 6 u) for 30 seconds with a 30 second rest period 
and the tubes were maintained in ice. The parasites were examined under a dissecting 
microscope to ensure they were fully destroyed.
3. The samples were placed in individual wells on the ELISA plate and were bound to the 
plate by incubating in the presence of carbonate/bicarbonate buffer for I -2h at 37°C. For 
blanks MES + OTP buffer was added instead of the sample
4. The plate was washed with BSA-Tween-PBS and incubated for 1h at 37°C with 
BSA-Tween -PBS.
5. The BSA-Tween-PBS was removed from the wells and anti-cttubulin or anti-/? tubulin 
antibody solution was added to each well ( 0.02ml antibody in ascites solution diluted with 
100ml BSA-Tween-PBS ). The plates were incubated for 1 h at 37°C.
6. Plates were washed with Tween-PBS 4 times with agitation over a period of 30min.
7. To exh well was added anti-mouse peroxidase linked antibody (diluted 1:400 in 
BSA-Tween-PBS). The plate was incubated for 1 h at 37°C.
8. Plates were washed 4 times with Tween-PBS followed by 4 washes in distilled water.
9. TMB enzyme substrate ( ISOul) was added to each well and plates were incubated for
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30min at 37°C. The reaction of horseradish peroxidase with TMB produced an Intense blue 
colour and the absorbance was measured at 690nm. The reaction was stopped by adding 2M 
sulphuric acid (20ul) to each well and a further reading for absorbance at 450nm was 
taken. A more consistent reading for absorbance was obtained by using two filters of 
690nm and 450nm in the plate reader.
Results 
ELISA I
Tubulin was extracted from 100,000 infective larvae of the Bearsden and HFRO Strains 
of Qa'rcumcmcta A Lowry protein assay was carried out (for method see previously ) 
and aliquots of each extract containing 50ug of protein were added to wells on the ELISA 
plate. One thousand larvae of each strain were sonicated and aliquots of equal volume of the 
sonicated material from each strain were added to wells on the ELISA plate. Results of the 
ELISA using anti-artubulin and anti-/? tubulin antibodies followed by peroxidase linked 
anti-mouse antibody and substrate are shown in Table 3.25. The peroxidase activity, 
which corresponds to the binding of antibody to the larval extracts, was measured 
spectrophotometrically at 450nm after the addition of substrates then sulphuric acid. The 
ratio of binding of anti-crtubulin to binding of anti-/? tubulin for both sonicated larval 
material and tubulin extracts from larvae is shown in Table 3.25.
ELISA 2
Using infective larvae of the Bearsden and HFRO strains of O.circumcincta 2,000 larvae 
were sonicated in equal volumes of buffer and aliquots of the sonicated material were added 
to wells on an ELISA plate. Increasing concentrations of anti-tubulin antibody were used in 
the ELISA. The working concentration of anti-tubulin antibod/ recommended by 
Amershams was 1 -2ug/ml. For this assay the normal concentration (1 -2ug/mt) and 2, 
5, 10, and 20 times this concentration were used. Results of the ELISA are shown in Table 
3.26 and graphs of the peroxidase activity (absorbance units at 450nm) against the
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concentration of anti-tubulin antibody used in the ELISAs with larvae of the Bearsden 
HFRO strains of O.circumfcfncta are shown in Figs. 3.20 and 3.21 respectively.
ELISA 3
The assay was carried out to compare the binding of anti-tubulin antibody to sonicated 
larval extracts of the Bearsden and HFRO strains of O.circumcincta. The larvae were 
untreated or incubated with ABZ for 24h at a concentration of 1 ug/ml or 5ug/ml prior to 
sonication. Results of the ELISA expressed as peroxidase activity bound to the larval 
extracts are shown in Table 3.27. Using the Student’s t-test a significantly higher level 
of a n ti-a  tubulin and anti-y? tubulin were bound to the material from larvae of the 
susceptible strain of O.circumcincta compared with material from larvae of the HFRO 
strain. There were some differences in binding of anti-tubulin antibodies between the 
sonicated material from larvae which were treated with ABZ or untreated but these 
differences were not consistent and not significant.
ELISA 4
Adult O.circumcincta were collected at necropsy from lambs in the dose titration trial 
Experiment 2 (see previously). The 5 lambs infected with the HFRO benzimidazole 
resistant strain of O.circumcinctahad been treated orally with FBZ at dose rates of 5, 10, 
20 and 40 mg/kg and one animal remained untreated as a control. From each lamb 10 
female and 10 male adult parasites were obtained and sonicated. Binding of anti-crtubulin 
and anti-/? tubulin to the samples measured as peroxidase activity is shown in Table
3.28.
ELISA 5
This assay was carried out using first stage larvae of O.circumcincta. The larvae were 
cultured from faeces using the method described previously (see General Materials and 
Methods ). The faeces for culture of first stage larvae were obtained from Lamb DB 33 
( see Fig.2.1), a lamb infected with the Bearsden strain of O.circumcincta and a lamb from
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Table 5,25
Results of ELISA 1 comparing the binding of anti-tubulin antibodies to 
tubulin extracts from 100,000 infective larvae of the Bearsden and HFRO 
strains of O.circumcincta and extracts from 1,000 sonicated infective
larvae of the same strains
Extract, Absorbance Units ± SEM at 450nm
a  tubulin p  tubulin d tp
Bearsden -  tubulin extract 0.081 ±0.019 0.043±0.002 1.88
HFRO -  tubulin extract 0.054±0.007 0.048±0.003 1.13
Bearsden -  sonicated larvae 0.155±0.006 0.098±0.002 1.58
HFRO -  sonicated larvae 0.079±0.003 0.049±0.002 1.61
Table 5.26
Results of ELISA 2 using varying concentrations of anti-tubulin antibody and 
extracts obtained after sonication of 2 ,000 infective larvae of the Bearsden 
benzimidazole susceptible and HFRO benzimidazole resistant strains of
O.circumcincta
Antibody cone,* Absorbance units ± SEM at 450nm
dc tubulin B tubulin
Susceptible Resistant Susceptible Resistant
2 0 X >2 >2 >2 >2
10X >2 1.856±0.035 >2 1.75!±0.033
5 X 1.703±0.018 1.192±0.016 1.615±0.031 1.094±0.028
2 X 1.385±0.006 0.670±0.007 1.323±0.030 0.534±0.018
IX 1.298±0.032 0.520±0.027 1.297±0.030 0446±0014
♦Normal concentration of antibody 1 -2ug/ml
Figure 5.20
6raph of peroxidase activity measured at 450nm against concentration of 
anti-tubulin antibody in ELISA 2 using sonicated infective larvae of the 
Bearsden strain of O.circumcincta.
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Figure 3.21
6raph of peroxidase activity measured at 450nm against concentration of 
anti-tubulin antibody in ELISA 2 using sonicated infective larvae of the
HFRO strain of O.circumcincta
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Table 3.27
Results of ELISA 3 using extracts from sonicated infective larvae of the 
Bearsden benzimidazole susceptible and HFRO benzimidazole resistant 
strains of O.circumcincta which were untreated or treated with ABZ for 
24h at a concentration of lug/ml or 5ug/ml.
Extract
Untreated 
Treated ( lug/ml) 
Treated (5ug/ml)
Absorbance units ± SEM at 450nm 
atubulin  B tubulin
Susceptible .Resistant Susceptible Resistant
1.427±0.016 0.918±0.066 1.474±0.007 0.626±0.010
1.435±0.035 1.086±0.037 1.340±0.024 1.047±0.014
1.690±0.143 0.887±0.053 1.779±0.012 0.794±0.008
Table 5.28
Results from ELISA 4 using sonicated adult O.circumcincta of the HFRO 
benzimidazole resistant strain. Parasites were obtained at necropsy of 
lambs used in dose titration tria l Experiment 2 and had been treated orally 
with FBZ at dose rates of 0 , 5 , 10, 20 and 40mg/kg.
Lamb Absorbance units ± SEM at 450nm
Dose FBZ (m g/kg) a  tubulin p  tubulin
0 0.167±0.004 0.206±0.014
5 0.185±0.005 0.233±0.004
10 0.238±0.009 0.249±0.003
20 0.163±0.005 0.206±0.009
40 0.151 ±0.004 0.175±0.003
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Table 3.29
Results of ELISA 5 using firs t stage larvae of O.circumcincta of the 
Bearsden and HFRO strains. Larvae were obtained from the faeces of a lamb 
infected with the Bearsden strain of O.circumcincta, Lamb DB33, which 
was infected with the HFRO strain and a lamb from dose titration tria l 
Experiment 3 after treatment of the lamb with FBZ at a dose rate of
40mg/kg.
Source of Larvae Absorbance units ± SEM at 450nm
a  tubulin B tubulin OLip
Bearsden Strain 1.412±0.010 0.959±0.024 1.472
HFRO Strain (DB33) 1.092±0.032 0.670±0.017 1.630
Dose Titration Expt.3 1.237±0.087 0.830±0.035 1.490
dose titration trial Experiment 3 after treatment of the lamb with FBZ at a dose rate of 
40mg/kg. Approximately 5,000 Lis of each strain were sonicated in an equal volume of 
buffer and aliquots were placed in wells in an ELISA plate. Results of the binding of anti-a 
tubulin and an ti-^  tubulin measured as peroxidase activity are shown in Table 3,29, In 
addition the ratio of binding of anti-atubulin to binding of a n t i- /  tubulin is shown in 
Table 3.29.
Discussion
Development of resistance by nematode parasites to the effects of benzimidazole 
anthelmintics may be due to an alteration in the binding of benzimidazoles to nematode 
tubulin (Lacey, 1985). This author used tubulin extracts from infective larvae of 
benzimidazole resistant and susceptible strains of H.contortus, O.circumcincta and 
Icoiubriform is and found reduced binding of benzimidazoles to extracts from 
benzimidazole resistant strains compared with binding to benzimidazole susceptible 
strains. This tubulin binding assay can be used to detect benzimidazole resistant strains of 
nematodes (Lacey and Snowdon, 1988) but in experiments with this assay (see 
previously) tubulin extracts from parasites with a high protein concentration were 
required and results were inconsistent when used with the HFRO benzimidazole resistant 
and Bearsden benzimidazole susceptible strains of O.circumcincta Foster etal, ( 1987) 
found that resistance to benzimidazoles exhibited by a strain of Physarum poiycephalum 
was due to a mutant form of p  tubulin.
An ELISA test fora and p  tubulin was developed in order to compare the levels of these 
protein subunits in benzimidazole resistant and susceptible strains of Ocircumcincta The 
assay was used to investigate if  there were differences in the mmnt of tubulin in the two 
strains which may be implicated In the development of resistance to m  effects of 
benzimidazDtes. Differences which may be detected using entMubulto antibodies would 
include differences in the amount of tubulin in the parasites, differences in the ratio of dr
m  p  fwiwlm or differences in the binding affinity of the antibodies to tubulin in the 
indtvitcM strains of Qcircumcmcta
In ELISA II the binding of anti-ct tubulin and anti-p  tuibulin was compared using 
tubulin extracts from infective larvae produced by homogenisation or by sonication of 
infective larvaeC Table 3.25). For both the tubulin extract and the sonicated material the 
binding of an ti-a  tubulin was reduced for larvae of the benzimidazole resistant strain 
compared with binding to the susceptible strain. There was reduced binding of an ti-^  
tubulin to sonicated material of the benzimidazole resistant strain compared with binding 
to sonicated material of the susceptible strain. However, there was no difference between 
binding of m \- p  tubulin to the tubulin extracts from the two strains of O.circumcincta
The resuts of the ELISA, using sonicated larval material were similar to results obtained 
using tubulin extracts from the same strains of larvae (Table 3.25). For the tubulin 
extracts larger numbers of larvae were required. During extraction of tubulin by 
homogenisation there may be losses of tubulin in the pellet after centrifugation and losses 
due to binding of the material to the glassware. A small sample of the pellet discarded after 
centrifugation of the homogenised larvae during the production of the tubulin extract was 
used in the ELISA and a small amount of anti-tubulin antibody bound to this pellet material 
which suggested that there was some loss of tubulin during the extraction process. When 
material from sonicated larvae was used in the ELISA the peroxidase activity was higher 
than with tubulin extracts from a significantly greater number of larvae. There may be 
more non-specific binding of anti-tubulin antibody to the sonicated material but the 
differences in binding of anti-tubulin antibodies to resistant and susceptible strains of 
0circumcmcta appeared to be consistent.
The main advantage of using sonicated larvae as the test material in the ELISA was that 
similar numbers of larvae could be sonicated to give an accurate comparison between the 
binding of anti-tubulin antibodies to benzimidazole resistant and susceptible strains of
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acfrcm cm cia When the tubulin extracts were used for the ELISA, although the same 
number of larvae were used initially, losses during homogenisation and centrifugation are 
not consistent between the preparations. Therefore the tubulin extracts had to be assessed 
for protein concentration in order to ensure that a similar concentration of extract was 
added to each ELISA well and that a true comparison of anti-tubulin antibody binding was 
being measured in the tubulin extracts. As mentioned previously the protein content of the 
tubulin extract gives an indication of the concentration of the tubulin extract but may not 
reflect the tubulin content in the extract because tubulin constitutes only 1-3$ of the 
protein content. For a direct comparison of the tubulin content of parasites it was more 
convenient to use sonicated larvae.
The ELISA was also attempted using low numbers of infective larvae which were 
sonicated. Peroxidase activity was measured with sonicated material from 100 Infective 
larvae but the difference in activity measured in the samples compared with the controls 
was small and therefore the test was more reliable with higher numbers of larvae 
( > 1,000 ).
In the ELISA the levels of binding of antl-aand p  tubulin to the larval extracts were 
compared. However the concentration of a: tubulin a n d / tubulin in the larval extracts 
could not be calculated because standard concentrations of pureatubulin and /  tubulin 
were not used in the assay. The aim of the assay was to investigate possible differences in 
the tubulin components of benzimidazole resistant and susceptible parasites and therefore 
measurement of the exact amount of tubulin in the extracts was unnecessary. The ELISA 
could be used to measure the level of tubulin in the extracts from larvae and might be 
useful in combination with tubulin binding assays. In these binding assays the amount of 
benzimidazole bound to the extract from larvae was expressed as binding per mg of protein 
in the extract but the results may be more accurate if the binding per unit of tubulin in 
the extract was measured (see previous discussion). This use of the ELISA as a
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quantitative assay for tubulin in extracts from larvae of O.circumcincta which were to be 
used in tubulin binding assays with tritiated benzimidazoles has not yet been investigated.
In ELISA 2 the effect of using increasing concentrations of anti-tubulin antibodies in the 
assays to try  to improve the final peroxidase activity was investigated. Using sonicated 
infective larvae of the benzimidazole resistant and susceptible strains of O.circumcincta 
there was increasing peroxidase activity with incubation in the presence of increasing 
concentrations of anti-tubulin antibodies (Table 3.26). At 10 times and 20 times the 
normal concentration of antibody the peroxidase activity was too great, too high an 
intensity of colour, to allow measurement in the plate reader. In order to avoid this 
problem the plate should be read at 690nm prior to the addition of sulphuric acid. After 
the reaction of peroxidase with TMB substrate the addition of sulphuric acid changes the 
colour from blue to yellow and causes a two-fold increase in the colour intensity (Bos et 
a/., 1981). The intensity of the blue colour can be measured at 690nm prior to the 
addition of sulphuric acid.
In ELISA 2 similar results were obtained with antmtubulin and anti-/? tubulin and 
the graphs (Figs. 3.20 and 3.21) of peroxidase activity at increasing concentrations of 
anti-tubulin had similar shapes for a n ti-a  tubulin and a n t i- /  tubulin. The antibody 
binding curves for ELISAs are usually sigmoidal in shape and ideally for the assay a 
concentration of antibody which corresponds to the steep portion of the curve should be 
used to maximise any differences in antibody binding. From Figs. 3.20 and 3 21 the best 
concentration of anti-tubulin antibodies for the ELISA would be 5 times the normal 
concentration (5 - lOug/ml antibody).
In ELISA 2 the binding of anti-tubulin antibodv to sonicated material from the HFRO 
strain of O.circumcincta was significantly lower than binding of anti-tubulin antibodies 
to sonicated larvae of the Bearsden strain at ail antibody concentrations except 20 times 
normal where the absorbance was too high to give an accurate Leading ( Table 3.26).
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The reduced binding of anti-tubulin antibody to material from the HFRO strain of 
O.circumcincta compared with binding to material from the Bearsden strain in ELISA 1 
and 2 mar/ be a result of changes in the affinity of the anti-tubulin antibody for the 
tubulin molecules or a reduced concentration of or and p  tubulin in parasites of the HFRO 
strain. Lacey (1985) noted a reduction in the binding of tritiated benzimidazoles to crude 
tubulin extracts from resistant strains of nematodes compared with binding to 
benzimidazole susceptible strains. These changes in binding of benzimidazoles in the 
resistant strain of parasites may be due to changes in the tertiary structure of the tubulin 
molecules which cause an alteration in the benzimidazole binding site and therefore there 
is reduced binding of benzimidazoles to the resistant parasites when compared with 
binding to the susceptible parasites. A change in the tertiary structure of the individuala 
or p  tubulin molecules or a change in the structure of the microtubules formed by these 
subunits may also cause a change in the antigenic determinant on the molecule. Any 
alteration in the antigenic determinant w ill cause a change in the binding of anti-tubulin 
antibody. Foster at a/., (1987) found changes in the p  tubulin molecule in a 
benzimidazole resistant strain of Physarumpolycephatum. No differences were detected 
by these authors in the a  tubulin molecule between benzimidazole resistant and 
susceptible strains. However, in ELlSAs 1 and 2 there were differences in the binding of 
both anti-ar tubulin and anti-/?tubulin. This may be more suggestive of an alteration in 
the overall tubulin concentration between larvae of the benzimidazole resistant and 
susceptible strains of O.circumcincta. The amount of tubulin in the larvae may be 
influenced by time of storage of the larvae. To try to eliminate differences in the time of 
development and storage which occur with infective larvae, first stage larvae were used in 
an ELISA (see later) There can be different sub-types of tubulin within a single species 
and differences in the binding of anti-tubulin antibodies m?y reflect differences in the 
tubulin sub-types found in various organelles within the parasite. These differences in
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the binding of anti-tubulin antibodies between the Bearsden and HFRO strains of 
O.circumcincta may be due to strain differences in type of tubulin present in the 
parasites and mar/ not have any relevance in dictating the level of resistance to the effects 
of benzimidazoles. Unfortunately other strains of parasites were not available to test if 
changes in the binding of anti-tubulin antibody were due to strain variation or linked with 
benzimidazole resistance.
In ELISA 3 there was no significant difference in the binding of anti-tubulin antibodies 
between larvae incubated in the presence of two concentrations of ABZ prior to sonication 
and untreated larvae (Table 3.27). Benzimidazoles are thought to act by binding to tubulin 
and preventing the formation of microtubules in nematodes (Borgers and De Nollin, 
1975). Destruction of microtubules or disruption of the equilibrium between formation 
and breakdown of microtubules by benzimidazoles may not have any effect on the overall 
concentration ofaand p  tubulin within the parasite cells. The sonication of the larvae was 
carried out on ice and therefore most of the microtubules should have disassembled to 
tubulin subunits at low temperature. The ELISA measures the ability of anti-tubulin 
antibody to bind to tubulin rather than measuring the degree of polymerisation of the 
microtubules in the larvae. There were some differences between cttubulin andp  tubulin 
levels between treated and untreated parasites of both the Bearsden and HFRO strains but 
these differences were not significant in most cases and were not consistent. As in other 
ELlSAs there were differences between the binding of anti-tubulin antibodies to sonicated 
larval extracts from the Bearsden benzimidazole susceptible strain and the HFRO resistant 
strain. However, treatment of the larvae with ABZ did not have a significant or consistent 
effect on either strain. Using treatment of the larvae with benzimidazoles prior to an 
ELISA for tubulin concentration was therefore not a suitable test to detect resistance to
benzimidazole in larvae of O.circumcincta
Adult O.circumcincta of the HFRO strain were obtained from lambs at necropsy in the
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dose titration trial Experiment 2 after treatment of the lambs with FBZ administered 
orally at dose rates of 0, 5, 10,20 and 40 mg/kg. Unfortunately adult O.circumcincta are 
not readily available because they are obtained at slaughter from the abomasum of the 
lambs. A lamb infected with the Bearsden susceptible strain of O.circumcincta was not 
available to allow a comparison of binding of anti-tubulin antibodies between the resistant 
and susceptible adult O.circumcincta. There were slight differences in the peroxidase 
activity measured in the ELISA for tubulin with the adult O.circumcincta which had been 
exposed to different concentrations of FBZ (Table 3.28). The adults exposed to lOmg/kg 
showed the highest binding of anti- a  tubulin and an ti-^  tubulin but there were no 
significant differences in the binding of anti-tubulin antibodies among the selected adult 
parasites. Egg hatch assays carried out on the progeny of these differentially selected adult 
O.circumcincta showed similar ED50s for TBZ and ABZ (see previously). This ELISA gave 
an indication of the concentration of a  and p  tubulin in the adult parasites and the 
similarity in the levels of tubulin in the parasites suggested that there was a high level of 
homogeneity in the population. The ELISA was carried out using specific numbers of maie 
and female worms to ensure that any differences detected in the binding of anti-tubulin 
antibodies would not be due to the possibly higher level of tubulin in female parasites 
which contain eggs.
First stage larvae were used in ELISA 5 to try to ensure that parasites of the Bearsden 
and HFRO strain were at exactly the same stage of development and had been produced 
under the same conditions to try to minimise possible environmental factors which could 
influence the level of tubulin in the parasites. With first stage larvae there was increased 
binding of anti-tubulin antibodies to sonicated larval extracts from the susceptible strain 
compared with sonicated extracts from the HFRO benzimidazole resistant strain of 
O.circumcincta(Table 3.29). The first stage larvae cultured from eggs passed by female 
O.circumcincta after treatment of the host with FBZ at 40mg/kg showed binding of
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anti-tubulin antibodies higher than the first stage larvae cultured from eggs of untreated 
adult parasites but lower than binding of anti-tubulin antibodies to first stage larvae of 
the susceptible strain. All the larvae were produced under the same conditions therefore 
differences in the level ofaandp  tubulin should not be due to environmental influences. 
These differences in the binding of anti-tubulin antibodies may indicate small differences 
in the amount of tubulin in different strains or groups of parasites. The ratio ofatubulin 
top  tubulin in the first stage larvae was similar in all cases (Table 3.29) and resembled 
the ratio obtained in ELISA 1 using sonicated infective larvae ( Table 3.25).
Overall in the ELISAs there was a lower level of binding of anti-tubulin antibodies to 
the HFRO resistant strain of O.circumcincta compared with binding to the Bearsden 
strain. These results suggested that the tubulin concentration in resistant parasites was 
not increased compared with benzimidazole susceptible parasites. Therefore an increase in 
the amount of available tubulin in resistant parasites was not the mechanism by which 
these strains of parasites could resist the effects of benzimidazoles. There may be changes 
in the tertiary structure of the microtubules or tubulin subunits which could result in 
decreased binding of anti-tubulin antibodies because of a change in the structure of the 
antigenic determinant. Alternatively, the microtubules which form in the resistant 
nematodes may be more stable than microtubules in susceptible parasites and are 
therefore less liable to disassemble at low temperatures, during sonication, during 
tubulin extraction and under the influence of benzimidazoles. This may explain the reduced 
concentrations of available a  tubulin andp  tubulin which were measured in resistant 
parasites during ELISAs.
There may be differences in the ability of sonicated material from the two strains of 
O.circumcincta to bind to the ELISA plate. Most protein molecules bind to plastic and it 
was assumed that the extracts from parasites would act in ? similar way and bind to the 
plate in a consistent manner. A method to eliminate this possible problem would be to bind
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anti-tubulin antibody onto the plate surface. The antigen, sonicated larvae or tubulin 
extract, could be added followed by anti-tubulin antibody, then peroxidase linked antibody. 
This method would add another layer to the sandwich ELISA. The main problem with this 
technique is that the anti-tubulin antibody added to the plate and the anti-tubulin antibody 
added after the antigen must be raised in different species. This is to prevent cross 
reaction on addition of the peroxidase labelled antibody.
In these ELISAs and the protein blotting experiment (see previously) monoclonal 
anti-tubulin antibodies produced against mammalian tubulin bound to nematode tubulin 
derived from all stages of the parasites. This underlines the amount of conservation of the 
tubulin molecule throughout the evolutionary process ( Dales, 1972).
General Discussion and Conclusions 
These ELISAs showed differences in the binding of anti-atubulin and anti-,# tubulin 
antibodies to parasites of different strains of O.circumcincta. However, there were no 
consistent differences in the anti-tubulin antibody binding between parasites treated with 
benzimidazoles or untreated. Similar results were obtained when first stage and infective 
larvae of O.circumcincta were used in the assays. The differences in binding of 
anti-tubulin antibodies may reflect differences in the affinity of the antibodies for tubulin 
or differences in the concentration of tubulin in the two strains of O.circumcincta There 
were differences between the HFRO benzimidazole resistant strain of O.circumcincta and 
the Bearsden benzimidazole susceptible strain detected using the ELISA for tubulin 
However, this test is not suitable for detecting resistance to benzimidazoles in nematode 
parasites because there is insufficient evidence on the exact biochemical mechanism of 
action of the benzimidazole anthelmintics including the role of tubulin and the possible 
changes in the tubulin molecule responsible for resistance to the effects of benzimidazoles.
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SUMMARY
A possible mode of action of the benzimidazole group of anthelmintics is binding to 
nematode tubulin causing depletion of microtubular structures with disruption of cellular 
transport systems. Tubulin was extracted from the pig intestinal nematode Ascar/ssuum 
and the sheep nematodes 0. circumcinctdand Haemonchus contortus The benzimidazoles 
albendazole and mebendazole were shown to inhibit the binding of colchicine to tubulin 
extracts from A sum  Tritiated albendazole, fenbendazole and mebendazole were 
synthesised and were used to study the binding of these drugs to tubulin extracts from 
A.suum, O.circumcincta and Hcontortus Binding of these benzimidazoles was variable and 
was influenced by the protein content of the tubulin extract. High concentrations of 
tritiated benzimidazoles bound to extracts synthesised using low numbers (< 100,000 ) of 
infective larvae of O.circumcincta and Hcontortus
The differential binding of tritiated benzimidazoles to tubulin extracts from nematodes 
as a test for resistance in these parasites to the effects of benzimidazole anthelmintics was 
investigated using tritiated fenbendazole, albendazole and mebendazole. Extracts from 
Hcontortus larvae which were resistant to the benzimidazoles bound less mebendazole and 
albendazole than extracts from benzimidazole susceptible larvae. With tubulin extracts 
from different strains of OcircumcinctarzsuMs were more variable and depended on the 
ligand used in the assays.
Displacement of albendazole binding to tubulin extracts from Hcontortus by 
albendazole and its metabolites , albendazole sulphoxide and albendazole sulphone, was 
found with albendazole proving to be the most potent inhibitor. However, in assays using 
O.circumcincta tubulin extracts albendazole, albendazole sulphoxide, albendazole 
sulphone and colchicine failed to inhibit, consistently the binding of tritiated albendazole.
An ELISA to measure binding of anti-alpha and anti-beta tubulin antibodies to extracts 
from O.circumcincta larvae found reduced binding of both antibodies to extracts from
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first stage and third stage larvae of the benzimidazole resistant strain compared with 
similar extracts from the benzimidazole susceptible strain. Treatment of the larvae with 
benzimidazoles prior to the ELISA for tubulin did not alter the antibofy binding to extracts 
from both the resistant and susceptible strains of O.circumcincta
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